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Abstract V 
LONGITUDINAL CHANGES IN BODY COMPOSITION WITH 
ADVANCING PREGNANCY AND THE RELATIONSHIP OF MATERNAL 
FAT DEPOSITION TO FETAL GROWTH 
A thesis submitted to the Faculty of Medicine for the Degree of 
Doctor of Philosophy 
by 
HORA SOLTANI-KARBASCHI, B Sc, RM, M Med Sei 
Obesity has long been recognised as a risk factor for the development of variety of life 
threatening diseases; examples include diabetes mellitus and cardio vascular disease. 
In particular, in young women, it is widely thought to predispose towards impaired 
glucose tolerance and gestational diabetes. Obesity is not only common but it is 
increasing in prevalence despite the efforts made by individuals and their health 
advisors to avoid it. 
Identification of factors contributing to obesity could be useful in planning 
preventative policies. 
Many women relate the onset of their obesity to one or more of their pregnancies. We 
now know that there is more to obesity than the actual amount of excess weight. The 
adverse metabolic effects of obesity are proved to be greater when excess fat 
deposition is central rather than peripheral. The idea that fat deposition may be 
directed to different body sites with different effects on glucose tolerance and insulin 
levels, is a relatively new concept. 
The majority of investigators have focused only on the magnitude of weight changes 
during pregnancy and postpartum. There is not much information with regard to the 
ýV 
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compartmental changes in body composition during and after delivery. Most studies 
in the developed world show maternal net fat gain accompanying pregnancy. The 
extent to which such fat gain is physiological, and what is its beneficial effects is 
unknown. It is therefore important to study the impact of other factors with possible 
effects on fetal growth and maternal body composition. The present work examines 
further the question of fat storage by means of a longitudinal study to establish 
changes in body fat content during normal pregnancy and postpartum and also its 
relationship to maternal glucose tolerance, fetal metabolism, new-born anthropometry 
and infant growth. 
For this purpose, 123 women were recruited at their first visit to Antenatal Clinics of 
the Northern General Hospital, from which 73 completed 3 visits during pregnancy 
and 46 participated in the whole course of the study. Maternal anthropometry and 
body composition were measured at 13 (5 - 15), 24 (23 - 32) and 36 (34 - 41) weeks 
gestation during pregnancy and also 6 weeks and 6 months postpartum. Skinfold 
thickness measurements and Bio-electrical Impedance were used to assess the changes 
in body composition during pregnancy and postpartum. 
Glucose tolerance tests were performed at 28-31 weeks gestation. Insulin and/or C- 
peptide levels were also collected at birth and assessed later. Infant anthropometry 
(weight, length and head circumference) were measured at birth, 6 weeks and 6 
months postpartum. 
The subjects were divided into four groups of under-weight, normal weight, over- 
weight and obese, based on their early pregnancy BMI. The statistical analyses were 
performed on the whole group and also the groups were then compared for the above 
mentioned variables. 
The two methods (Skinfold thickness measurements and Bio-electrical Impedance) 
showed a reasonable agreement in predicting the fat changes during pregnancy. A 
considerable variation was observed, however, between the two methods in the results 
of changes from early pregnancy to postpartum. Therefore, direct interpretation of 
skinfold thickness (which was consistent with the converted version of it to fat mass) 
was alone chosen to derive the conclusions. 
VII 
During pregnancy, a formula which is corrected for hydration changes during 
gestation, was used to convert skinfold thicknesses to fat mass. The results confirmed 
that a substantial net gain of fat was made during pregnancy of which a significant 
amount was still retained at 6 month postpartum. Maternal weight increased (10.87 
kg ± 4.67), but it reverted to the early pregnancy values by 6 months postpartum. The 
rate of fat and weight changes was significantly higher in the first half of pregnancy 
compared to later. The observed changes in maternal weight and fat mass, during 
pregnancy were not significantly different between the BMI groups (normal weight, 
over-weight and obese group). At the postpartum period, the obese group retained 
more of the net fat gain than the other two groups. A state of redistribution of fat 
tissue was observed in the subjects in particular in the obese group who had a 
tendency towards central fat retention. 
Gestational fat gain was not directly related to infant birth weight. In this well 
nourished population, maternal early pregnancy lean body mass (LBM) was the most 
significant predictor of infant birth weight. 
There was a positive correlation between maternal BMI and cord insulin (r=0.44, 
p=0.002) and/or C-peptide (r=0.33, p=0.008). In addition higher levels of insulin 
were observed in large for gestational age (LGA) babies in comparison with the 
average for gestational age (AGA) babies. These observations might have an 
important impact on the care of overweight women. It may be that reduction of 
maternal BMI in the prepregnancy period in the obese women would reduce the risk 
of gestational diabetes and also the rate of fetal hyperinsulinemia and macrosomia. 
Further investigation on this hypothesis is needed. 
In summary; obese women had significantly heavier babies than the normal weight 
women. Maternal fasting glucose was significantly correlated to infant birth weight. 
On the other hand, maternal fasting glucose and the level of fetal insulinisation was 
significantly associated with maternal early pregnancy BMI. This is likely to be a 
metabolic effect operating throughout gestation. What we can suggest is that , in the 
studies of maternal glucose metabolism and fetal growth, the confounding effects of 
maternal BMI should be seriously considered. 
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Chapter 1 
Introduction and 
background to the studies 
During pregnancy, the maternal body undergoes tremendous changes. Some of these 
changes are visible and easily detectable, whereas some others are more complicated and 
require more sophisticated methods to be appreciated. The morphologic, physiologic and 
metabolic changes occurring during pregnancy are presumed to facilitate fetal growth and 
development. 
As it has been suggested by Knopp et al. (1981), fetus does not act solely as a parasite to 
drain the fuels from the mother. He believed that as well as the "fetal pull" in respect to 
nutrient flow, across the placenta, there is a "maternal push" through some physiologic 
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and metabolic adaptation. Some of these adaptations can be understood by longitudinal 
studies of weight changes during pregnancy. Body composition measurements, however, 
would give a more detailed insight to this matter. 
Studies on fat deposition during pregnancy, have produced various results. The majority 
of the studies suggest that a considerable portion of weight gain is body fat mass (Taggart 
et al. 1967, Van Raaij et al. 1987, Forsum et al. 1988). Eighty five percent of energy cost 
of pregnancy was accounted for fat gain (Hytten 1991). Hytten et al. (1966) found that 
maternal fat stores reach a maximum in the mid second trimester. Fat deposition 
thereafter remained constant or even diminished in the third trimester, in average weight 
women. This is concurrent with a physiologic state of reduced insulin sensitivity in late 
pregnancy which would leave glucose available for the use of the fetus. This sequence of 
events seem to benefit fetal growth, since its maximum growth is in the third trimester. 
It has already been shown that maternal weight gain is positively correlated with infant 
birth weight (Eastman and Jackson 1968) but which component of weight gain has the 
closest association with intrauterine growth is still to be investigated. The data from 
Gambian studies indicates that poorly nourished women store less fat than do well- 
nourished women, they also deliver smaller babies (Lawrence et al. 1987). The literature 
is not consistent in the matter of the relationship between fetal growth and fat retention 
during pregnancy in well nourished Western women. 
In the postpartum period, knowledge of the magnitude of fat mobilisation could have an 
important practical impact on maternal well-being. It may help to understand the relation 
of maternal gestational fat gain/retention to consequent development of obesity. The 
I. 
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present study was designed to examine further the question of fat storage by means of a 
longitudinal study to establish the pattern of anthropometry and body composition 
changes during gestation. It was also aimed to investigate the relationship of the above 
mentioned factors with maternal glucose tolerance, fetal metabolism, newborn 
anthropometry and infant growth. This section commences with illustrations of 
terminology, methodology of body composition measurements, and their application to 
gestational period. 
Human body composition 
A complete chemical analysis of the human is a formidable task which has been carried 
out on a number of occasions, but not sufficiently often to give the range of variations in 
people of different age and sex and in different stages of life cycle. Chemical analyses on 
small animals have been made, but the results do not necessarily apply to the human. 
However, for more than a century, it has been known that the human body contains many 
of the elements of the earth, twenty five of which appear to be essential for normal 
physiological functioning. About 4-6 percent of the human body is composed of 
minerals, primarily calcium and phosphorus in the bones, but also including others such 
as iron, potassium, sodium, chloride, and magnesium. The vast majority of the human 
body consists of four elements; carbon, hydrogen, oxygen and nitrogen. These elements 
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are the structural basis for body proteins, carbohydrate, fat and water. For practical 
purposes, the human body is divided into two, three, four, or five compartments. The 
terminology and the background of each model of body composition will be described. 
Terminology and current knowledge on human body composition 
Fat and fat free mass are two terms used in scientific literature relating to body 
composition. The total amount of fat in the body consists of both essential and storage 
fat. Essential fat is necessary in certain body structures such as the brain, nerve tissue, 
bone marrow, heart, and cell membranes. Essential fat in adult males represents about 3 
percent of the body weight. Adult females also have additional essential fat associated 
with their reproductive process. This additional 9-12% of sex specific fat gives them a 
total of 12-15% essential fat. Storage fat is simply a depot for excess energy and the 
quantity of body fat in this form may vary considerably. Some storage fat is found around 
body organs for protection, but over 50% of total body fat is found just under the skin and 
is known as subcutaneous fat. 
Fat free mass primarily consists of protein and water, with smaller amounts of minerals 
and glycogen. The tissue of the skeletal muscles is the main component of fat free mass, 
but the heart, liver, kidneys, and other organs are included also. Another term that is 
often used interchangeably with fat free mass, is lean body mass (LBM). However, LBM 
is slightly different from fat free mass because the fat in the cell membranes is excluded 
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from FFM, but is retained in LBM due to the anatomical proximity of this small amount 
of fat to lean tissues (Roubenoff and Kenaylas 1991). Total body water (TBW) overlaps 
with LBM, but these two compartments differ in that the TBW does not include 
extracellular connective tissues or intracellular non water structures. Total body water 
forms a fairly constant proportion of LBM of about 73% (Behnke 1961, Pace and 
Rathbun 1945). The common terms to describe body composition are summarised in a 
review by Jensen (1992) of research techniques for body composition measurements. 
These are presented in table 1.1. 
Table 1.1. Body composition terms (Jensen 1992) 
Term Explanation 
Body fat mass Quantity of triglyceride fat in the body 
Adipose tissue mass Fat (-83%) plus its supporting cellular and extracellular 
structures (consisting of --2% protein and -15% water) 
Lean body mass Nonadipose tissue body mass 
Fat free mass Lean body mass plus non-fat components of adipose tissue 
Body cell mass Cellular components of the body 
Extracellular Solids (ECS) Total body bone mineral (skeleton, -85% of ECS) + fascia, 
cartilage, etc. (-15% of ECS ) 
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Background to the physiological studies of human body composition 
Although an interest in human body composition can be traced to the late 1800s, research 
to establish indirect measurements of body composition began during the 1940's. In fact 
attempts to assess body fat content from density arose as a result of a practical problem. 
Some men on a draft for recruitment into the US navy were marked unfit for the service 
by a medical board because their weight exceeded the maximum permissible for their 
heights. As these men were professional footballers in their civilian life, it seemed 
unlikely that they were unfit for their naval service because of obesity. A US naval 
surgeon, Behnke et al. (1942) examined the men. They were weighed in air and under 
water. Their density was calculated and found in some cases to be as high as 1.090 to 
1.097, indicating a fat content of 4 percent or less. From this it was concluded that the 
excess weight was mainly due to extra muscle and not fat. Since that time a variety of 
methods based on different assumptions of body composition have been introduced, 
which are discussed below. 
Two-component model of body composition 
It was through the pioneering efforts of Behnke and his co-workers that the first truly 
noninvasive in vivo technique of measuring body composition was developed. They 
actually established the first two-compartment model of body composition: 
"Wt = Fat + Non-fat (or lean mass)" 
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where the densities of the fat and lean compartments are assumed constant. Behnke et al. 
(1942) reasoned that if whole body volume or density could be measured and if the body 
could be considered as only two compartments, each with constant but different densities, 
then the proportional masses of each component could be calculated. This model is still 
used by many investigators, mainly because of the advantage of simplicity. The non- 
invasive technique developed by Behnke et al. has often been referred to as the "reference 
method". Many of the methods developed since then have been evaluated or calibrated 
against the original densitometric technique, thus elevating it to a "standard" by some 
investigators. Virtually all of the equations based on anthropometric measurements, for 
example, have relied directly or indirectly on estimates of body fat that use underwater 
densitometry as their absolute measure or "standard, " independent of possible density 
changes in the lean tissue related to sex, race, age or special circumstances like pregnancy 
and disease. Over the last few decades, however, investigators have developed newer 
procedures, both direct and indirect, and have recognised differences in density of the 
various subcomponents of the non-fat or lean tissues in the body. These observations 
have led to multicompartmental models of body composition. 
Multicompartmental models of body composition 
The chemical analysis of human cadavers reported by Forbes and Lewis (1956), 
Widdowson and co-workers (1951,1964) indicated that lean body mass (LBM) had a 
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relatively constant composition, at least for its water and potassium content. This 
observation stimulated the development of water and potassium measurements in vivo as 
indices of fat free mass. The conceptualisation of a metabolically active component of 
lean tissue mass, called the body cell mass (BCM), was then introduced by Moore et al. 
(1963). He believed that the human body can be divided to three compartments: 
"Man = CM + EST + Fat" 
CM is the cell mass which is the active tissue, carrying out all the work of the body. 
EST is the extracellular supporting tissue which supports the cell mass. This again can be 
subdivided into two parts: the extracellular fluid, and minerals and protein fibres in the 
skeleton and other supporting tissue. The extracellular fluid comprises the blood plasma 
and lymph and fluid which bathes the cells. The advantage of this model was that BCM 
could be calculated directly from total body potassium (TBK) measurements and 
extracellular fluid volume could be calculated by bromide dilution. Alternatively, many 
investigations continue to assume, on the basis of the initial cadaver studies of Forbes et 
al. (1961) that the TBK/LBM ratio is a constant for adults. 
During the derivation of the two compartment model, Keys and Brozek (1953) divided 
the mammalian body into four chemical groups; water, protein, ash or bone mineral, and 
fat. Anderson (1963) later used measurements of body potassium and water to estimate 
these components. Only recently has technology been available that allows for the in vivo 
determination of these four compositional variables. 
The current model of body composition, and the most informative, consists of five major 
compartments (Halliday and Miller 1977, Lukaski and Johnson 1985): 
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"Weight = protein + Water + Minerals + Glycogen + Fat" 
Although this five-compartment model is traceable to the chemical data obtained from 
human cadaver analyses, the recent development of in vivo elemental analyses has made 
it more practical (Schoeller et al. 1980). No single measurement technique, however, has 
the capacity to provide such a detailed resolution of body composition at this time. Body 
glycogen stores, for example, are usually assumed to be approximately 0.6% by total 
weight of fat free mass (FFM) of the body. 
The two and multicompartmental models served as the basis upon which all body 
composition methods were developed. The two compartment model, however, continues 
to have the widest acceptance and application, mainly because of the simplicity of its 
interpretation. 
9 
Methodology of body composition measurements 
In this section, some of the theoretical and practical aspects of the methods of body 
composition measurements will be discussed. These methods are summarised as a 
practical guide in a review by Jeb and Elia (1993). They described the techniques under 
two groups of reference body composition methods (densitometry, total body water, total 
body potassium, in vivo neutron activation analysis, dual energy x-ray absorptiometry, 
computed tomography and magnetic resonance scanning) and bedside or field techniques 
(anthropometry, bioelectrical impedance analysis, infrared interactance, and urinary 
metabolic excretion). Field techniques are derived from a statistical comparison with 
measurements from the reference methods. Thus they are less direct and produce less 
accurate results than the reference methods, but practically they are more accessible and 
subject friendly than the reference methods. 
Reference methods: 
Densitometry 
The assessment of human body composition by measurement of whole body density is a 
common method used for normal healthy people. This method is based on the two 
compartmental model, in which the density of the fat and fat-free mass is known and 
constant. 
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Density is measured as the mass of the body in air divided by the volume of body tissues, 
and in body composition analysis is usually expressed as grams per millilitre (g/ml) or 
grams per cubic centimetre (g/cc3). The standard for the comparison is water, which has 
a density of 1 g/ml. Corresponding densities for the fat and fat free tissue are considered 
to be 0.9 and 1.1 subsequently (Brozek et al. 1963, Mendez et al. 1960). The density of the 
human body as a whole may have a wide range, approximately 1.02 to 1.10. 
The most widely used technique of measuring whole body density is the determination of 
the body volume according to Archimedes' principle, which states that the volume of an 
object submerged in water equals the volume of water the object displaced. If one 
measures mass in air and mass in water, the difference, corrected for the density of the 
water corresponding to the water temperature at the time of underwater weighing, is the 
apparent body volume. With this technique it is mandatory to determine the lung volume 
during submersion (residual lung volume) which makes a sizeable (1-2 L) contribution in 
the estimate of total body volume. A second volume, gastrointestinal gas, is considerably 
smaller in magnitude and is never measured (Buskirk 1961). It is however assumed to be 
-100 ml, based on previous radiological studies. Because the intra-individual variability 
in gastrointestinal gas volume can be quite large (50-300mL), this variable can 
compromise the precision of the densitometric method (Bedell et al. 1956). An 
alternative way of measuring volume, is to use a form of body volumeter in which the 
volume of the water displaced is measured directly using a tilted burette attached to the 
side of the tank of water that the subject is submerged in. As weight is generally more 
accurately recorded than volume, the under water weighing is more acceptable. 
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A common equation for the calculation of percent body fat (%F) from body density (Db) 
is that proposed by the Brozek et al. (1963): "%F = (4.570 / Db) - 4.142". Another 
equation was developed by Siri (1956): "%F = 4.950 / Db) - 4.50". Within densities of 
1.10-1.03, the two equations give results within 1% body fat. For subjects with more than 
30% fat, the Siri equation yields higher values than the equation of Brozek (Lohman 
1981). Very useful body compositional data can be gained from the hydrodensitometric 
technique. However, its use in populations unaccustomed to swimming or apprehensive 
about submersion in water may result in longer periods of time required to densitize the 
subjects to obtain valid and reproducible body composition estimates. This technique 
requires a great deal of cooperation from the study subject and is relatively expensive. 
Total body water 
The findings that water is not present in stored triglyceride and that water occupies a 
relatively fixed fraction (73.2%) of the fat free mass (Pace and Rathburn 1945) have 
stimulated the determination of total body water (TBW) as an index of human body 
composition: 
"FFM (kg) = TBW (kg)/ 0.732" 
The isotope dilution technique has been used to estimate TBW. Some general 
assumptions of the isotope dilution technique are that the isotope has the same 
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distribution volume as water, it is exchanged by the body in a manner similar to water, 
and it is nontoxic in the amounts used (Pinson 1952). 
In this technique the known tracers which nowadays are stable, non-radioactive isotopes 
of water containing deuterium or 18-oxygen have been used to estimate TBW. Tritium is 
commonly used since the analysis is rapid, cheap and simple to perform, although since it 
is radioactive, it is not the method of choice, particularly for children and women of 
childbearing age. 
In practice the subject must receive a precisely known amount of the tracer, orally or 
intravenously. After equilibration, the tracer is measured in a sample of a body fluid; 
plasma, urine or saliva. 
Implementation of this technique is difficult outside of a specialised research laboratory 
and it is also time consuming and rather expensive. 
Total body Potassium 
Potassium is the major intracellular cation in lean tissue but it is virtually absent in 
adipose tissue, therefore, knowledge of total body potassium permits estimation of lean 
body mass (Jensen 1992). A small percentage of all potassium is the naturally occurring 
radioactive isotope 40K. Sufficiently sensitive detectors surrounded by adequate shielding 
can detect the decay of body 40K. Comparing this radioactivity to known amounts of 
potassium permits calculation of total body potassium and thus lean body mass (Garrow 
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1982). Alternatively, 42K can be administered to a subject and the radioactivity can be 
measured by methods that do not require extensive shielding and sensitive detectors 
(Pierson et al. 1984). 
Once total body potassium (TBK) is determined , LBM could be estimated with a factor 
dependant upon the potassium content of the LBM. 
LBM = TB K/concentration of K per kg of LBM 
The potassium content. of the lean tissue is often taken as 60 mmol/kg for females and 66 
mmol/kg for males (Forbes et al. 1961, Pierson et al. 1974). 
The accuracy of measuring body potassium is good and its precision depends on the 
efficiency and the duration of counting. One of the major drawbacks to TBK 
measurements is the influence of body size and geometry on the measured counts. 
Adipose tissue exerts a shielding effect and fewer counts can be recorded in a obese 
subject compared to lean individual for a similar amount of potassium. 
Although absolute measurements of TBK can be obtained with the use of highly 
sophisticated equipment, the cost of instrumentation and technical support, may be 
prohibitive for some research applications. 
Dual energy X-ray absorptiometry 
Dual energy X-ray absorptiometry (DEXA) was originally used to assess bone density. It 
works based on scanning the body with photons at two different energy levels. The 
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differential absorption of the photons is then measured and from this, it calculates both 
bone mineral and soft tissue. It subsequently divides the latter into fat and fat free soft 
tissue. The data may be analysed to yield information about the composition of the whole 
body or individual segments, e. g. limbs or abdominal regions. 
The method requires patients to lie on a table while they are scanned. The time taken 
varies depending on the machine employed, but it does not exceed 20 minutes for a 
single whole body composition analysis. The coefficient of variation of fat free tissue 
measurements is approximately 2%, which is acceptably precise. The accuracy of DEXA 
appears to be excellent in comparison with other techniques (Mazess et al. 1990). One of 
the limiting factors for the use of this machine, is the size of the scanning area which is 
too small for very obese or tall people. The radiation exposure, makes this technique 
unsuitable for children or pregnant women. 
In vivo neutron activation analysis 
In vivo neutron activation analysis (IVNAA) involves irradiating an individual with 
neutrons to change some of the body's nitrogen, chloride, and calcium to radioactive 
isotopes. The isotopes revert to a stable condition by the emission of energy which can 
be measured. It is possible then to calculate total body nitrogen (a major indicator of lean 
body mass), body chloride, and body calcium (Cohn et al. 1985). 
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IVNAA is probably the ultimate multi-compartment model, allowing, elemental analysis 
of the body. However, of the techniques mentioned, this is the most restricted since it is 
available in only a few centres world-wide. Because of the high radiation, it is also 
unsuitable for pregnant women and children. 
Imaging techniques 
These techniques provide a visual image of adipose tissue and non-fat tissue with whole 
body scans, but the level of precision for the whole body measurements is generally 
worse than those can be obtained by the other means (e. g. UWW and DEXA). 
However, such techniques offer a uniquely direct approach to the estimation of a 
particular body compartment. They have the advantage over other body composition 
methods in being able to assess the size of the individual organs or tissues, as well as 
providing information about adipose tissue or muscle and its distribution at particular site 
of the body. The disadvantages are that they are expensive, time consuming and in the 
case of X-ray or computerised tomography (CT) scans, they involve a radiation dose to 
the subject. Therefore, they are not recommended for pregnant women or children. They 
are also complex and need professional assistance to perform. Access to such equipment 
is often limited. 
CT scanning. Computerised tomography is based on irradiation of the body with X-rays. 
Depending on the density of the tissues, a signal would be reflected to the detector. The 
maximum signal is received when there is no tissue between the X-ray source and the 
16 
detector. The image is constructed from differences in the physical density of tissues. 
High image contrasts can be observed between different body compartments (bone, fat 
free tissue, adipose tissue and air which appear as grey shading), ranging from black to 
white for high to low densities, respectively (Foster et al. 1988). 
Magnetic resonance. This approach is based on the fact that atomic nuclei, made up 
principally of neutrons and protons, can behave like magnets. When a radiofrequency 
wave is applied to the body, some nuclei absorb energy and align themselves in the 
direction of magnetic field. When the radio wave is turned off, the nuclei return back to 
their original position, releasing the energy that they had earlier absorbed. This emission 
of energy can be detected and from its frequency and intensity images of tissues can be 
constructed. 
MRI is safe and needs minimal cooperation from the subjects. The procedure is however, 
slow and expensive. There is limited experience of its use in pregnancy. 
Field techniques: 
Anthropometry 
Simple measurements of body weight, height and subsequently body mass index (BMI), 
are of great use in nutritional assessment, but they hardly give any information about 
body composition. BMI which is weight divided by a power of height, usually (height)2, 
has found to be useful in evaluating groups of people. Individuals with high indices are 
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classified as overweight, even obese, and those with subnormal indices as 
undernourished. BMI is not however, an accurate index of body composition. This is 
evident from the fact that despite the well demonstrated difference in body fat mass the 
average BMI is about the same for both sexes during the adolescent and young adult 
years. 
Measurements of skinfold thicknesses and body circumferences have been used for 
decades as rapid, inexpensive methods of estimating body fat content and its distribution 
(Deurenberg 1992). 
Skinfold thicknesses. This method is probably the most widely-used technique for 
estimating fat mass. The assumption behind this approach is that the majority of the body 
fat resides in the subcutaneous regions and that there is a fairly consistent relationship 
between subcutaneous and visceral fat. The measurement is made by grasping the skin 
and adjacent subcutaneous tissue between the thumb and forefinger, shaking it gently to 
exclude underlying muscle, and pulling it away from the body just far enough to allow the 
jaws of the calliper to impinge on the skin. The callipers exert a standardised pressure on 
the measurement site. Duplicate readings are made at each site to improve the accuracy 
and the reproducibility of the measurements. Subcutaneous fat fold measured at one or 
more sites can then be interpreted using previously validated equations into an estimate of 
fat mass. In the UK, the equations of Durnin and Womersley. (1974) are probably the 
most widely used for adults, based on measurements made at four sites - triceps, biceps, 
subscapular and suprailiac. A logarithmic transformation of the sum of four skinfold 
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thicknesses produces a linear relationship with body density which is age and sex 
specific. Fat mass is then calculated using the equation of Siri (1956) or others. 
The suprailiac, subscapular, triceps, and thigh skinfolds appear to be particularly 
important in predicting total body fat in women. The selection of the site and the 
technique of the measurement can lead to substantial inter observer variation, but 
performed by a single observer the method can yield extremely reproducible results 
(Fuller et al. 1991). For longitudinal studies the measurements should ideally be made by 
a single observer. The absolute accuracy is difficult to establish and will vary with the 
prediction equation. 
Body circumferences. The measurements of body circumferences do not give information 
on body composition, but they are useful indices in the assessment of the changes over a 
period of time or inter-individual differences. Some measures such as waist and hip 
circumferences are valuable in fat distribution determination, and have been used as risk 
indices for disease. Arm circumferences, particularly in association with triceps skinfold 
thickness, have been used to estimate mid-arm muscle circumference as an indicator of 
protein energy malnutrition. 
A tape which does not stretch and is sufficiently long to cover the entire circumference, is 
required to measure any circumference. What should be carefully defined is the site of 
measurement which is usually chosen with respect to anatomical landmarks. The 
position of the subject, whether supine or standing, can have major effect on the 
measurement at some sites and should be controlled. The WHO (1988) standards for 
waist and hip circumferences are based on measurements made in the standing position. 
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Infrared interactance 
Infrared interactance, a relatively recent technique, is based upon the principle of light 
absorption and reflection using near infra-red spectroscopy. When electromagnetic 
radiation strikes a material, the energy is reflected, absorbed or transmitted depending on 
the scattering and absorption properties of the sample. Energy transmitted into the 
sample is scattered and reflected back out of the sample. The pattern of reflection gives 
information about the chemical composition of the sample. For estimation of human 
body composition, a computerised spectrophotometer is used with a single, rapid 
scanning monochromator and fibre optic probe. The probe emits electromagnetic 
radiation from the monochromator to a selected site on the body, collects interactive 
energy, which is the combination of reflected and scattered energy, and conducts it to the 
detector. The signal penetrates the underlying tissue to a depth of 1 cm and the 
composition is assessed only at the examined site. It would seem unlikely that one could 
validly extrapolate compositional data from a limited (1 cm depth) subcutaneous depot to 
the entire body and expect consistent and valid results. 
Urinary metabolite excretion (Creatinine) 
As a result of nitrogen metabolism, mainly in skeletal muscle, creatinine would be formed 
from two precursors; creatinine and creatine phosphate. Therefore, 24 hour 
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measurements of excreted creatinine by an individual could be used in order to assess the 
muscle mass (Heymsfield et al. 1983). Although the correlation of the excretion rate with 
lean body mass is reasonable, the need for restricted diets, the high variability, and the 
practical difficulties of urine collection severly limits the ability of this technique to be 
used as a body composition measurement or as measure of changes in lean body mass. 
Bioelectrical impedance Analysis (BIA) 
This method is based upon the nature of the conduction of an applied electrical current in 
an organism. In biological structures application of a constant, low-level alternating 
current produces an impedance to the spread of a current that is frequency dependent. 
The living organism contains intra- and extracellular fluids that behave as electrical 
conductors and cell membranes that act as imperfect reactive elements. At low 
frequencies (-4 KHz) the current mainly passes through the extracellular fluids while at 
higher frequencies (500-800 KHz) it penetrates the intra- and extracellular fluids (Nyboer 
1970,1972). 
Electrical conduction is related to the water and electrolyte distribution in the biological 
conductor. The hypothetical relationship between impedance and electrical volume was 
proposed by Nyboer et al. (1943), who demonstrated that electrically determined 
biological volumes were related inversely to impedance (Z). Assuming that body has the 
simple geometric shape of a cylinder, the theoretical relation between body water and 
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impedance is of the form of. TBW=p x H2 /Z, where TBW is total body water, p is the 
resistance of the body fluid, H is the body height and Z is the measured impedance value 
(Lukaski et al. 1985). Although there are difficulties in applying this general principle in 
a system with as complex geometry and bioelectrical characteristics as the human body, 
this relationship has been used to derive models for the prediction of human body 
composition (Thomasett 1962, Hoffer et al. 1969, Lukaski et al. 1985) by assuming that 
the body is a series of connected cylinders. Using densitometric data but lacking accurate 
residual volume measurements, Nyboer et al. (1983) developed preliminary statistical 
relationships between conductance and body composition variables in college students. 
Segal et al. (1985) attempted to verify these regression equations and found unsatisfactory 
predictors of fat free mass in men and women aged 18-50. Lukaski et al. (1986a) 
conducted a study on 47 men and 67 women to validate the relationship between 
conductance and fat free mass. Comparison of densitometrically determined and 
impedance predicted fat free mass yielded an error of prediction of 2-2.5 kg and a 
calculated error of relative body fatness of 2.7%. Relative to densitometry the observed 
error of calculated body fatness was larger by anthropometry (3.9%) than by impedance 
(2.7%). In the studies by Lukaski (1985,1986b), Kushner and Schoeller (1986) the 
conductance method was proved to be the best single predictor of total body water. 
Because fat free mass, including the protein matrix of adipose tissue, contains virtually all 
the water and conducting electrolytes in the body, conductivity is far greater in the fat free 
mass than in the fat mass of the body (Pethig 1979). 
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In practice, a small current, usually 800 µA, is passed between electrodes on the hand and 
foot and the voltage drop is measured to give an estimate of the body resistance or 
impedance. Prediction equations are required to translate the measured impedance into 
an estimate of water volume. When total body water assumed to be a fixed proportion of 
the lean tissue, LBM could then be calculated. Fat mass is also calculated by difference 
from body weight and the calculated lean tissue. 
The measurement itself takes only a matter of seconds. Minimal undressing is required to 
yield the appropriate sites. Also, minimal preparation of the site is required, except in 
particularly hairy subjects. Since the technique is measuring body water, it is important 
to ensure as far as possible that subjects are normally hydrated. To assist in this, usually 
measurements are made -2 hours after eating and within 30 minutes of voiding. There is 
less observer error associated with BIA than skinfold thicknesses (Fuller et al. 1991) 
especially in the obese. Although the position of the electrodes are important, the sites 
are easier to define than for skinfold thicknesses. In terms of electrode positioning, that of 
the wrist is the single most important site, since the arm makes such a large contribution 
to the total measurement. In recent years, some influential surveys with multiple 
observers, notably The National Health And Nutrition Examination Survey (NHANES), 
have turned to impedance as a measure of fatness (Woteki et al. 1988). 
In summary, BIA offers the advantage of rapid, safe, relatively cheap and noninvasive 
measurements that can be done at the bedside. Its disadvantages include the possible 
need for prior knowledge of the degree of fatness in subjects who are obese and the 
possibility that changes in electrolyte milieu of the body will affect measurements (Cohn 
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1985). Deurenberg (1996) suggested that that the predicted body fat mass from BIA in 
obese subjects must be interpreted with care. He believed that changes more than 1-2 kg 
TBW or 2-3 kg FFM can be more reliably detected in the obese group. 
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Annlication and limitation of body composition measuring methods to 
pregnancy and lactation 
The additional calorie increment estimated as necessary during pregnancy (about 250-300 
kcal/day) was determined to a large extent by a calculation of net fat gain in healthy 
women (WHO 1986, Hytten 1980). Weight gain recommendations during pregnancy 
therefore assume certain fat changes occur during normal pregnancy. 
Fetal growth may be influenced more by specific maternal tissue changes, for example, 
by accretion of lean tissue, fat, or body water. 
Gestational diabetes mellitus (GDM) could endanger maternal and fetal life. Twenty five 
percent of infants born to diabetic mothers are hypoglycaemic and hyperinsulinemic 
Andersen et al. 1982). The association of excess fat and particular patterns of fat 
distribution with metabolic disturbances has been well established (Kissebah et al. 1982). 
To what extent and how obesity during pregnancy could be related to GDM is to be 
investigated. All these reasons make the information on maternal body composition, a 
valuable addition to the clinical care and evaluation of the nutritional needs of pregnant 
women. However, due to practical limitations, data on body composition and its changes 
during pregnancy have been limited. 
In identifying appropriate methods to study longitudinal changes in maternal body 
composition, the type and magnitude of the expected changes must be taken into 
consideration. Basically, determination of fat storage is more complicated in pregnant 
women than non-pregnant women, because within a wide range of maternal weight gains 
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there are considerable changes in many components of body composition during 
pregnancy. The question of the methodology for the assessment of body composition of 
pregnant women therefore has remained unanswered over the years. Some of the 
methods are unsafe during pregnancy, others are not potentially valid in this period. Most 
techniques currently used to estimate body composition are based on the measurements of 
LBM. Of the commonly used methods, only densitometry is dependent on both fat and 
lean tissue, but the fat estimate is still highly influenced by the variability of the lean 
tissue density. In the two compartment model, as explained above, the weight of fat is the 
difference between the two large masses; body weight and lean body mass. Therefore, a 
small relative error in the lean body mass estimation will produce a much larger error in 
calculated body fat. In the light of expected changes in the maternal body composition , 
the theoretical assumptions behind the three standard methods (UWW, TBW, TBK) as 
well as the other most commonly used methods of measuring body composition will be 
discussed. 
Under water weighing: Under water weighing (densitometry) provides a reliable 
estimation of density and has been used as the criterion measure for the estimation of fat 
for more than 50 years. Although, under water weighing provides an accurate estimation 
of density, the conversion from body density to percentage of body fat is open to 
controversy. Basically, the assumptions behind the criterion methods would be violated 
by the changes which are known to occur during pregnancy. The fact that FFM of the 
developing fetus is less than the average density of 1.10 g/ml suggest that an 
underestimation of maternal FFM could result. Furthermore, the assumption that 73.2% 
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of the FFM is water can be challenged in pregnancy due to the large and significant 
increase in fluid retention which occurs in mid to late gestation. In a study by Van Raaij 
et al. (1988), new equations were developed specifically to take into account the 
alterations in density and composition of the maternal FFM throughout pregnancy, but 
validation of these equations have not been reported. 
The problem of validity of hydrostatic weighing is of particular concern when attempting 
to use other methodologies, such as bioelectrical impedance in measuring FFW, in that 
such methods have been developed using regression from the hydrostatic weighing 
technique. 
Total body Potassium: The measurement of TBK is again based on the assumption of a 
standard value for the concentration of the potassium in the lean tissue. The vast majority 
of the body's potassium is intracellular ( approximately 98%), therefore, total body 
potassium is actually a reflection primarily of the intracellular compartment. Substantial 
changes in the extracellular compartment can go undetected which is obviously of 
importance during pregnancy. To have a reasonable estimation of the weight of lean 
tissue, the ratio of the intracellular to the extracellular tissue must be either close to the 
norm or assessed independently. 
Total body water: To calculate the lean tissue from TBW, the water content of the lean 
tissue must be known. The average percentage of water in the lean tissue of adult women 
is known with fair accuracy but the addition of nonfat tissues during pregnancy would 
make a considerable difference in the hydration of lean tissue from approximately 72.5% 
at 10 weeks gestation to about 75% at 40 weeks in women with generalised oedema (Van 
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Raaij et al. 1988). This difference could lead to underestimation of fat deposition by 
about 50% or more in women gaining 3 to 4 kg of fat. 
The interpretation of body water changes might be improved with a measure of 
extracellular water. Variation in the extracellular water could be substantial and it can be 
determined either with an extracellular tracer such as bromide or by subtraction of 
intracellular water measured by TBK from total body water. 
Despite their limitations, TBW, UWW, and TBK are considered to be the three best 
methods for studying body composition in pregnancy and lactation. However, the 
measurement of TBK and UWW require special, large equipment and considerable 
patient cooperation, and TBW estimation requires special isotopes that are relatively 
expensive. 
In the case of relatively new techniques such as DEXA, IVNAA, and CT scanning, 
radiation exposure makes these techniques unsuitable for pregnant women. Magnetic 
resonance imaging is safe and needs minimal cooperation from the subjects, but being 
slow and expensive would exclude this method from the list of options for many 
researchers. A consideration of the cost, availability, safety and acceptability of the 
methods has encouraged the use of simpler methods, such as Skinfold thickness 
measurements (STM) with callipers and Bio electrical impedance (BIA). 
Skinfold thickness measurement: Skinfold thickness changes have been widely used to 
estimate variation in the fat content of pregnant women. Skinfold can be measured 
quickly with relatively inexpensive equipment. However, the method is open to 
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inaccuracy. A high degree of standardisation and extensive training is required to 
achieve reliable and reproducible measurements (Taggart et al. 1967). 
To convert skinfold thickness measurements to estimate of body fat, standard regression 
equations are used. Generally, these are based on studies correlating skinfold 
measurements to body fat measured by total body water, body density or total body 
potassium. Because the most widely used regression equation during pregnancy is 
developed in studies of nonpregnant subjects (Durnin and Womersley 1974), the results 
should be interpreted with caution. 
On the other hand, longitudinal studies on STM in pregnancy (Taggart et al. 1967) 
suggest that skinfold thicknesses may be increased by water retention. Therefore, the 
variation in the skinfold may not necessarily indicate a change in body fat content. The 
magnitude of this hydration effect may also vary from one site to the another (Adair et al. 
1984, Taggart et al. 1967, Forsum et al. 1989). Some specific regression equations for 
pregnant women have been developed which were derived from small number of subjects 
(Forsum et al. 1989). The usefulness of the equations is partly dependent on the 
comparability of the measurement techniques used in the study population and the 
reference population. It may also be affected by differences in age, ethnic background, 
and exercise patterns of the reference and the study population. Bearing in mind the 
limitation of STM, in several studies skinfold thickness values have been used without 
calculating body fat content. In this approach, either individual (Frisancho et al. 1977, 
Maso et al. 1988, Viegas et al. 1987) or sum of the several measurements (Taggart et al. 
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1967, Lawrence et al. 1984, Arroyo et al. 1978) have been used, but they did not assume 
that all the measured changes directly reflect changes in body fat. 
Bio electrical impedance Analysis (BIA): As explained above, this technique is thought 
to be an accurate means of assessing TBW in non-pregnant human and that the lean 
weight is assumed to be 72.3% H2O. The applicability of this method in pregnancy was 
studied by Lukaski (1994), who indicated that the significant increase in the TBW can be 
accurately assessed by tetrapolar BIA, but the conversion of TBW to FFM will be in 
error. The higher water content will indicate a much greater FFM that actually exists. 
The overestimation of FFM may or may not cause an error in the evaluation of fat. 
Although more research is required to test the validity of this method, there are no 
suitable measuring techniques to provide the criterion measure at this time. In fact, due to 
lack of validation, there is no way of verifying which method is the best nor can it 
actually be suggested that any method would provide acceptable results. 
In brief, there are many different methods that can be utilised to measure body 
composition in the living organism, some are highly practical and some of which are 
highly limited, due to economics, to a very few research or clinical institutes. As all of 
these methods are relatively indirect or predictive, there are errors (or variations) 
associated with each. These variations are caused by the errors of measurement (in 
relation to a specific technique) and biological variation of the subject. Conditions such 
as pregnancy make the matter more complicated, due to water retention and alterations in 
hydration constant of LBM. Hence, the vicious circle of alterations in maternal body 
composition and inaccuracy of the methods of measuring body composition, severely 
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limits the selection of an appropriate technique. Attempts has been made to develop 
pregnancy specific formula to predict maternal fat mass from densitometric (Van Raaij et 
al. 1988) and skinfold measurement (Forsum et al. 1989) techniques. However, 
depending on the type of study, what should be considered besides the accuracy and 
reliability of the method, is the availability and the convenience of the subjects. 
The state of current knowledge on body composition during pregnancy 
and lactation 
Body composition changes during pregnancy: 
During pregnancy weight is gained and fat is stored in some areas more than the others. 
It is hypothesised that the excess weight and stored fat which could partly be an energy 
reserve for lactation, is mobilised during the postpartum period. The changes in the 
relative contribution of the components of weight during the reproductive cycle, are not 
well defined. The basic changes which occur during pregnancy are the addition of 
products of conception (fetus, placenta and amniotic fluid), there are also changes in 
uterine and breast tissue, body water (intracellular and extracellular water), and maternal 
fat. They change in variable amounts among women during pregnancy, thereby distinctly 
affecting the interpretation of individual weight gain. 
The average weight gain after a typical 40 week pregnancy amounts to approximately 
12.5 kg, about a 20% increase in body weight for most of women (average weight = 60 
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kg) (Forbes 1962). Most of this weight gain (68%) occurs during the last 20 weeks of 
pregnancy. It is known that about 40% of the total gain is represented by the products of 
conception. The remaining 60%, therefore, is the mothers' body weight change. 
These figures could be different in developing countries, as the average weight gain in 
developing countries like Gambia, Thailand and Philippines, are estimated about 7-8 kg 
(Durnin 1987), of which 50% is accounted for by the products of conception. 
To have a comprehensive understanding of body composition during pregnancy, it is 
imperative to know about the composition of the products of conception. Obviously, the 
proportion of fetal weight varies throughout the course of gestation. At term, the fat 
content of the fetus has been estimated at approximately 14% of body weight 
(Widdowson and Dickerson 1964). In another attempt to assess total maternal fat by 
Forsum et al. (1989), the fat content of the fetus was reported to be about 500 g in late 
pregnancy. 
In addition to the fat percentage, the total water weight of the fetus, placenta, and 
amniotic fluid amounts to 3.8 kg of a total 4.7 kg (81%). In fact, it has been estimated 
that 60% of the total weight gain of the fetomaternal unit is water (Forbes 1987). 
There is evidence that some of the weight gain of the pregnant female is due to increases 
in mammary, uterine, kidney and heart tissues. There is also, an increase in plasma 
volume and other fluid volumes (mostly extracellular fluid) (Hytten 1980). An increase 
of -9 litres of water during pregnancy has been reported. In fact, TBW changes during 
pregnancy have been studied by many investigators. The least water change was an 
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increase -5.7 kg in the study by Forsum et al. (1988) and the greatest was -8.5 kg in the 
study by Campbell (1983). 
Comparison of the incremental gestational changes in total body potassium also reveals 
substantial differences among the studies. The incremental potassium values in the study 
of Forsum et al. (1988) from early to late pregnancy is approximately one-third that of the 
other two studies by Pipe et al. (1979) and Emerson et at. (1975). In Forsum study a loss 
of lean tissue was observed. Clapp et al. (1988) however, showed an increase of both fat 
and lean tissue during the first 7 weeks of gestation. In fact, in the study by Forsum, the 
increase from prepregnancy to term is so low that it is insufficient to account for the 
amount of the potassium others have estimated to be required for the contribution of the 
conceptus alone. Nevertheless, all three above mentioned studies (Forsum, Pipe, 
Emerson) show postpartum figures that are very close to their early pregnancy values. 
Using the potassium values, a maternal gain of 1.2 to 2.1 kg of lean tissue between early 
and late pregnancy, is estimated, excluding the conceptus (Pipe et al. 1979). Bone, 
however, is likely to increase relatively little. Putting all these findings together, there are 
only slight increases in the dry weight of lean tissue but substantial changes in the 
composition of the lean mass during gestation, because of increased water content. 
Fat stores, also, increase during pregnancy but there has been a difficulty in quantifying 
this change. Deposition of fat is mainly on the hips, thighs (the classical sites for female 
fat distribution), back and abdomen. Several researchers have attempted to monitor 
maternal fat changes during the gestational period. Hytten (1980) estimated that well. 
nourished women retain -4 kg body fat whereas studies in Scotland (Durnin 1987) and 
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the Netherlands (Van Raaij et al. 1987) suggest that this figure could be too high. On the 
other hand, Forsum et al. (1988), reported that Swedish women retain an average of 5-6 
kg body fat during pregnancy and that 60% of this fat is gained before weeks 16-18. 
Also, during lactation these Swedish women were slow to mobilise the fat retained during 
pregnancy. 
The variation in the results of the studies mentioned above could partly be explained by 
the different population and designs used in those studies. However, in a recent study by 
Lederman et al. (1993), using several methods of body composition measurements in the 
same subjects concurrently, considerable discrepancies were found between the results of 
each method. Three standard methods (TBW, TBK and UWW), which are based on the 
two compartmental model were used in this study. They also used a multicompartment 
model ( discussed by Selinger 1977) based on direct measurement of the compartments 
(water and bone) that contribute most to variation in body density, particularly during 
pregnancy. In their study, body fat mass was measured in 65 pregnant women at 14 and 
37 weeks gestation. The widely different results of fat gain from 14 to 37 weeks, 
obtained with each method, were as follows; TBW: 0.3 kg, TBK: 8.1 kg, UWW: 5.6 kg 
and MCM: 2.6 kg. This study confirmed the potential influence of methodological error 
on the results. 
Body composition changes during postpartum period: 
Assessment of body composition during the postpartum period would suffer less from the 
lack of certainty and precision. In the post partum period falls in the body weight and 
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fatness, particularly at the hips and thighs, are expected. Up to now, the composition of 
the tissue lost is not well established nor whether the compartments vary according to the 
degree of weight gained. In weight reduction of the obese the composition of the weight 
loss is on average, 75% adipose tissue and 25% lean body mass (Gar ow et al. 1979). 
The composition of tissue lost also depends on the initial level of fatness, being higher in 
the fatter subjects (Forbes 1987). The maternal changes are not simply decreases in the 
adipose tissue mass, however. There is also a reduction in the volume of maternal 
organs, e. g. the breast and uterus. 
As with pregnancy, the interpretation and the comparisons of reported studies on post 
partum changes are complicated by differing methodologies and different study designs. 
Ohlin & Rossner (1990), presented the results of the body changes of 1423 Swedish 
women during and after pregnancy. There Aas a fall in full term body weight of 12.5 kg 
over 12 months, with half the postpartum weight loss occurring in the first three months 
and a residual weight difference at 12 months of +1.5 ± 3.6 kg (mean±SD) in comparison 
with prepregnancy weight. Post partum weight losses were higher in women with high 
scores for duration and intensity of breast feeding at 2.5 months but not at 12 months. 
Butte et al. (1984) observed a weight loss of 2 kg, on average, in 45 American women 
between I and 4 months postpartum. 
Measurements of skinfold thicknesses showed falls at the subscapular and supra-iliac 
sites and paradoxical small but not significant increases at the triceps site. Adair et at. 
(1984) reported a marked increase in both triceps and subscapular skinfold thicknesses in 
the mother after parturition. Studies in less affluent countries (mainly countries with 
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marked seasonality variation) give a different view. The average weight gain in these 
countries is estimated about 7-8 kg. In Gambia (Lawrence et al. 1987), a successful 
outcome of pregnancy was observed with less fat storage (comparing with developed 
countries). In this population, lactating women gained weight in the dry season but lost 
weight in the wet season, when less food was available. This illustrates the importance of 
climatic factors above all the previously mentioned factors in causing the variation in this 
study area. However, Schutz et al. (1980) found that the energy cost of lactation was met 
mainly by fat losses in the rural Guatemalan women. The discrepancy between the results 
of different studies during postpartum period may also be explained by the lack of 
consistent definition of true breastfeeding. 
In brief, a substantial weight loss occur mainly during early postpartum. Nevertheless 
weight losses during lactation can not always counter-balance the weight gained during 
pregnancy in well nourished women. This could be due to food availability and reduced 
physical activity in the developed countries. The possibility of retention of extra weight 
and fat may lead to development of obesity with each pregnancy. 
The controversy surrounding the field would urge the need for repeated experiments, 
particularly on local populations, which would add valuable information on the 
physiology of maternal-fetal energy requirements. 
36 
Intermediary metabolism with an emphasis on 
glucose metabolism, insulin action and adipose tissue 
Intermediary metabolism has been extensively reviewed by Lönnroth and Smith 
(1992) and also by Jefferson and Neely (1982). Some aspects of these reviews which 
are thought to be important in the consideration of diabetes mellitus and obesity are 
discussed below. A detailed description of biochemical pathways in fuel metabolism 
are beyond the scope of this thesis, so it is focused on the issues of metabolism that 
are most relevant to the subsequent research protocol. 
Glucose metabolism: 
Of the major nutrients or metabolic fuels that the body relies on, for its energy 
requirements (e. g. glucose, fatty acids, ketone bodies, to a lesser extent lactate, 
pyruvate and amino acids), glucose is the most important. The concentration of 
glucose is tightly controlled, because it is essential for the central nervous system. If 
the rate of glucose entry into the extracellular fluid compartment were to become less 
than the rate of glucose exit out of the compartment, hypoglycaemia would develop. 
Conversely, hyperglycaemia would result if the rate of glucose exit from the 
extracellular fluid were to become less than the rate of glucose entry. Entry of the 
glucose to extracellular spaces is from either exogenous or endogenous sources and it 
should be maintained within a limited range (3 to 7 mmol/l in different nutritional 
states). In the fed state, when exogenous glucose is abundant (e. g. after a high 
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carbohydrate meal), the body stores the excess glucose as glycogen in liver and to a 
lesser extent in muscle, and also as triglycerides in adipose tissue. During the 
postabsorptive state (after overnight fasting), the liver is the source of endogenous 
glucose which is derived from glycogenolysis (breakdown of glycogen to glucose) and 
from conversion of amino acids, lactate, pyruvate, and glycerol to glucose by the 
process of gluconeogenesis. Whatever the source of glucose to the plasma, it is taken 
up from the circulation by body tissues to be metabolised. Organs which are involved 
in glucose metabolism are divided to four groups by Bonadonna and Defronzo (1992). 
These four groups are summarised as follows: 
1. Glucose dependent organs: This group, including brain and red blood cells (RBC), 
utilises glucose in a fixed rate. The brain and the RBCs are strictly dependent on 
glucose for their normal metabolism. Glucose levels below a certain level (3.6 
mmol/1) lead to a life threatening situation due to damage to neurones. A complex 
homeostasic mechanism is then readily activated to improve the situation. 
Although brain and RBC's glucose utilisation is constant over time (about 100 
mg/min), feeding and consequent exogenous glucose availability are phasic. At times 
in the day, glucose availability greatly exceeds the needs of glucose dependant organs, 
and because glucose is not allowed to accumulate in the extracellular space, the 
excess glucose must be disposed of by the other organs. The next group of organs are 
responsible for this function. 
2. Insulin dependent organs: This class of organs disposes of the carbohydrate that 
exceeds the need of brain and RBCs. These organs which include skeletal muscle and 
adipose tissue, should adjust their glucose uptake to effective glucose availability. 
Their glucose uptake is also dependent on the changes in the circulating insulin. 
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Skeletal muscle and adipose tissue are both sensitive to insulin, the former has a 
greater impact on glucose homeostasis, the latter, however, is not regarded as 
important for glucose metabolism (Bjomtorp and Sjostrom 1978). This is because 
the fat-free cytoplasm (i. e. the glucose metabolising mass), in the adipose tissue is 
only 0.7 to 0.8 kg, much less than the 28 kg of muscle mass in a 70 kg person. 
3. Glucose sensor organs: Liver and pancreatic beta cells belong to this group. Plasma 
glucose concentrations would regulate pancreatic insulin secretion. Hepatic glucose 
production is also influenced by the plasma glucose levels. Hormonal regulation, 
however, has a much greater influence on the hepatic glucose production than glucose 
levels per se. 
4. Glucovorous organs: The fourth group of organs which have essential roles in 
carbohydrate metabolism, are the gut and the kidneys. The gut is primarily 
responsible for absorption and entry of new glucose and the kidneys are able to re- 
absorb and re-enter the glucose to the circulation. Above a certain plasma glucose 
(-10 mmol/1), however, the kidneys, are not able to absorb all of the filtered glucose 
and this is when glucosuria appears. 
In general, all of these four types of organs described earlier, share a common 
function; transferring glucose from one physio-anatomical space to another. In the 
most relevent organs to our subject of study: adipose tissue, muscle and also liver, 
metabolism is regulated by insulin and its counterregulatory hormones: glucagon, 
catecholamines, glucocorticoids and growth hormone. When insulin is ascendant, 
secretion of antagonists is suppressed and, when it is in short supply, the antagonists 
tend to be abundant. Insulin dominance favours anabolic processes, i. e., glycogen 
synthesis, fatty acid and triglyceride synthesis, protein synthesis, whereas dominance 
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of the antagonists promote catabolic processes, i. e., triglyceride hydrolysis, fatty acid 
oxidation, ketogenesis, proteolysis, glycogenolysis. 
The Insulin Action: 
Insulin is produced in the pancreatic beta-cells as the primary product "preproinsulin". 
This peptide is rapidly converted to proinsulin which is in turn, converted to insulin 
plus C-peptide by specific proteolytic steps within the beta-cell secretory granule. 
The normal products are therefore, insulin, an equimolar amount of C-peptide and a 
small amount of unconverted proinsulin. Upon their release from the B cell to the 
blood stream, a large amount of the insulin is cleared from the portal vein during the 
first passage through the liver; the most important insulin target for glucose 
homeostasis. This clearance results in a relatively constant peripheral level of 
circulating insulin . Proinsulin which has about 5% of the 
biological activity of 
insulin is cleared less efficiently and may form 20% of the insulin in the peripheral 
circulation. C-peptide is excreted into the urine and can be assayed there or in plasma. 
This is a useful procedure since the C-peptide is produced in amounts equimolar to 
insulin and its radioimmunoassay can be used to evaluate a patient's endogenous 
insulin synthetic capacity (Horowitz et al. 1978). 
Insulin is primarily responsible for glucose homeostasis but it is involved in the 
prevailing anabolic states and in suppressing catabolic processes. It also functions as 
an essential factor for the maintenance or growth of virtually all types of cells. 
Insulin encourages protein synthesis and inhibits protein breakdown in skeletal and 
cardiac muscle and in other tissues, thus reducing the amino acid supply of the liver 
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from those sources. Similarly the anti-lipolytic effect of insulin in fat cells inhibits the 
release of FFA from adipose tissue and thus decreases the FFA concentration of liver 
output. By acting directly on the liver cell, insulin promotes glycogen deposition and 
inhibits its glucose release. 
Adipose tissue: 
This tissue is the major energy store in the body, capable of satisfying the basic energy 
requirements for considerable length of time. Its major metabolic functions are 
removal from plasma of fatty acids and other substrates used to synthesise fatty acids, 
storage of these fuels as triglycerides in lipid droplets during periods of nutrient 
excess, and breakdown (hydrolysis) of triglycerides with release of fatty acids and 
glycerol into the blood during the periods of increased energy demands or deficiency 
of exogenous nutrients. Glucose seems to be of a great physiological importance for 
lipogenesis, since it provides the triglyceride backbone, the glycerol part, through 
glycolysis (Jefferson and Neely, 1978). 
Fat cells in the adipose tissue are uniquely adapted for their main function of storage 
and release of energy. The fat within the adipocyte is triglyceride of a composition 
giving a semifluid central fat droplet at body temperature. The adipocyte is 
morphologically a rather conventional cell as far as its size is concerned. When 
accumulating triglyceride, the cell size increases enormously with perhaps a 20-fold 
increase in diameter and consequently their capacity by thousandfolds (Björntorp 
1982). The flexibility in size not only means a vast ability to vary storage capacity but 
also may explain the metabolic aberrations in some obese individuals. Björntorp 
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(1982), suggested that excessive storage of fat in adipocyte stretches the cytoplasm 
which is a metabolically active part of the cell, in a thin layer over the central globule. 
The cell surface, containing receptors for hormonal binding, would also be expanded. 
Another possible result of increased size of fat cell that was pointed out by the same 
author, was the decreased extracellular space, allowing less abundant flow of various 
components in this area. He then concluded that the morphology of adipose tissue 
because of geometrical reasons can vary the metabolic capacity. This could partly 
explain the metabolic abnormalities in obesity where an increased amount of fat is 
stored in enlarged adipocytes or in an increased number of fat cells or combination of 
both (see below). 
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Pathogenesis of obesity in association with diabetes 
Non-insulin dependant diabetes (NIDDM) is usually, associated with obesity. A 
number of studies have shown that obesity is a strong risk factor for the later 
development of this disorder. The evidence for that could be summarised as follows: 
(1) adult subjects with recent onset of NIDDM are more obese than those without the 
disease (Knowler et al. 1981), 
(2) a correlation has been seen between the degree of obesity in population and the 
prevalence of diabetes (West 1978). Also, in a study by Hanson et al. (1995), weight 
gain was strongly correlated to diabetes incidence (in this study, in the case of 
women, it was only true for the ones who were not initially overweight. This finding 
of Hanson et al., shows the importance of weight gain in women in relation to the 
incidence of NIDDM but it does not rule out the relationship between long term 
obesity and diabetes), 
(3) weight reduction in NIDDM, especially when the disease is of recent onset, 
improves glucose tolerance (Henry et al. 1986). 
(4) the incidence of diabetes in obese subjects is greater than in the non-obese 
(Haffner et al. 1990). 
Furthermore, from the studies on the endocrine and biochemical abnormalities of 
overweight, it has been known that a state of hyperinsulinemia exists in obesity (Elahi 
et al. 1982, Polonsky et al. 1988). This could, in turn, reflect a resistance to the effect 
of insulin on glucose clearance in target cells. 
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It has been suggested that obesity shares the characteristic of insulin resistance with 
diabetes. Although both of these conditions are believed to be determined at least in 
part genetically, literature surveys suggest that obese individuals and the majority of 
non-insulin dependent diabetic patients have altered body composition and patterns of 
insulin resistance (Bogardus et al. 1984, Evans et al. 1984, Campbell et al. 1988, 
Defronzo 1988, Groop et al. 1989). 
From these observations stems the long held hypothesis that obesity may be 
considered a pre-diabetic state. In the next part, considering the basic concepts of 
normal glucose metabolism and its regulation in relation to adipose tissue, the link 
between these two developing disorders; "obesity and diabetes" will be discussed. 
Before that it is necessary to be familiar with the basic definition and common 
characteristics of each of these relatively well known diseases. 
Human obesity 
Obesity may simply be defined as a condition in which there is an "excessive storage 
of calories as body fat". Apparently it is not a single condition but is a syndrome of 
varied aetiology with regard to its natural history, associated disease and 
complications. 
Obesity runs in families but this does not necessarily mean that it is inherited 
genetically. It could rather be as a result of metabolic, social and environmental 
influences. Interestingly, many women relate their onset of obesity to their pregnancy. 
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No matter what the underlying aetiology, the common denominator of all forms of 
obesity is an imbalance of energy intake and energy expenditure, and it is now clear 
that there is a great variation among individuals, both in the ease with which obesity 
develops and in the factors regulating energy balance. 
A high calorie intake has long been considered to be the major cause of obesity in 
man. In fact, the term of "obesity" is derived from a Greek word, meaning 
"overeating" and implies that the primary defect is on the intake side of the energy 
balance equation. 
It is however, worth noticing that many individuals developing obesity, do so 
primarily because of a decreased energy expenditure. A significant example could be 
the increasing incidence of obesity in the 'modernised' societies in which physical 
activities are reduced, therefore, minimum energy for daily activities is required. The 
prevalence of obesity as measured by BMI has increased gradually in the UK during 
the last 50 years (National Dairy Council 1993). Based on a comparison between 
"The dietary and nutritional survey of British adults" in 1986/7 with a "Health survey 
for England" in 1991, the rate of overweight and obesity has increased clearly in spite 
of little difference in dietary intake (White et al. 1991). 
It is the case that most of obese individuals, after reaching a certain point of body 
weight, stay in equilibrium for many years. 
Despite all of these social and environmental changes, the question that still remains 
unanswered is why some people seem to be more prone to put weight on than the 
others, and to what extent it could be related to life style or conditions like pregnancy. 
f 
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Classification of obesity: 
Obese individuals can be classified in several ways: according to the anatomical 
characteristics of the adipose tissue, fat distribution, and based on the age and onset of 
obesity or etiological factors. Obesity could also be classified based on its prevalence 
in association with mortality and morbidity indexes. Each of these set of 
classifications are described below. 
Fat cell size and number: Anatomically, obesity has been considered as an increased 
triglyceride content per adipocyte, and from this it could be subcategorised to two 
forms. In a hypothesis by Hirsch et al. (1979), these two forms are described as 
hypertrophic and hyperplastic obesity. Based upon their theory the stored fat could 
either be distributed in the increased number of normal weight adipocyte 
(hyperplastic) or in the enlarged fat cells (hypertrophic obesity). It could also be in the 
combination of both which seems to occur in most cases. 
When obesity develops in adulthood or during pregnancy, mature fat cells are less 
able to replicate in human (Hirsch et al. 1979, Bjorntorp and Sjostrom 1971). 
Therefore, it is more likely that adulthood obesity is of the hypertrophic form and this 
type of obesity is associated with metabolic abnormalities (hyperglycaemia, 
hyperlipidemia and hyperinsulinism). It has also been seen that under these 
conditions, the increased fat deposition is predominantly truncal (see below). In 
contrast, childhood obesity appears to be more from the hyperplastic form and clinical 
diabetes is observed to be much less common in obese children (Bray 1992). A 
protective factor in this regard could well be the ability of the adipocytes to replicate 
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in response to overfeeding. Adults having predominantly hyperplastic (hypercellular) 
obesity but without enlargement of fat cells as well are relatively uncommon. An 
increased total number of fat cells is usually present in individuals who are more than 
75% above their desirable weight (Hirsch et al. 1989). 
Overweightness: Apart from the theory of adipose tissue cellularity which points to 
the obesity as a serious medical condition, there is a milder condition of excess fat 
categorised as "overweight". This situation is defined as an excess of weight in 
relation to height. Overweightness is also seen to be associated with increased 
prevalence of heart diseases and diabetes mellitus (Van Italli 1985, Stamler 1979). 
To distinguish between different degrees of obesity, although there are sophisticated 
techniques for measuring body fat, they have not been used in larger population 
studies. Therefore, the degree of obesity and overweightness is expressed with 
simpler indices such as weight for height, body mass index and waist/hip ratio. They 
have been constructed to standardise weight for height. The most widely used of 
these indices is BMI, which is addressed above. 
Body mass index has been recognised as a surrogate measure of body fatness, 
especially for epidemiological purposes. Nevertheless, persons with similar BMI 
might show a quite wide variation in body fat. Therefore, it must be borne in mind 
that the BMI characterises groups rather than individuals. 
Various statistical cut-off points have been used to distinguish between obese, 
overweight, and also normal weight people and these are designed based upon the data 
on mortality and morbidity. In large samples (N>105) the relation between mortality 
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and BMI is J or U shaped, and average mortality rates appear to be at approximately 
BMI>28 kg/m2 (Waaler 1984). However, an international classification of obesity has 
been proposed by Garrow (1981) and endorsed by a panel of the World Health 
Organisation (1988). The categories in this thesis accord with those adopted by the 
WHO classification which are as follows: 
Level of BMI index Description 
20 or less Underweight 
over 20 to 25 Desirable (Normal-weight) 
over 25 to 30 Moderate overweight 
30 to 40 Severe overweight or Obese 
over 40 Morbidly obese 
It is interesting to know the rate of obesity in United Kingdom, based on this 
classification is 13% for men and 16% for women and the mean BMI for women and 
men were 25.4 and 25.6, respectively (White 1991). In my own study of early 
pregnant women attending Antenatal Clinics of Northern General Hospital in 
Sheffield, the mean BMI was also 25.4 and the rate of obesity (BMI>29) was 17.5% 
(Soltani 1993, M Med Sci dissertation). 
Regional fat distribution 
In this regard, obesity could be categorised based on accumulation of fat in a 
particular location. According to this criterion obesity consists of two main 
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subgroups; upper body segment (truncal, central or android obesity) and lower body 
segment (peripheral or gynoid obesity). The first type is characterised by an excess 
amount of fat accumulation in the shoulders, abdomen and nape of the neck. In 
contrast, the latter type is associated with a predominant accumulation of buttock and 
thigh fat. These two subgroups can simply be evaluated by measuring skinfold 
thickness on the trunk and extremities or by measuring circumferences. Waist to hip 
girth ratio (WHR) is the most common index that is been used for this purpose. WHR 
is obtained by the measurement of the waist girth dividing by the maximal hip girth. 
WHR>0.85 is considered as a characteristic of upper body segment obesity in women 
(Kissebah et al. 1982). 
In summary, BMI represents a simple index of obesity in population studies, with no 
detailed information on body composition. Although different weight for height 
indices may be optimal risk predictors in different populations, adipose tissue 
distribution is optimally predicted by indices such as waist-hip ratio. In a recent study 
(Han et al. 1995) waist circumference in women was shown to be an even better 
predictor of intra-abdominal fat mass (IFM) than WHR. The correlation between 
BMI and IFM was almost as good as waist circumference. 
Diabetes mellitus 
Diabetes is a state of abnormal carbohydrate metabolism and its common symptoms 
involve; thirst, polyuria, weight loss, fatigue, pruritus vulvae (Vaginal candidiasis), 
hunger, blurred vision and other diabetic complications. 
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Current knowledge of the aetiology and pathogenesis of diabetes, although still 
incomplete, has indicated that this disease is heterogeneous in nature. Thus diabetes 
is considered as a syndrome. 
The syndrome of diabetes has been classified into diabetes mellitus type I, type II, 
impaired glucose tolerance (IGT) as well as gestational diabetes, previous abnormal 
glucose tolerance and potential abnormality of glucose tolerance (Harris et al. 1979). 
Diabetes Type I (Juvenile onset diabetes), has been relatively well characterised as 
having a positive association with genetic HLA (histocompatibility antigens) on the 
Chromosome six. It could also be due to some viral infection destroying beta cells. 
Islet cell antibodies are present at the onset, and there is a defect in insulin secretion of 
such severity that exogenous insulin is mandatory for sustaining life. The term insulin 
dependent diabetes mellitus (IDDM), for type I, comes from the last feature. 
In contrast, type II diabetes mellitus (non insulin dependent diabetes mellitus 
(NIDDM) or maturity onset diabetes), has been less well characterised. In this type, 
although having a genetic background, there is a strong association with insulin 
resistance and abnormality in insulin secretion. 
Both type I and type II diabetes mellitus are defined either by fasting hyperglycemia 
(>8 mmol/L) or levels of plasma glucose during a glucose tolerance test above certain 
limits (2 hr value > 12 mmol/L after 75 g glucose). 
The state of impaired glucose tolerance (IGT) is characterised by plasma glucose 
levels during a glucose tolerance test which lie above normal but below the frankly 
diabetic levels. What should be remembered is that the limits of plasma glucose have 
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been defined differently by various investigators for each type of diabetes mentioned 
above. 
Gestational diabetes (GDM): This is defined as carbohydrate intolerance of variable 
severity with onset or first recognition during pregnancy (Metzger 1991 ). Women 
with GDM are normally older and tend to be more obese than women who have 
normal glucose tolerance (NGT) in pregnancy (Gabbe 1986). GDM during pregnancy 
is associated with an increased perinatal morbidity and mortality and an increased loss 
of viable fetuses. There are certain important risk factors associated with gestational 
diabetes (Sacks et al. 1987): 
" Previous history of gestational diabetes; 
" Family history of diabetes (first degree relatives); 
9 Obesity; 
" Maternal age over 25; 
9 Previous infant with congenital anatomical malformation; 
9 Previous macrosomic infants; 
" Previous poor obstetric history. 
Since gestational diabetes is associated with the same complications as the other types 
of diabetes, including congenital malformations (Hod et al. 1995), it is important that 
this disease be diagnosed early and controlled carefully. In the past, urine 
examination for glucose has been used as a screening test for GDM. This approach is 
no longer used in our Maternity Unit in Northern General Hospital (Sheffield) because 
it resulted in too many false positive screens. Although it is still being practised in 
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some other ante natal clinics in UK. Fifty percent of healthy pregnant women have 
glucosuria at some stages while their blood glucose levels remain well within the 
normal limits (Davison and Hytten 1975). More recently, the oral glucose tolerance 
test has become the most common screening test, generally carried out between 28 
and 32 weeks gestation. 
Once the diagnosis is made, the principles for the treatment of GDM are similar to 
those women with pre-existing diabetes. The frequent feeding diet, composed of high 
carbohydrate (55 to 60% of total energy), low fat (20 to 30%) and low protein (15 to 
20%) should be advised. Although some authors report good results using diet 
therapy alone or in combination with oral hypoglycaemic agents in certain patients 
with gestational diabetes, most authorities believe that better control can be achieved 
using diet therapy and small doses of regular and intermediate-acting insulin (Berne et 
al. 1985). Because rigid control of blood sugar level is so important, as with the other 
types of diabetes, a team management, including a physician and a dietician, is 
necessary. 
There is no doubt that GDM must be considered a disease entity that presents 
significant perinatal risks and entails a considerable enhanced risk for later 
development of diabetes in the mother (Gabbe 1986). There is growing evidence that 
the perinatal risks can be reduced by a systematic approach to identification and 
managment of this disorder (Gabbe 1985). There are however, arbitrary views 
regarding the diagnostic cut off points between normal and abnormal glucose 
tolerance in pregnancy (Naylor 1989). 
Aetiologically, despite the differences between all types of diabetes mellitus, a state of 
reduced insulin sensitivity (insulin resistance) plays an important role, with the 
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exception of IDDM which is due to a loss of beta cell function (insulin deficiency). 
This common characteristic of different type of diabetes is briefly discussed below. 
Insulin resistance: definition and mechanism 
Insulin resistance exists when a given, known quantity of insulin produces less than 
the normal expected biological effect. The causes of insulin resistance according to 
its known aetiologic mechanisms are classified by Olefsky (1982). These are 
summarised as follows: 
9 An abnormal beta-cell secretory product; 
a. abnormal insulin molecule 
b. incomplete conversion of proinsulin to insulin 
" circulating insulin antagonists; 
a. elevated levels of counterregulatory hormones, e. g., growth hormone cortisol, 
glucagon, catecholamines, progestrone, or human placental lactogen (HPL). 
b. antiinsulin antibodies 
c. antiinsulin receptor antibodies 
9A target tissue defect in insulin action; 
a) insulin receptor defects 
b) post receptor defects. 
In nonpregnanct states, a target tissue defect in insulin action may contribute a rather 
more significant role in the causes of insulin resistance. 
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Regarding insulin action, the first step is binding to its cell surface receptors. The 
insulin receptor complex is then formed and one or more signals are generated. This 
signal or "second messenger" of insulin action could be responsible for the variety of 
insulin actions. In many instances, the effect is through a multistep sequentially 
linked enzymatic system (i. e., activation of glycogen phosphorylase) or a series of 
enzymes involved in the degradation of a particular substrate (i. e., glucose). Clearly, 
abnormality in any stage of insulin action cascade, can lead to insulin resistance. 
Insulin resistance is comprised of two states; decreased sensitivity and/or decreased 
responsiveness. In the former state, an increase in hormone concentration is required 
to produce a normal biological response. In the latter state, the dose response is 
unchanged but the maximal possible response is reduced. Usually a combination of 
these states is responsible for insulin resistance. 
For convenience, these abnormalities are defined under subheadings of insulin 
receptor defects and postreceptor defects. 
Insulin receptor defects: Decreased insulin receptors which reflect reduced insulin 
sensivity, have been described in a variety of pathophysiologic studies. The most 
common of these are obesity. It has also been described following glucocorticoid or 
oral contraceptive therapy. 
What should be noticed is the fact that the function of insulin receptors is not as 
simple and it has been suggested that cells possess `spare receptors' to maximise the 
effect of insulin (Olefsky 1976). This concept is based on the observation that a 
maximal insulin effect is achieved at an insulin concentration which occupies less 
than the total number of cellular receptors. 
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Postreceptor defects: At this level within the cells of insulin sensitive tissues a change 
in the function of hormone-receptor complexes and/or enzyme deficiency could result 
in tissue resistance to insulin action. This, of course, could be related to insulin 
responsiveness. 
Diagnosis of insulin resistance: Many studies of insulin activity are focused on the 
blood glucose regulatory effects of insulin. The sensitivity and responsiveness to 
insulin in controlling blood glucose levels is measured. This is partly due to the 
technical ease of measuring blood glucose levels and partly because of the 
interrelationship between blood glucose levels and insulin secretion. The 
methodology of diagnosis of insulin resistance is described recently by Martinez et al. 
(1993), a summary of which is outlined below. 
The in vivo methods in use can be classified as `closed loop' techniques in which 
insulin and glucose concentrations are allowed to interact freely (e. g. Glucose 
tolerance tests with or without concomitant intravenous boluses of insulin), `open 
loop' techniques in which insulin and/or glucose levels are fixed (e. g. Euglycemic 
glucose clamp) and `model methods' in which a mathematical model would be used 
to analyse the interactions between insulin secretion patterns and glucose disposal. 
The euglycemic hyperinsulinemic glucose clamp, has become the gold standard for 
measurement of insulin action. This method uses a variable glucose infusion to 
maintain a constant plasma glucose level, whilst a high dose of insulin is infused 
systematically. The insulin infusion tends to increase peripheral glucose uptake and to 
suppress endogenous glucose output. The rate of glucose infusion is calculated to 
match the total reduction in the plasma glucose level induced by the insulin infusion. 
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It is thus a marker of insulin sensitivity. This method requires expensive equipment 
and considerable technical skill and is also labour intensive, therefore, it does not 
seem to be appropriate for population studies (Stanley et al. 1993). 
In the case of pregnant women, in vitro methods if accurate, would be more 
acceptable. Using the C2C12 mouse myoblast cell line, Bruce et al. (1994), have 
demonstrated that changes in insulin sensitivity with advancing pregnancy can be 
provoked by human pregnancy serum. This technique will be described later. What is 
basically examined in this technique is the possible effect of counter-regulatory 
hormones in the pregnant women's serum on insulin resistance. From a comparison 
of the results gained from this model system to those studies using the Euglycemic 
clamp technique at various gestational stages, it was concluded that the model was 
relatively accurate (Bruce et al. 1994). 
The relationship of obesity (insulin resistance) and type II diabetes 
mellitus 
Obesity as a state of chronic hyperinsulinemia is believed to be associated with insulin 
resistance. The fact that hyperglycaemia is a characteristic of obesity has been known 
since the early 1960s but the mechanism behind this remains mysterious. 
From a review of the available data, the hyperinsulinemia is initially due to hyper 
secretion by beta-cells to compensate the insulin resistance in obesity (Bonora et al. 
1984, Polonsky et al. 1988). Decreased hepatic removal of the hormone, although not 
as evident, is one of the other factors that has been suggested to have a role in 
hyperinsulinemia ( Davidson et al. 1987). With duration or severity of obesity, there 
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may be a further deterioration in insulin sensitivity. Nonetheless, glucose tolerance is 
only mildly impaired because the beta-cells are able to further augment their secretion 
of insulin, although it has been shown, that this increase is not fully compensatory. 
Beta-cells in obese persons are unable to secrete enough insulin to maintain the same 
glucose disposal rate as in lean controls (Bonadonna et al. 1990). Consequently, any 
event leading to a deterioration in glucose homeostasis, causes more sustained 
hyperglycaemia in obese persons than in normal weight individuals. If, moreover, for 
either genetic or environmental reasons, a modest loss of beta-cell mass occurs, the 
remnant pancreas, which under normal circumstances should still be able to guarantee 
glucose homeostasis, in obese persons fails to do so . 
It is also hypothesised that even mild hyperglycaemia could impair insulin secretion 
and aggravate peripheral insulin resistance. Based on the glucose toxicity concept 
which was proposed first by Unger and Grundy (1985), higher abnormal blood 
glucose levels per se could impair the ability of beta-cells to respond to a 
hyperglycaemic stimulus. The mechanism by which hyperglycaemia per se causes 
insulin resistance seems to be related to down-regulation of glucose transport in the 
insulin dependent tissues (Sasson et al. 1987). Another factor that is supposed to 
aggravate glucose metabolism and insulin resistance is the presence of elevated free 
fatty acids (FFA). By a substrate competition mechanism, FFA can potentially 
increase hepatic glucose output (gluconeogenesis) and impair glucose removal by the 
peripheral tissues (Struck et al. 1966). One study suggests that elevated FFA 
concentrations can also impair the interaction of insulin with its own receptor and 
some of the postbinding events involved in the transduction of the signal from the 
receptor to the effectors (Svedberg et al. 1990). These two last mentioned factors are 
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well documented in animal models of diabetes and in vitro systems. Slight 
hyperglycaemia and increased FFA supply/oxidation may account for the presence of 
the metabolic/hormonal abnormality that differentiate obese NIDD patients from non- 
diabetic obese individuals. In fact, once this pathogenic cascade has started, it has the 
potential to progress and become a vicious cycle that eventually leads to overt 
hyperglycaemia. However, prospective studies are still needed to confirm or disprove 
the concepts of this hypothesis. 
Relation of body fat distribution to metabolic complications of 
obesity 
Recent interest in the importance of metabolism in relation to fat distribution stems 
from the work of Vague (1956) which has gone on to demonstrate that women with an 
"android" type of fat distribution, predominantly in central, truncal sites have a greater 
frequency of diabetes than those with a more peripheral "gynoid" fat distribution. 
Indeed, epidemiological studies have documented that a central pattern of fat 
distribution, as characterised by an increased ratio of the waist to hip circumference, is 
a strong, independent predictor for the later development of NIDDM (Haffner et al. 
1990). 
In a study by Kissebah et al. (1982), plasma glucose and insulin levels during oral 
glucose loading were significantly higher in women with predominantly upper body 
segment obesity than in women with lower body segment obesity. Furthermore, 
significant correlations were observed between the abdominal fat cell size and glucose 
or insulin areas. 
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From this and other similar studies, the insulin resistance associated with obesity is 
clearly more pronounced in subjects with centrally localised obesity. On the other 
hand, some studies have defined visceral (intra-abdominal) fat mass to show the 
strongest correlation with insulin resistance (Björntorp 1989). Because WHR and 
visceral fat mass are highly correlated and both closely associated with insulin 
resistance, it seems likely that the risk subcompartment of the WHR is in fact, the 
visceral fat mass. Intra-abdominal fat storage is supposed to be from the hypertrophic 
type of adipocytes. 
Apparently, visceral fat has a higher turnover than other adipose tissue regions. This 
is probably because the lipolytic potential and FFA release, are amplified by the low 
effectiveness of insulin to inhibit lipolysis in these fat tissues (perhaps due to 
predominant hypertrophic adipocytes). The effect of FFA in abnormal metabolism, 
apart from increasing gluconeogenesis and impairing glucose storage, is suggested to 
involve diminishing insulin clearance as well (Strömblad and Bjöntorp 1986). 
In addition, increased levels of testosterone and cortisol (Jung 1984), as insulin 
antagonistic hormones have been observed in obese subjects with a central pattern of 
obesity. 
In summary, a specific pattern of metabolic, morphological, and hormonal features 
distinguish obese persons with a central fat distribution from obese individuals with 
peripheral fat localisation. Still, there are more studies needed to reveal whether this 
association of central fat distribution to abnormal metabolism is a cause-effect 
relationship or just a coincidence. 
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Carbohydrate Metabolism in Pregnancy 
During pregnancy fetal demand for fuel increases and this demand is met by increased 
energy intake, decreased energy expenditure and changes in fuel metabolism. The 
primary adaptation in energy utilisation during pregnancy includes a shift in the fuel 
sources. Fat becomes the major maternal fuel whereas glucose is the major fetal fuel. 
Approximately 50%-70% of the kilocalories required daily by the fetus in the third 
trimester are derived from glucose (Battaglia 1986). 
The changes in fuel metabolism has been described by Knopp et al. (1981) as two 
different metabolic phases in early and late pregnancy (figure 1.1). They called early 
pregnancy an "anabolic state" when maternal body is able to accelerate fat storage 
and enhance glucose removal from the circulation. At this stage the fetus is small in 
size and requires relatively few nutrients. In the latter part of gestation when fetal 
growth is much more rapid, they believed that there is a competition for glucose 
supply between the mother and the fetus. Consequently, the mother uses fat as an 
alternative fuel supply to glucose. This is based on the concept of "accelerated 
starvation" during pregnancy which was originally suggested by Freinkel (1965). 
According to his assumption, there is a tendency for an accelerated rate of fat 
mobilisation in this stage of pregnancy. This stage was called "catabolic phase" 
which comprises the last trimester of pregnancy. 
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Figure I. I. Fuel disposition in pregnancy. The upper panel (I) represents early 
gestation in which glucose is the primary maternal metabolic fuel and triglyceride 
fatty acids (TGFA) are stored. The lower panel (II) represents late gestation in which 
free fatty acids (FFA) are seen as the primary maternal metabolic fuels and glucose is 
diverted from maternal tissues for fetal use. (Knopp et al. 1981, with permission). 
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It has been reported that basal fasting glucose is slightly but significantly lower in 
pregnancy (Kitzmiller 1980). Also, a number of studies have shown a fall in the level 
of fasting plasma glucose as pregnancy advances to the third trimester (Lind et al. 
1973, Fisher et al 1974). This is in line with the above mentioned assumption of 
Knopp et al. The fall in the maternal plasma glucose may well be due to the enhanced 
consumption of glucose by the fetus, placenta and also by some of the expanding 
maternal tissues. The mother's body adapts to the situation to maintain glucose 
homeostasis, in part, by using other fuel substrates like fatty acids and sparing glucose 
for the tissues the most in need, fetus and placenta (Fraser 1991). Another way of 
adapting maternal body to the increased glucose requirements, is shown to be by 
increasing the capacity of gluconeogenesis (Kalham et al 1979). Perhaps the most 
effective way of adaption of maternal body to increased nutrient requirements in late 
pregnancy, is `the state of increased insulin resistance'. A loss of insulin action will 
result in greater substrate availability for feto-placental growth and energy needs 
(Catalano et al. 1991). 
Serial measurements of individuals and groups have shown a progressive elevation of 
insulin concentrations into the third trimester of pregnancy (Jovanovic et al. 1981). 
Nevertheless, despite the considerable increase in the insulin levels, there is a gradual 
decline in oral glucose tolerance during normal pregnancy (Kühl et al. 1975). These 
observations led the investigators towards the assumption of insulin resistance during 
pregnancy. Many investigators using different techniques, focused on verification of 
this assumption and the mechanism behind it. Using the euglycemic clamp technique, 
Catalano et al. (1991) showed that insulin sensitivity decreases significantly (56%) 
through to 36 weeks gestation from preconception level. 
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Further evidence that pregnancy induces a state of insulin resistance is the fact that 
gestational diabetes usually appears in late pregnancy and that such patients often 
require large amounts of insulin to attain glycemic control (Roversi et al. 1980). 
The reason for the insulin resistance in pregnancy is still unknown. Theoretically, it 
may be induced by either changes in insulin -receptor binding, postreceptor changes or 
a combination of both (Pederson 1984). As has been discussed previously, decreased 
insulin-receptor binding has been observed in human obesity and non-insulin 
dependent diabetes mellitus, which are like pregnancy, characterised by decreased 
glucose tolerance and increased insulin resistance (Pederson 1984). 
Most of the available data point to insulin-receptor binding, not being significantly 
decreased in the target tissues investigated, despite the hyperinsulinemia in late 
pregnancy. Furthermore, significant differences in insulin receptor binding between 
pregnant women with normal glucose tolerance and normal weight women with 
untreated GDM have not been found. This implies that the pregnancy-induced insulin 
resistance must be due to postreceptor changes and that the difference in glucose 
tolerance between normal pregnant women and women with GDM can not be 
attributed to a different insulin receptor binding (Kühl 1991). 
The other possible mechanism explained for insulin resistance in pregnancy is the 
high rate of anti-insulin hormones such as oestrogen, prolactin, human placental 
lactogen (HPL), cortisol and progesterone (Jovanovic and Peterson 1991). The timing 
of hormonal presentation in pregnancy is observed to be in inverse order to their 
relative gluconeogenic properties. For example, human chorionic gonadotropin 
(HCG), is in higher values in early pregnancy which has no gluconeogenic effect and 
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cortisol, a relatively late appearing hormone, has the most potent gluconeogenic 
effect. 
In contrast to the report of Kühl (1991), insulin resistance during pregnancy, has been 
suggested to be due to the alterations of the number or affinity of insulin binding sites 
on receptor cells (Pagano et al. 1980). The changes in insulin binding are believed, 
however, to be mediated at least in part by hormonal changes that occur during 
pregnancy (Jovanovic and Peterson 1991). 
Despite all the above mentioned changes, in normal situations, the pancreas can 
increase insulin production to compensate the effect of resistance to insulin. 
However, 1% to 5% of women fail to do so and develop gestational diabetes, or 
carbohydrate intolerance (Fraser 1994). Having said that, there is still controversy 
concerning the true defect in gestational diabetes and this argument may arise from the 
fact that gestational diabetic women constitute a heterogeneous group with varying 
patterns of insulin secretion (Hadden 1985, Hollingsworth 1983). 
Based on our previous discussion, maternal obesity could represent a significant risk 
factor for the development of gestational diabetes mellitus and subsequent adult onset 
diabetes. However many overweight women do not manifest carbohydrate intolerance 
when they are carefully screened during pregnancy. 
It has also been mentioned that upper body obesity is an apparent marker for both 
impaired glucose tolerance and hyperinsulinemia. In addition obese women who 
formerly had gestational diabetes mellitus have elevated waist to hip ratios compared 
with control women matched for body weight (Ward et al. 1985). Hence, maternal 
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body shape (body fat distribution) may explain more the heterogeneity of 
overweightness and carbohydrate metabolism during pregnancy. 
Currently, however, there is little data available concerning the relationship between 
maternal fat distribution and carbohydrate metabolism during pregnancy. We 
therefore sought to investigate whether maternal obesity per se, or more specifically 
body fat distribution is associated with alterations in carbohydrate tolerance observed 
during normal pregnancy. 
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The effect of maternal anthronometrv and metabolic 
changes on fetal growth 
As it has been pointed out earlier, certain changes occur during pregnancy in maternal 
anthropometry and physiology. In terms of lipid metabolism, fatty acid oxidation and 
production increase (Knopp et al. 1973). The consequent changes; increased glucose 
production, hyperinsulinemia, increased insulin resistance and elevation of plasma 
lipids are consistent with early diabetes in the nonpregnant person. Therefore, 
pregnancy has been described as a "diabetogenic" state. As long as these 
physiological changes are within a normal range, not only are they beneficial to the 
fetus but also essential for its normal growth. If these alterations exceed significantly 
those levels in normal pregnancy, because of other causes of pancreatic deficiency or 
conditions such as obesity, gestational diabetes will occur. In this state one is 
concerned about fetal growth. 
In understanding both the maternal adaptations to pregnancy and their effects upon the 
infants, the flow of the substrates across the placenta could be important. It is known 
that glucose freely crosses the placenta by facilitated diffusion (Jovanovic and 
Peterson 1991). Observations in many species, including man, indicate that fetal 
blood glucose concentration is always lower than that of the mother and this could be 
because the main process for glucose transfer is dependant on the capacity for passive 
diffusion of glucose. 
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Nevertheless the transport of insulin through the placenta in either direction is shown 
to be impaired (Spellacy et al. 1973c). Normally the fetus produces its own insulin in 
low amounts and this is an important hormone regulating its growth. The blood 
glucose of the fetus is normally controlled on the maternal side of the placenta by the 
maternal insulin. The fetal beta cells are relatively unresponsive to a glucose stimulus 
(Spellacy et al. 1973d). In the case of infants of diabetic mothers however, 
hyperinsulinaemia occurs which frequently results in neonatal hypoglycaemia. 
Hyperglycaemia and hyperinsulinaemia in utero produces infants which are 
excessively large and obese (macrosomic) and this typifies the infants of diabetic 
mothers. 
The metabolic fuels that are transferred in excess from mother to fetus are potent 
insulin secretagogues. Chronic exposure of the fetal pancreas to these substrates 
could result in beta cell hyperplasia and augmented insulin secretion. Insulin is 
believed to promote and control the utilisation of metabolic fuels by the fetal tissues 
cultured in-utero and hence, plays a pivotal role in the control of fetal development. 
Although, studies on offspring of twins in a Scandinavian population have provided 
evidence that the major part of the variation in birth weight is genetic (Magnus et al. 
1984), the wide variation of birth weight in normal pregnancy could be due to the 
physiological variation in maternal glucose metabolism. Maternal fat mass has been 
found to correlate with maternal insulin levels in late pregnancy (Karam et al. 1963). 
Moreover, various parental morphometric factors, in particular, maternal pregravid 
weight and weight gain during gestation, have been suggested to correlate with fetal 
growth and birth weight. Including other factors such as gestational age and sex can 
improve the correlation but the overall correlation remains low (Thomson et al. 1968). 
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This triggers the assumption that in addition to genetic factors, other maternal 
environmental factors must have an important effect on fetal growth. 
Despite the wide investigations on fetal growth, much remains to be understood. The 
regulation of fetal growth involves a complex mechanism; including the mother and 
the placenta as well as the fetus. The majority of the studies on fetal growth, 
considered only one or few factors (mainly maternal pregravid weight and gestational 
weight gain) in relation to infant birth weight. Therefore, in addition to assessing the 
magnitude of the changes in maternal anthropometry during and after pregnancy, the 
purpose of the following study is to evaluate the relationship of maternal carbohydrate 
metabolism with placental weight and neonatal anthropometric measurements. It also 
seemed to be of interest to study the interrelationship between maternal BMI, maternal 
fat mass, fetal insulinisation and fetal growth. 
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Aims and Objectives: 
Our intention was to examine further the question of fat storage by means of a 
longitudinal prospective study to establish changes in body fat during normal 
pregnancy and the postpartum period, and also its relationship to fetal metabolism, 
new-born anthropometry and early infant growth. More precisely the aims were to: 
9 Study maternal anthropometry and body composition longitudinally during 
pregnancy in healthy volunteers. 
" Investigate the effect of initial maternal BMI on the magnitude of the 
anthropometric changes during pregnancy. 
" Conduct postpartum follow up studies of maternal fat distribution in relation to 
changes seen in pregnancy and also in relation to maternal body type. 
9 Establish any relationship of obesity/type of fat distribution to glucose tolerance 
test results in late pregnancy. 
" Investigate the metabolic status of the new-born in relation to maternal body 
composition and degree of obesity, by measurements of neonatal anthropometry 
and insulin levels of cord blood. 
69 
Chapter 2 
Material and Methods 
Subjects: 
A verbal approach was made to 150 pregnant women to see if they were interested in 
taking part in the study. A total of 127 agreed to participate and were actually 
measured for the first time. They all gave written consent after the aims and methods 
of the study had been explained. 
Women were classified to four groups of under-weight (UW: BMI<19.8), normal- 
weight (NW: 19.8-26), over-weight (OW: >26-29) and obese (OB: >29) based on 
their BMI in early pregnancy (Institute of Medicine 1990). Attempts were made to 
have 30 subjects in each BMI group but due to restriction of timetable, 9 UW, 32 OW, 
36 OB and 50 NW women were recruited. It was observed that there was hesitation 
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on the part of overweight group to discuss body composition , surprisingly 
however, 
the obese group were amongst the most co-operative subjects. 
The subjects had singleton pregnancies and were not on any chronic drug therapy. At 
the time of recruitment, none of the subjects was known to be diabetic. 
Racial characteristics: 
The majority of the subjects were Caucasians, there were only one Indian (NW), two 
Afro-Caribbean (NW), one Pakistani (UW), and one Arab subject (OW). From the 
last two mentioned subjects; one withdrew due to lack of time and the other one 
however was excluded due to premature labour (24 wks). 
Study Design 
Women were recruited from the Antenatal Clinics of Northern General Hospital in 
Sheffield. The recruitment was started on March 1st 1994 and it was completed on 
11.10.94. The measurements on the last mother and baby was performed on 11.11.95. 
Total body fat (TBF) was estimated in a longitudinal study by using Bioelectrical 
Impedance (BI) and Skinfold Thickness Measurement (STM). 
Serial measurements of anthropometric and body fat composition were made on three 
occasions during pregnancy and in two occasions after delivery on mothers. The 
gestational age was calculated from the date of the last menstrual period, confirmed by 
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the ultrasound scanning at booking visit. The time and the number of subjects 
measured in each occasion are as follows: 
Table 2-1. The time in which measurements were made: 
Visits during pregnancy gestational age (weeks) Number of subjects 
Median (range) 
1 13 (9 -15)* 127 
2 25 (23-32)t 78 
3 36 (33-40) 80 
postpartum 
46 weeks 51 
56 months 48 
*: Only one subject was studied at 5 weeks. 
t: Four subjects failed to attend when first were requested and were studied at 32 weeks. 
Anthropometric data (e. g. weight, length, head circumference) was also collected on 
50 infants within 48 hours of birth. Birth weights and placental weights were 
obtained later from the hospital notes. Fifty one women and their babies remained in 
the study at six weeks and 48 at six month postpartum (of three women who left the 
study, one had a subsequent pregnancy at 8 weeks postpartum, the other two could not 
afford the time). 
Cord blood samples were collected from 62 new-borns (of women who were studied 
during pregnancy) at birth in order to assess the insulin and C-peptide levels. 
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Glucose tolerance tests were performed on 38 volunteer pregnant women who were 
already taking part in the longitudinal study (including 2 UW, 6 NW, 11 OW and 19 
OB) at 28-31 weeks gestation. 
In vitro assessments of insulin sensitivity were performed on plasma from 12 pregnant 
women. For the details of collected data refer to appendix 2. 
Ethics Committee Approval: 
The protocol was submitted on February 14th 1994 and approved by the Ethics 
Committee of Northern General Hospital . An information sheet and a consent 
form 
was made available for the subjects (these were attached to the protocol, Appendix 3). 
Based on the guideline 4 of the Data Protection Act (1984), the content of the study 
was described for women (verbally and in writing). The subjects were given the 
opportunity to ask any question in relation to the clarity of the study. There was no 
pressure on women to take part or continue taking part in the study. Volunteers were 
assured about the confidentiality of the collected data. The subjects were also offered 
feedback following the completion of the study. A summary of the findings was sent 
to the volunteers who were interested in the results. 
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Methods 
Skinfold thickness measurements 
All skinfold measurements were made by one observer (the author), with a Holtain 
skinfold calliper, exerting a constant pressure of 10 g/mm2. Its dial is marked in 
divisions of 0.2 mm but readings of 0.1 can be easily estimated (Holtain LTD, 
Crymych, UK). The procedure was carefully standardised, and each measurement 
was made in triplicate on the left side of the body; the results were averaged. The 
skinfold measurements quoted include double layers of skin and of subcutaneous 
tissue. During the measurements, the subjects were standing comfortably erect with 
the upper extremities relaxed at the sides of the body. The calliper jaws were applied 
1 cm distal to the thumb and finger raising the fold, and the thickness was recorded to 
the nearest 0.2 mm. The sites and the relative techniques used, are as follows: 
Triceps: The triceps skinfold was measured in the mid-line of the posterior aspect of 
the arm, midway between deltoid process and olecranon, over the triceps muscle. 
Biceps: This was measured as the thickness of a vertical fold raised on the anterior 
aspect of the arm (at similar place to the triceps), over the belly of the biceps muscle. 
Suprailiac: This was measured in the mid-axillary line immediately superior to the 
iliac crest. An oblique skinfold was grasped just posterior to the mid-axillary line 
following the natural cleavage lines of the skin (which is aligned inferomedially 45° to 
the horizontal). 
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Subscapular: Just below the inferior angle of the scapula was picked up and 
measured approximately 45° to the horizontal plane in the natural cleavage lines of the 
skin. 
Mid thigh: The thigh skinfold was measured in the mid-line of the anterior aspect of 
the thigh, midway between the inguinal crease and the proximal border of the patella. 
This was performed while the body weight was shifted to the other foot, to leave the 
measuring leg relaxed. 
Hip Circumference: 
An inelastic tape was placed around the buttocks at the point yielding the maximum 
circumference in a horizontal plane without compressing the skin, while the subject 
was standing erect with her arms at the sides and the feet together. The subjects wore 
only non-restrictive briefs. The measurement was recorded to the nearest 0.1 cm. 
Waist Circumference: 
The subjects were undressed and the measurements were performed directly on the 
skin. The measurements were made at the level of umbilicus with the subject 
standing, her arms by her sides and her feet together. The measurements were 
recorded to the nearest 0.1 cm. 
Maternal height 
Maternal height was measured in the subject (without shoes) with the heels together 
and with the so-called Frankfurt plane of the head in a horizontal position (WHO 
1987). The subject was asked to breathe in deeply with the legs stretched but the feet 
flat on the ground. 
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Presence of generalized oedema 
Generalized oedema was assessed by physical examination of the mothers, and asking 
questions about tightening of their rings. It was also checked in the maternal records 
following the routine antenatal check up. 
Maternal body weight and fat mass 
Maternal body weight (MBW) was measured in a light clothing (without shoes) with a 
Seca scale (760 Cranlea, Birmingham). MBW was measured to the nearest 0.1 kg. 
The same balance was used throughout the study. Body fat mass was assessed by two 
methods: the Skinfold method and Bioelectrical Impedance method. 
By the Skinfold method body fat mass was derived from the sum of the four skinfold 
measurements (triceps, biceps, suprailiac, and subscapular) and body weight using 
equations presented by Durnin and Womersley (1974): 
Density = 1.1599 - 0.0717 x log (triceps + biceps + subscapular + supra-iliac) 
Percentage body fat was then calculated from the body density values obtained, using 
Siri's equation (1956): 
Percentage body fat = [(495/body density) - 450] x 100 (1) 
For measurements made throughout pregnancy, the specific pregnancy equations (Van 
Raaij et al. 1988) that account for the altering composition of the maternal fat-free 
body throughout pregnancy, were also used to convert body density to percentage 
body fat: 
for 12 wk gestation FM = W/100 x (497/D - 452.3) (2) 
for 24 wk gestation FM = W/100 x (504.3/D - 460.4) (3) 
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and for 36 wk gestation FM = W/100 x (516.3/D - 473.7) (4) 
These were compared with the results using the equation of Siri (1956) for conversion 
of body density (from STM) to percent body fat. 
In addition to four above mentioned skinfolds, midthigh skinfold was also measured 
as an indicator of peripheral pattern of fat distribution. From direct comparison of 
these skinfolds, changes in fat distribution during pregnancy and postpartum were 
studied. 
BMI: Body mass index was measured as: weight/height2 (kg/m2). 
WHR: Waist hip ratio was measured as: Waist circumference/Hip circumference 
(cm). 
In order to determine the reliability of the measurements, 6 non-pregnant women were 
measured on four occasions within the same day. Table 2.2 shows the mean and 
coefficients of variation between each measurement on the same subject. 
Table 2.2. Mean and coefficients of variation between skinfold 
measurements on the same subjects (n=6) 
Mean Coefficients of Variation 
Triceps 23.51 3.1% 
Biceps 11.39 8.2% 
Subscapular 18.01 7.0% 
Suprailiac 15.59 7.3% 
Midthigh 39.65 2.4% 
Total skinfolds 108.15 2.1% 
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The results of our experimental study was consistent with the similar one (which was 
performed with a single experienced observer) in the study by Taggart et al. (1967). 
As in their study, biceps and suprailiac involved a higher degree of inaccuracy than 
the others. However, the agreement between replicates were shown to be reasonably 
good (in fact the variability of our study was slightly less than the study by Taggart). 
In this part, the subjects were divided to two groups of BMI? 25 and BMI<25. As we 
expected, the values of coefficients of variation were higher in the group with the 
greater BMI, indicating less reliability of skinfold measurements in the overweight 
group (table 2.3). 
Table 2.3. A comparison of coefficients of variation on 
skinfold measurements in two groups of under and over 
BMI: 25. 
BMI >_ 25 BMI < 25 
Measurement Mean Coefficients Mean Coefficients 
sites of Variation of Variation 
Triceps 28.36 3.3% 18.66 2.9% 
Biceps 15.37 11.9% 7.41 4.6% 
Subscapular 17.68 6.4% 18.34 7.5% 
Suprailiac 18.33 8.3% 12.82 5.8% 
Mid-thigh 43.36 2.1% 35.94 2.8% 
Total skinfolds 123.09 2.3% 93.16 1.6% 
The coefficients of variations between the 4 consecutive measurements of waist, hip, 
mid-thigh and up-thigh circumference on the same subjects (n=6) were 1.2%, 0.7%, 
0.5%, 0.6% respectively. 
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Bioelectrical Impedance 
The four electrode Bioelectrical Impedance Analyser (BIA EZ Comp 1500 Cranlea 
UK) was used to measure the body composition of the women. 
In our experimental study (6 non-pregnant women), we actually noticed a great deal of 
variability after having a big meal (less than 2 hours), coffee and tea did not show any 
effect on the obtained data. The measurements therefore, were made on average, at 
about 3 hours after a meal. 
During the measurements the subjects 
wore clothes but no shoes or socks, and 
were supine on a couch. Measurements 
were taken on the left side of the body. 
After cleaning with alcohol and drying 
all skin contact areas, arginine foil spot 
electrodes were placed on the dorsal 
surfaces of the hands and feet at the 
distal metacarpals and metatarsals 
respectively, and also between the medial 
and lateral malleoli at the ankle (Figure 
2-1). 
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Figure 2.1. Diagrammatic representation 
of impedance using a four electrode 
arrangement. 
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The more detailed placement of the sensors are described below: 
On the back of one hand the sensor pad was placed on the third knuckle of the middle 
finger. The second pad was placed on the arm just behind the wrist at the crease 
observed when the hand is bent back. The edge of the sensor pad was placed to just 
touch the crease. The pad on the foot was applied just below the place where the big 
toe and the first toe join. The position for the sensor pad at the ankle was found by 
placing the thumb and forefinger on the two protruding bones on either side of the 
ankle and then bringing the fingers forward to the midway point between the two 
bones. The sensor pad was then placed at the bend of the ankle, in line with the tibia. 
Infant weight measurements 
An Electronic Digital Baby Scale (727 digital scale, Seca, Cranlea, Birmingham) was 
used. A light weight towel was left on the scale and then the scale was calibrated to 
zero each time. The infant was weighed without any clothes and nappy (nude). The 
baby was placed on the scale so that the weight was distributed equally on each side of 
the center of the pan. Weight was recorded, to the nearest 5 g, with the infant lying 
quietly (which sometimes required a great deal of patience! ). 
Infant length measurements 
Recumbent length of the infant was measured using the rollometer (511A 100 cm, 
Raven, Castlemead publication, UK). This equipment is made of material that is 
warm to the touch and is especially made for infants. The infant's head was held in 
the Frankfurt plane position aligned perpendicular to the measuring table. The legs 
were extended at the hips and knees so they would lie flat against the tabletop. Giving 
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a brief instruction to the mother, she was asked to position the infant's head against 
the headboard. In the meanwhile, putting one hand on the knees of the baby to ensure 
the legs remain flat on the table, the movable board was firmly pushed against the 
heels. The measurement was read direct from a cursor line. The length was recorded 
to the nearest 0.1 cm. 
The pressure applied to the foot-board was tried to be sufficient to compress the soft 
tissues of the foot but not enough to alter the length of the vertebral column. The 
accuracy of the instrument is claimed to be zero to minus 3 mm. 
Infant head circumference 
The head circumference of the baby was measured when lying on the bed. An 
adjustable round and non-stretching tape about 0.6 cm wide (Lasso, Child growth, 
London) was used. Anteriorly, the tape was placed just superior to the eyebrows and 
posteriorly it was placed over the bony occiput so that the maximum circumference 
was measured. The tape was pulled tightly enough to compress the hair. The 
measurement was recorded to the nearest 0.1 cm. 
Glucose Tolerance Test 
Glucose tolerance tests were performed on 38 pregnant women at 28-31 weeks 
gestation (mean 29 weeks). The subjects had been instructed: 
-Not to eat anything after 10.00 p. m. on the night before the test and not to have 
breakfast on the day of the test. 
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-Not to drink or eat or smoke during the test. 
The test was started at 9.00 am when a capillary blood sample of 0.2 ml by finger 
prick was obtained. A standard glucose drink (75 g glucose dissolved in 200 ml 
water) was given to the women. They remained at rest until another capillary blood 
sample was taken two hours after the drink. 
Blood samples were collected in the mini-tubes containing fluoride heparin 
(anticoagulant agent) and they were assayed within 2 hours of collection. 
The blood samples were then centrifuged and serum glucose was measured by the 
glucose oxidase method with a Glucose Analyser (Yellow Springs Instrument [YSI], 
Model 23 AM, Clandon Distributor, UK). The principles of the Glucose Analyser 
method is described in appendix 1. 
Criteria from the Report of the Second Meeting of the World Health Organisation 
Expert Committee on Diabetes Mellitus (WHO 1985) were applied to classify the 
impaired glucose tolerance and gestational diabetes. The diagnostic criteria for 
capillary plasma, which was used in our study are as follows: 
Table 2.4. Diagnostic criteria for gestational diabetes from capillary plasma (WHO 
1985). 
Glucose concentration, mmol/litre (mg/dl) 
Impaired Glucose Tolerance Gestational diabetes 
Fasting values < 7.8 >_ 7.8 
2 hrs value after 75 g 8.9-12.2 > 12.2 
glucose load 
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Measurement of infant insulin and C-peptide levels: 
Cord blood collection: 
Cord blood samples were collected in test tubes containing fluoride heparin. 
Thereafter, they were centrifuged at 2000 r. p. m. for 15 minutes to separate the plasma 
from the blood cells. The golden coloured plasma was pipetted off and placed in a7 
ml sample tube, labelled with the mother's name and were stored at -20° C before 
assay. 
Serum insulin and C-peptide levels were measured by a double antibody 
radioimmunoassay technique in our laboratory (Clinical Sciences Centre). The limit 
of sensitivity for each assay is insulin 2.5 . tU/ml, C-peptide 0.47 ng/ml. The 
interassay and intraassay coefficients of variation were 7.4% and 6.8% for insulin, 
8.5% and 6.4% for C peptide. 
C-peptide measurements 
Guildhays's C-peptide RIA kit which is especially designed for the determination of 
C-peptide in human serum was used (Appendix 1). 
Standards, non specific binding (NSB) controls and subjects samples were incubated 
with C-peptide antiserum reagent for 24 hours. The C-peptide tracer reagent (labelled 
with Iodine-125 isotope) was then added and allowed to react for a further 24 hours at 
+4°. Separation was achieved by incubation with the separation reagent for 30 
minutes, followed by centrifugation and decantation of supernatants. C-peptide 
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concentrations were calculated from the measurement of the bound fractions 
(separation reagent pellets) in a gamma counter. 
The sample and standard counts were expressed as a percentage bound of total counts, 
minus the "NSB Control" counts. 
A standard curve was drawn by plotting the percentage bound of each standard against 
the respective concentration. Each sample concentration (C-peptide level in mmol/L) 
was obtained by interpolating the sample percentage bound on the standard curve. 
Insulin measurements 
The technique for the measurements of plasma insulin levels was very similar to that 
of C-peptide measurements. The antisera was guinea-pig antisera, again from 
Guildhay. Known aliquots of samples (50 µL) were incubated with the antisera for 
approximately 16 hours. The insulin was then labelled with Iodine-125 (this is from 
life screen LTD) during a 24 hour incubation. The assay was terminated by a2 hour 
phase separation using a second antiserum (anti guinea-pig precipitating rabbit 
serum). The difference with the C-peptide measurement was that a separate 
polyethyleneglycol (PEG) accelerator solution and pH buffer was added with the 
second antibody. The sample tubes were again centrifuged and the supernatant 
removed. The tubes were then counted for gamma radiation. 
The plotting of the standard curve and calculation of the insulin levels were attained in 
a similar manner to that of C-peptide. 
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Haemolysis to any degree could greatly affect on the accuracy of the insulin assay but 
not the C-peptide (O'Rahilly et al. 1987). Therefore, in samples that appeared to be 
haemolysed only C-peptide was measured. 
Insulin was measured in mU/1. This value can be converted to mmol/ml for a direct 
comparison to C-peptide which is measured in mmol/ml (Lin et al. 1981). 
In vitro measurements of insulin sensitivity: 
To study longitudinal changes in insulin sensitivity throughout pregnancy blood 
samples were taken from 32 women at early (10-15 weeks gestation), and late 
gestation (33-36 weeks). Seventeen samples were also available from the middle of 
pregnancy (24-28 weeks gestation). From the total (32 women) 3 were excluded, due 
to having GDM (two cases) and IGT (one case). Efforts were made to have the blood 
samples at the same time as routine blood sampling at the ante natal visits. The data 
on blood samples are enclosed in appendix 2. 
The blood samples were collected in test tubes containing lithium heparin and then 
they were centrifuged within 2-3 hours (they were kept in the fridge before the 
centrifugation). The plasma was pipetted and stored in -20° C. Because of the time 
consuming nature and expense of these experiments, the blood samples of 12 
(randomly selected) subjects (see appendix 2, marked subjects) were assessed. The 
samples from the rest remain frozen for the possible future studies. 
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An in vitro method of tissue cell culture; the myoblast cell line ( developed by Bruce 
et al. 1994) has been used to evaluate the effect of pregnant sera on the insulin 
stimulated glucose uptake by the C2C12 mouse myofibres. 
C2C12 myoblasts and myofibres : 
Cells were seeded into 12 well plates at 104 cells per well in high glucose (25 mM) 
DMEM (Dulbeccos Modified Eagles Medium) containing 10% fetal calf serum (FCS) 
and grown until confluent when the medium was changed to high glucose DMEM 
containing 2% horse sera. Differentiation was usually complete within 4 days and 
cells were used between 4-7 days. 
Incubation with sera from pregnant subjects: 
Fully differentiated myofibres were incubated with media supplemented with 10% 
sera from pregnant subjects for 24 hours with and without 10"7 M insulin. Media was 
removed and cells assayed for glucose uptake. 
Glucose uptake measurements: 
The growth media was removed from the wells and replaced by 0.5 ml of glucose free 
RPMI' medium containing 2% horse serum and the appropriate concentration of 
insulin. Cells were then incubated at 37° C for 15 minutes when 5Oµ1 of 2.22 mM H3 
2-deoxyglucose were added (final concentration 0.2 mM) and the cells incubated for a 
1 RPMI: Roswell Park Memorial Institute (liquid media for cell culturing) 
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further 10 min. The medium was then removed, the cells washed twice with cold 
phosphate buffered saline (PBS) and then dissolved in 1.0 ml of 1.0 M NaOH. 
Aliquots were then taken for counting and protein determination. 
(Insulin and C-peptide measurements as well as the actual experiment of in vitro 
insulin sensitivity was conducted by Mrs Bruce; Senior technician in the laboratory of 
Obstetrics and Gynaecology, Clinical Sciences Centre). 
The full details of each experiment can be seen in appendix 1. 
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Statistical Analysis 
The data are presented as meant SD for quantitative variables. Statistical significance 
was considered to be present at the 0.05 level. All the data were analysed using 
statistical package for social sciences (SPSS). 
In order to assess the relationship between the two methods of measuring body fat 
mass (Bioelectrical Impedance and Skinfold thicknesses Measurements), the analysis 
of measurement method comparison data (Bland and Altman, 1986) were performed. 
Mean differences (dif) and the level of agreements (dif ±2 SD) were calculated to 
know by how much these two methods are different. Pearson correlation coefficient 
(r) were determined to investigate the strength of the relationship between the two 
methods. The two values of fat mass by STM, using two different formulae were also 
compared in the same way. 
Maternal body weight (MBW), total skinfold thickness (TSF), fat mass (FM), lean 
mass and water content of the body were studied during pregnancy and postpartum. 
Serial changes of each variable were reported for the all subjects, and the results were 
compared between the groups using summary measures. 
Summary measures (Mathews et al. 1990) were obtained for each study, allowing 
comparison of the selected features of each woman over time. This method is 
believed to be the most useful approach to the analysis of serial measurements. It uses 
the individual as the basic unit and has the ability to cope with missing observations 
and variable timing of the observations. The summary measures calculated, were rate 
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of changes, the absolute differences between certain points and also delta area under 
the curve (AAUC). The summary measures were then compared using one way 
ANOVA (Tukey's honestly significant difference test). 
Rate of changes in maternal body weight, total skinfold thickness and fat mass were 
compared for the whole study group from 13 weeks to 24 weeks (rate 1-2) with 24 to 
36 weeks (rate 2-3), using student paired t-test. 
Pearson and Spearman correlation coefficient were used as appropriate to correlate 
infant birth weight to various maternal and fetal variables. 
Multiple linear regression analyses (forward method) were performed to assess the 
interrelationships between each of the new-born anthropometric indicators (weight, 
length and head circumference) with maternal anthropometry and lifestyle habitus as 
well as fetal insulinisation, sex and length of gestation. The Coefficient of multiple 
determination (R) is given to express the extent of variation in a given birth 
parameter explained by the subset of variables included in the model. Caution should 
be used in interpreting the coefficients because they reflect the influence of other 
predictor variables in the equation. 
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Chapter 3 
Results 
Of 127 subjects who agreed to take part in the study, four cases were later excluded 
from the study. One of them developed pregnancy induced hypertension (PIH), 
leading to premature delivery. There was also one case of idiopathic premature labour 
(24 weeks), one subject moved out of the country and the baby of one subject died on 
the first day postnatal, secondary to unexplained Antepartum Hemorrhage (APH). 
This left 123 pregnant women of whom 68 completed 3 visits during pregnancy (semi- 
longitudinal); 48 of whom completed the whole longitudinal study. The remainder 
made less frequent visits, the number of subjects in each visit can be seen in table 2-1. 
The main reason for not being able to participate in all stages of pregnancy was stated 
to be the lack of time due to pressure of motherhood. Because of the variability of the 
numbers of participants in each stage of the study, the numbers of subjects will be 
given in the relevant section. 
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A compilation of anthropometric, obstetrics and basic characteristics of the whole 
group and also of each BMI group at the first visit can be seen in table 3.1-5. 
Table 3.1. Characteristics of the whole study group (n=123) 
mean SD range 
Early pregnancy weight (kg) 71.41 16.24 (39.00 - 117.50) 
prepregnancy body weight (kg)* 67.52 15.80 (36.00 - 110.00) 
Height (m) 1.62 0.05 (1.50 - 1.77) 
Body mass index (kg/m2) 26.95 5.82 (16.44 - 45.89) 
Waist-hip ratio 0.90 0.11 (0.75 - 1.74) 
Age at first visit (y) 25.89 4.78 (15.00 - 43.00) 
Gravida 2.21 1.20 (1.00 - 7.00) 
Parity 0.82 0.85 (0.00 - 4.00) 
Gestational age at 1st visit (wks) 13.17 1.73 (5.00 -15.00) 
TSF (mm)t 111.97 40.64 (41.95 - 193.70) 
fat mass (kg) (STM)$ 23.57 9.85 (6.56 - 50.23) 
fat mass (kg) (BI)4 25.66 11.34 (7.00 - 58.00) 
lean mass (kg) 4 46.06 6.19 (32.00 - 67.20) 
water content (L) 4 30.46 3.93 (22.00 - 40.00) 
Length of gestation (wks) 39.20 1.40 (35.00 - 42.00) 
Infant birth weight (g) 3456.20 492.96 (2510.00 - 4480.00) 
Placental weight (g) 620.04 126.56 (335.00 - 945.00) 
n= 85, self reported values. 
t: Total skinfolds (sum of skinfolds: triceps, biceps, subscapular, supra-illiac and midthigh). 
$: As measured by Skinfold thickness measurements at first visit. 
4: As measured by Bioelectrical Impedance at first visit. 
91 
Table 3.2. Characteristics of Under-weight group (n = 9) 
mean SD range 
Early pregnancy weight (kg) 51.77 6.75 (39.00 - 59.00) 
prepregnancy body weight (kg)* 51.26 9.46 (36.00 - 58.00) 
Height (m) 1.65 0.07 (1.54 - 1.74) 
Body mass index (kg/m2) 18.77 1.01 (16.44 - 19.48) 
Waist-hip ratio 0.85 0.05 (0.78 - 0.95) 
Age at first visit (y) 22.33 4.41 (15.00 - 29.00) 
Gravida 2.33 1.11 (1.00 - 4.00) 
Parity 1.00 0.70 (0.00 - 2.00) 
Gestational age at 1st visit (wks) 12.55 2.35 (9.00 -15.00) 
TSF (mm)t 56.50 10.66 (41.95 - 68.41) 
fat mass (STM) (kg) $ 10.49 2.13 (6.56 - 13.18) 
fat mass (BI) (kg) ý" 11.44 2.06 (7.00 - 14.00) 
lean mass (kg) 4 40.33 4.94 (32.00 - 45.00) 
water content (L) + 26.77 3.89 (22.00 - 32.00) 
Length of gestation (wks) 38.66 0.86 (37.00 - 40.00) 
Infant birth weight (g) 3151.11 323.70 (2740.00 - 3820.00) 
Placental weight (g) 601.11 142.69 (410.00- 830.00) 
n=5, self reported values. 
t: Total skinfolds (sum of skinfolds: triceps, biceps, subscapular, supra-illiac and midthigh). 
1: As measured by Skinfold thickness measurements at first visit. 
ý: As measured by Bioelectrical Impedance at first visit. 
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Table 3.3. Characteristics of Normal-weight group (n = 48) 
mean SD range 
Early pregnancy weight (kg) 60.17 6.18 (46.00 - 71.00) 
prepregnancy body weight(kg)* 56.97 4.98 (45.21 - 66.04) 
Height (m) 1.62 0.06 (1.50 - 1.76) 
Body mass index (kg/m2) 22.68 1.30 (20.02 - 24.67) 
Waist-hip ratio 0.87 0.06 (0.75 - 0.99) 
Age at first visit (y) 25.35 5.16 (16.00 - 43.00) 
Gravida 1.93 1.15 (1.00 - 6.00) 
Parity 0.62 0.81 (0.00 - 4.00) 
Gestational age at 1st visit (wks) 13.16 1.50 (9.00 -15.00) 
TSF (mm)t 82.46 23.22 (44.15 - 161.33) 
fat mass (STM) (kg) $ 16.44 3.69 (9.51 - 24.85) 
fat mass (BI) (kg) 4 16.89 3.45 (10.00 - 25.00) 
lean mass (kg) 4 43.85 5.66 (34.00 - 67.20) 
water content (L) 4" 28.97 3.13 (23.00 - 37.00) 
Length of gestation (wks) 39.43 1.44 (35.00 - 42.00) 
Infant birth weight (g) 3341.97 481.07 (2565.00 - 4450.00) 
Placental weight (g) 589.70 131.73 (335.00 - 945.00) 
*: n= 35, self reported values. 
t: Total skinfolds (sum of skinfolds: triceps, biceps, subscapular, supra-illiac and midthigh). 
$: As measured by Skinfold thickness measurements at first visit. 
4": As measured by Bioelectrical Impedance at first visit. 
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Table 3.4. Characteristics of Over-weight group (n = 32) 
mean SD range 
Early pregnancy weight (kg) 71.32 6.24 (59.00 - 83.00) 
prepregnancy body weight (kg)* 67.29 9.26 (57.15- 86.99) 
Height (m) 1.60 0.05 (1.51 - 1.70) 
Body mass index (kg/m2) 27.53 1.34 (25.39 - 29.93) 
Waist-hip ratio 0.91 0.07 (0.78 - 1.06) 
Age at first visit (y) 26.70 4.92 (18.00 - 36.00) 
Gravida 
Parity 
Gestational age at 1st visit (wks) 
TSF (mm)t 
fat mass (STM) (kg) $ 
fat mass (BI) (kg) 4 
lean mass (kg) 4 
water content (L) + 
Length of gestation (wks) 
Infant birth weight (g) 
2.29 1.34 (1.00 - 7.00) 
0.93 0.78 (0.00 - 2.00) 
12.96 1.64 (9.00 -15.00) 
124.90 21.72 (66.86 - 166.46) 
24.60 3.88 (14.86 - 32.59) 
26.79 3.48 (20.00 - 33.50) 
44.53 4.04 (37.00 - 55.00) 
28.97 3.13 (23.00 - 36.00) 
39.15 1.52 (35.00 - 42.00) 
3363.12 499.95 (2510.00 - 4460.00) 
Placental weight (g) 610.96 111.32 (345.00 - 890.00) 
*: n= 21, self reported values. 
t: Total skinfolds (sum of skinfolds: triceps, biceps, subscapular, supra-illiac and midthigh). 
$: As measured by Skinfold thickness measurements at first visit. 
4": As measured by Bioelectrical Impedance at first visit. 
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Table 3.5. Characteristics of Obese group (n = 34) 
mean SD range 
Early pregnancy weight (kg) 92.57 11.11 (76.00 - 117.50) 
prepregnancy body weight (kg)* 86.52 13.49 (61.60 - 110.00) 
Height (m) 1.63 0.05 (1.53 - 1.77) 
Body mass index (kg/m2) 34.60 3.98 (30.09 - 45.90) 
Waist-hip ratio 0.98 0.16 (0.82 - 1.74) 
Age at first visit (y) 26.85 3.72 (20.00 - 35.00) 
Gravida 2.50 1.11 (1.00 - 5.00) 
Parity 0.97 0.96 (0.00 - 4.00) 
Gestational age at 1st visit (wks) 13.53 1.94 (5.00 -15.00) 
TSF (mm)t 156.56 23.24 (116.10 - 193.70) 
fat mass (STM) (kg) $ 36.14 6.31 (25.36 - 50.23) 
fat mass (BI) (kg) 4 40.50 7.05 (31.00 - 58.00) 
lean mass (kg) 'T" 52.07 4.38 (45.00 - 61.00) 
water content (L) 4. 34.15 2.73 (30.00 - 40.00) 
Length of gestation 39.12 1.34 (36.00 - 41.00) 
Infant birth weight (g) 3681.91 463.23 (2590.00 - 4480.00) 
Placental weight (g) 676.44 114.59 (480.00 - 875.00) 
*: n= 24, self reported values. 
t: Total skinfolds (sum of skinfolds: triceps, biceps, subscapular, supra-illiac and midthigh). 
1: As measured by Skinfold thickness measurements at first visit. 
4: As measured by Bioelectrical Impedance at first visit. 
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The data on prepregnancy weight was reported by the mothers and the correlation 
coefficient between the self reported weight and measured weight at early pregnancy 
was highly correlated (r=0.93, p<0.05). Therefore the self reported prepregnancy 
weights seem to be a useful guide. 
Lifestyle habitus: 
The Northern General Hospital (where the subjects were recruited), serves women 
from a wide range of social classes (above average, average, below average and the 
most deprived) in Sheffield (Sheffield Health Authority and Family Health Authority, 
1994). However, the most prevalent one is the last mentioned. By the above 
mentioned Authority, deprivation has been defined as "a state of observable and 
demonstrable disadvantage relative to the local community or the wider society or 
nation to which an individual, family or group belongs". Nevertheless, we classified 
the subjects in social classes, based on their occupation using the criteria established 
by the Great Britain Office of Population Censuses and Surveys (1991). Figure 3.1 
shows this classification of the subjects in the whole group as well as in each BMI 
group. 
Mothers were also asked about alcohol consumption and smoking. Most of them were 
not smokers and took no alcohol. Some of them however were smokers and had 
occasional drinks (1-2 units per week). The data on cigarette smoking, alcohol 
consumption and parity can be seen in Figure 3.2-4. 
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Social class based on maternal occupation 
(a) 
Professional U] Intermediate [II] 
1% 11% 
Unclassified [VI] 
43% 
Stilled, Non-manual (111N] 
35% 
(b) 
LIJ 0/0 o [IIIN] 0% 22% [IIIM] 
0% 
[VI] [IV] 
56% 11% 
['I] 
11% 
(d) 
(c) 
[I] pl] 
2% 6% 
M] 
46% 
[IIINJ 
42% 
2% 2% 0% 
(e) 
[I] [II] 
0% 12% 
[VI] 
44% 
ONE 
[IIIN] 
35% 
M [IV] [I II M] 
0% 3% 6% 
Figure 3.1. Maternal social class based on occupation a) whole group b) under-weight 
group c) normal-weight group d) over-weight group e) obese group. 
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Unskilled [V] Skilled, Manual [IIIM] 
2% Partly skilled [IV] 6% 
2% 
Cigarette Smoking 
(a) 
10-20 cigarettes/day 
16% 
3-5 cigarettes/day 
8% 
A 
is Non-smokers 
76% 
(b) kw) 1 a2('day 
17% 
3-Slday 
8% 
N th-snr4cef5 
75% 
(d) (e) 
Figure 3.2. Percentage of cigarette smoking in the study subjects: a) whole group 
b) under-weight group c) normal-weight group d) over-weight group e) obese group 
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Alcohol Consumption 
vki) 
38% 
G(0) 
62% 
0 G(1): occasional alcohol consumption 0 G(O): no alcohol consumption 
(b) 
GO) (; (0) 
44% 56% 
(c) 
G(1) 
44% G(O) 
56% 
(d) 
G(1) 
39% 
"ýi 
G(O) 
61% 
(e) 
Figure 3.3. Percentage of alcohol consumption during pregnancy: a) whole group 
b) under-weight group c) normal-weight group d) over-weight group e) obese group 
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Maternal Parity 
(a) 
(b) 
(2) (0) 
22% 22% 
(1) 
56% 
(dl 
(2) 
27% (0) 
33% 
(1) 
40% 
(cl 
(2) (3 or more) 
8% 2% 
(1) (0) 
38% 52% 
(e) 
(3 or more) 
(2) 9% (0) 
32% 
(1) 
50% 
Figure 3.4. Percentage of maternal parity: a) whole group b) under-weight group 
c) normal-weight group d) over-weight group e) obese group 
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A) Comparison of the methods: 
Bio-electrical Impedance versus Skinfold thickness 
measurements 
Two methods of assessing body fat mass; Bio electrical Impedance (BI) and Skinfold 
Thickness Measurements (STM) were compared during pregnancy and postpartum. 
Body density derived from skinfold thickness measurements were converted to fat 
mass using Siri's equation. During pregnancy, the specific equation by Van Raaij was 
also used and the results obtained with these two formulae were compared. Table 3.6 
shows the estimates of the fat mass by each method and formula during pregnancy and 
postpartum. 
Statistical results of the comparisons between the obtained values can be seen in table 
3.7-9. Although the methods were highly significantly correlated, it does not mean 
that they agree exactly. In order to know by how much the two methods are likely to 
differ from each other, the limits of agreement were calculated. 
Table 3.7. shows a comparison of fat mass obtained by skinfolds using two different 
formulae of Van Raaij (Fmv) and of Siri's equation (Fms). The mean difference was 
0.25 kg between the two obtained values at the first visit (13 weeks gestation) and it 
increased with advancing pregnancy. As we expected, limits of agreement were small 
in early pregnancy, they became wider, however, by late pregnancy. 
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Table 3.8. shows the comparison of BI with STMv. A considerable difference was 
observed between the values obtained by each method, higher values derived from BI. 
The discrepancy between the two methods was increased with advancing pregnancy. 
Table 3.9. represents the comparison of the BI and STMs during pregnancy and 
postpartum in predicting body fat mass. Similar to the previous one, BI shows higher 
estimates than STMs and the limits of agreement became wider with increasing 
gestational age. At postpartum, the mean difference between the two methods was, 
reduced and the limits of agreement became smaller. This should indicate a better 
agreement between the two methods and less variability of the results, at postpartum 
period. Nevertheless the discrepancy between the two methods is still too high to be 
acceptable. For instance, at 6 months postpartum, on average BI shows values 0.79 kg 
higher than STMs, and the values estimated by BI may be 4.75 kg below or 6.33 kg 
above the STMs. 
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Table 3.6. Estimates of body fat mass* at different stages of reproduction and 
postpartum, using Bio-electrical Impedance and skinfold thickness measurements 
Weeks gestation + FMBT (kg) FMv (kg) FMs (kg) 
13 25.52 ± 11.40 23.32 ± 9.82 23.57 ± 9.85 
25 31.17 ± 11.51 27.63 ± 9.75 28.63 ± 9.88 
36 34.14 ± 11.11 29.29 ± 9.93 31.60 ± 10.17 
Post partum 
6 weeks 30.65 ± 11.03 - 29.62 ± 9.74 
6 months 28.80 ± 12.13 - 28.01 ± 10.62 
*: (X ± SD) 
f: median of gestational weeks 
FMBI : Fat mass derived from Bio-electrical Impedance 
FMv: Fat mass derived from Skinfold Thickness measurements (using Van Raaij formula) 
FMs: Fat mass derived from Skinfold Thickness measurements (using Siri formula) 
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Table 3.7. Comparison of fat mass obtained by Siri's formula (FMs) with fat mass obtained 
by Van Raaij formula (FMv) 
correlation* 
coefficients 
mean differences 
(kg) 
limits of 
agreement (kg) 
Visit 1 1.00 0.25 (0.17 to 0.33) 
Visit 2 1.00 1.00 (0.70 to 1.30) 
Visit 3 1.00 2.30 (1.68 to 2.92) 
*: All the correlation coefficients are statistically significant. 
Visits: Gestational weeks and number of subjects for each visit were explained in table 2.1. 
Table3.8. Comparison of fat mass obtained from Bio-electrical Impedance (FMBI) with FMv 
correlation* 
coefficients 
mean differences 
(kg) 
limits of 
agreement (kg) 
Visit 1 0.97 2.31 (-3.23 tO 7.85) 
Visit 2 0.96 3.36 (-3.24 to 9.96) 
Visit 3 0.96 4.48 (-1.21 to 11.03) 
*: All the correlation coefficients are statistically significant 
Visits: Gestational weeks and number of subjects for each visit were explained in table 2.1. 
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Table 3.9. Comparison of FMBi with FMs 
correlation* 
coefficients 
mean differences 
(kg) 
limits of 
agreement (kg) 
Visit 1 0.97 2.06 (-3.44 to 7.56) 
Visit 2 0.96 2.35 (-4.07 to 8.77) 
Visit 3 0.96 2.54 (-3.26 to 8.34) 
Visit 4 0.98 1.04 (-3.78 to 5.86) 
Visit 5 0.96 0.79 (-4.75 to 6.33) 
*: All the correlation coefficients are statistically significant 
Visits: Gestational weeks and number of subjects for each visit were explained in table 2.1. 
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B) Changes in body composition and 
anthropometric indices during pregnancy 
and postpartum 
Maternal body weight (MBW), total skinfold thickness (TSF), fat mass (FM), lean mass 
(LM) and water content of the body were studied during pregnancy and postpartum. 
The subjects were divided to four groups of under-weight, normal-weight, over-weight 
and obese based on their early pregnancy BMI. The distribution of each BMI group in the 
population under the study is shown in figure 3.5. 
The absolute changes of each variable during pregnancy and postpartum were reported 
and also certain summary measures were compared between the BMI groups. 
The ratio of subjects who continued participating in the study up to 6 month postpartum 
for each group of underweight, normal weight, over-weight and obese are 1/9,18/48, 
12/32 and 17/34 respectively. The rate of withdrawal from the study was not 
significantly different between the groups, except for the obese and under-weight group. 
The latter group was not considered separately in the postpartum period, since there was 
only one UW person left. 
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The results of one way analysis of variance suggest that there is no significant differences 
between the groups in respect to "maternal age, parity, gestational age , 
breast feeding and 
in having generalised oedema during pregnancy. Therefore, the groups are considered to 
be matched. 
The rate of breast feeding at 6 weeks post partum were 35/51, including: UW: 1/1, NW: 
13/18, OW: 9/13 and OB: 12/19. At 6 month postpartum, however, they were only 4/48 
who were breast feeding; UW: 0/1, NW: 3/18, OW: 1/12 and OB: 0/17. 
50 
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Figure 3.5. Bar charts presenting distribution of each BMI group in total population 
under the study (classification based on maternal early pregnancy BMI: Under-weight, 
Normal weight, Over-weight and Obese respectively). 
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<19.8 19.8- 26.0- >29.0 
25.0 29.0 
BMI classified groups 
Skinfolds and fat distribution during 
pregnancy and postpartum 
Skinfolds and fat distribution in early pregnancy 
For the analysis of the data, logarithmic transformation was considered since the 
distribution of the skinfolds were not normal and it was positively skewed. However, the 
log transformation did not fully normalize the data and therefore the raw values were used 
directly. Table 3.10 represents general information about the distribution of skinfold 
thicknesses, waist and hip circumferences as well as waist hip ratio (waist/hip: WHR) at 
13 (5-15) weeks gestation. As it is apparent in this table, the average indices of fat 
distribution increases with an increase in BMI and the distributions of fat are also 
different in each group. 
Table 3.11 shows the correlation coefficients between skinfolds at each measured site, 
total skinfold (TSF), waist, hip circumference and WHR with certain maternal 
characteristics (i. e. weight, height, fat mass (from BI and STM), BMI and WHR. 
Each site of subscapular and suprailiac had the highest correlation with TSF. Weight had 
the highest correlation with subscapular skinfold and the least with mid-thigh. There was 
little, if any correlation between the measured values for skinfolds, waist, hip and WHR 
with maternal height. Interestingly, fat mass values from Bio-electrical Impedance did 
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not show a great difference with BMI and also weight in correlating with skinfolds and 
circumference measurements. Expectedly, all skinfolds show a high correlation with fat 
mass (from STM), and the highest was with TSF. The correlation of WHR with skinfolds 
were not impressive. Waist circumference per se was found to have a better correlation 
with the above mentioned maternal characteristics than WHR. It should be also noticed 
that by 13 weeks gestation, there is a slight increase in waist circumference due to 
enlarged uterus. 
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Pattern of changes in skinfolds and fat 
distribution during gestation 
Changes in skinfold thicknesses and circumferences between different measurements are 
shown in table 3.12. Of the women who completed the study, 12 (3 NW, 3 OW and 6 
OB) had generalised oedema. Presence of generalized oedema did not have a significant 
effect on the pattern of the changes in skinfolds during pregnancy and postpartum. 
The suprailiac site showed the highest and biceps the least contribution to the total 
increase of skinfolds during pregnancy. The increase in subscapular and triceps are not 
significantly different. The increase in mid-thigh skinfold was much less than the 
suprailiac but slightly higher than the other measured sites. The table also shows that the 
increment in total skinfolds is higher between the first and second trimester 
measurements during pregnancy. 
The suprailiac skinfold decreased considerably at 6 weeks postpartum from 36 weeks 
pregnancy, the others showed only small changes. From 6 weeks to 6 months 
postpartum, triceps and biceps (unlike the others) seem to increase. Although there were 
some apparent losses in most of the measured sites from 36 weeks pregnancy to 6 
months postpartum, at 6 month postpartum all the skinfolds were higher than 13 weeks 
gestation values. This suggest that a considerable amount of subcutaneous fat is retained 
at 6 months postpartum in the whole population under the study. WHR seems to not vary 
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all, however, each of the waist and hip circumferences increased from 13 weeks gestation 
to 6 month postpartum. 
Figure 3.6. shows the schematic presentation of the changes of five measured skinfolds at 
each stage of gestation from the first visit value at 13 weeks gestation in all subjects. 
1 
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{ BICEPS 
' SUBSCAPULAF 
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36 As 6 mo postpartum 
24 As 6 As postpartum 
Gestational age: pregnancy & postpartum 
Figure 3.6. Changes in five skinfolds during pregnancy and postpartum in all the subjects. 
The changes are expressed as the difference of the mean values at each stage from the first 
visit value. Number of subjects during pregnancy 77 and at postpartum was 48. 
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Comparison of the pattern of skinfold 
changes between the groups of normal 
weight, over-weight and obese women 
Figure 3.7 shows the average changes of each skinfold thickness (triceps, biceps, 
subscapular, supra-iliac and mid-thigh) from the first visit value, for the groups of normal 
weight, over-weight and obese. From this graph, the supra-iliac skinfold seems to be 
increased relatively more than the others in all the groups during pregnancy, but there is a 
different pattern of changes in the postpartum period. Statistical tests were performed to 
investigate the significance of the observed differences. The summary measures chosen 
to compare each of the five skinfolds and sum of the skinfolds (TSF), were the 
differences from 13 weeks to 36 weeks gestation (1-3) and to 6 months postpartum (1-5) 
as well as the differences from 36 weeks pregnancy and 6 weeks postpartum to 6 months 
postpartum (3-5 and 4-5 respectively). The results of one way ANOVA for the summary 
measures suggest that TSF changes are significantly different between the groups of 
normal and obese in the postpartum period (36 weeks gestation to 6 month postpartum). 
The changes in triceps and subscapular are not significantly different between the groups. 
The increase in biceps is significantly higher in the obese and over-weight groups than in 
the normal weight group from 13 weeks pregnancy to 6 months postpartum. The 
increment in mid-thigh skinfold was also higher in the obese group than the normal 
115 
weight group. At the supra-iliac site, again, the obese group showed the highest increase 
through the whole course of the study (13 wks gestation to 6 months postpartum) and the 
least decrease during the postpartum period. The changes in the latter site were not 
significantly different between the groups, only over the pregnancy period (13 wks to 36 
wks gestation). The significant differences in skinfold changes between the BMI groups, 
can be seen in table 3.13. 
The individual plots of total skinfold (TSF) changes from 13 weeks gestation, for each 
BMI group are presented in figure 3.8. The normal weight group show a homogeneous 
pattern of TSF changes over the whole course of the study. Whereas, the over-weight and 
obese groups seem to be more scattered and mostly tend to increase or stay higher in the 
postpartum period. From the comparison of the selected summary measures of TSF, the 
obese group were significantly different from the normal group in respect to changes from 
36 weeks gestation to 6 months postpartum. While the normal weight group tend to have 
a reduction of TSF, the obese group seem to increase total skinfold thicknesses at 
postpartum ( table 3.13). 
The changes in waist circumference (WC) and WHR from 6 weeks to 6 months 
postpartum were also compared between the three BMI groups. The results for each BMI 
group are as follow: (WC: -3.25,0.04,1.54 and WHR: -0.18,0.01,0.01). The changes in 
the obese group were significantly different from the normal group in respect to both 
indices of fat distribution. 
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Figure 3.7. Changes in five measured skinfolds during pregnancy and postpartum in 
groups of normal weight, over-weight and obese. The changes are expressed as the 
difference of the mean values at each stage from the first visit value. 
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Body weight and body fat mass using 
skinfold measurements: 
Table 3.15 shows the absolute estimated values of weight and fat mass from skinfold 
measurements in all the subjects. In 80 women who were measured at 13 weeks and 36 
weeks gestation, body weight and fat mass (from skinfold measurements) increased by 
10.87 ± 4.67 kg (x± SD; p<0.05) and 4.62 ± 3.35 kg, respectively. 
Rate of fat gain was significantly higher from 13 to 25 weeks than 25 to 36 weeks 
gestation (0.26 ± 0.18 > 0.14 ± 0.24 kg/week, P=0.001), (n=68). Nevertheless, rate of 
total weight gain was not significantly different between these two stages of pregnancy 
(0.51 ± 0.26 and 0.45 ± 0.31 kg/week, p=0.16). 
At 6 weeks postpartum, maternal body weight and fat mass were 2.74 ± 5.01 kg (p < 
0.05) and 3.55 ± 3.63 kg (p < 0.05) above 13 weeks gestation, (n = 48). The results 
showed a significant increase in fat mass from 13 weeks gestation to 6 months 
postpartum (2.58 ± 4.44, p<0.05), however, the increased weight (1.11 ± 5.97 kg, p= 
0.2) was not statistically significant. 
Expectedly, there was a sharp weight loss rate (0.93 ± 0.33) from the late pregnancy (36 
weeks gestation) to 6 weeks postpartum and also the rate of fat mass loss was 0.18 ± 0.20 
kg/week at that period of time. From 6 weeks to 6 months postpartum, however, the rate 
of loss of body weight and fat mass significantly (p < 0.05) reduced to 0.02 ± 0.07 and 
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0.01 ± 0.6 kg/week, respectively. In fact the weight and fat mass losses from 6 weeks to 
6 months postpartum (1.12 ± 4.31, p=0.08 and 0.07 ± 3.35, p=0.15 respectively) were 
not statistically significant. 
Prepregnancy fat mass was also calculated from the self reported prepregnancy weight 
and four skinfold thicknesses using the equation proposed by Durnin and Womersley 
(1974). Three of the skinfolds which were measured and used for calculation (biceps, 
triceps and subscapular) are among those which change least during early pregnancy 
(Taggart et al 1967). Therefore, the extrapolation of skinfold thicknesses from week 13 
(5-15) to the prepregnant state is likely to be justified. 
To gain the values for body fat mass at full term pregnancy, linear extrapolation was used 
from the rate of fat gain in late pregnancy and measured fat mass at 36 weeks gestation. 
From these and estimated prepregnancy fat mass, were calculated the gain in fat mass 
during pregnancy (7.03 ± 3.91, p<0.05), (n =62) and also the retained fat mass due to 
pregnancy at 6 months postpartum (4.37 ± 4.61, p <0.05), (n = 45). 
Similarly, using the prepregnancy weights and extrapolated weight at term, total weight 
gain during pregnancy was estimated to be 17.58 ± 7.56 kg and retained fat gain due to 
pregnancy up to 6 month was 6.24 ± 7.93 kg. 
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Body composition using Bio-electrical 
Impedance: 
Body composition of the subjects were also measured by Bio-electrical Impedance 
technique. The values for each body compartment (fat mass, lean mass and body water) 
obtained using BI, are shown in table 3.14. 
Using this method, body fat mass, body lean mass and water content of body increased 
significantly (p < 0.05) from 13 weeks to 36 weeks gestation (7.04 ± 3.65 kg, 3.76 ± 2.34 
kg and 3.32 ± 2.79 respectively, n=80). At 6 weeks postpartum (n=51), body fat mass 
were on average 2.37 ± 4.18 above 13 weeks gestation values whereas the small gain in 
body lean (0.48 ± 2.27, p=0.14) and body water (0.43 ± 2.36) were not significant. 
Comparing the values at 13 weeks pregnancy to those at 6 months postpartum (n=48), 
none of the changes including fat mass (1.16 ± 5, p=0.12), lean mass (-0.01 ± 3.09, p= 
0.99) and body water (-0.05 ± 1.57) were significant. 
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Comparison of Normal weight, over- 
weight and obese group in respect to 
weight and body composition: 
Table 3.15 shows the absolute values of estimated maternal weight and body 
composition during pregnancy and postpartum in groups of under and normal weight as 
well as over-weight and obese groups. 
Total weight gain and fat gain in kg (STMv) for the course of measurements during 
pregnancy (13 to 36 weeks gestation) for each group are as follows: 
13 to 36 weeks gestation 
Groups 
Normal weight 
Over-weight 
Obese 
fat mass (STMv) Weight 
4.92 ± 2.71 
5.29 ± 4.50 
3.75 ± 2.76 
11.01 ± 3.22 
11.91 ± 6.38 
9.68 ± 4.30 
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Table 3.15. Maternal weight and body composition (mean ± SD) as assessed by Skinfold 
measurements and Bio-electrical Impedance during pregnancy and postpartum in 
different BMI groups. 
Weeks Subjects Weight *Fat oFat Lean WaterBl 
gestation (n) (kg) masssTM massBt massBj (L) 
(kg) (kg) (kg) 
Normal weight & Under-weight group 
Pregnancy 
13 59 58.53 ± 15.28 ± 15.84 ± 43.07 ± 28.46 ± 
7.04 4.09 3.90 5.69 3.37 
25 33 64.86 ± 18.97 ± 20.98 ± 44.15 ± 29.70 ± 
8.09 4.83 5.53 4.27 3.23 
36 32 70.74 ± 20.66 ± 23.84 ± 46.92 ± 32.02 ± 
8.63 5.54 5.38 5.29 4.04 
Postpartum 
6 weeks 19 62.54 ± 20.12 ± 19.61 ± 42.95 ± 29.11 ± 
8.76 5.31 5.73 4.52 4.19 
6 months 19 60.16 ± 18.15 ± 17.42 ± 42.74 ± 28.42 ± 
8.51 4.98 5.22 4.17 2.43 
Over-weight group 
Pregnancy 
13 32 71.33 ± 24.35 ± 26.80 ± 44.53 ± 29.69 ± 
6.24 3.87 3.48 4.05 3.32 
25 20 79.63 ± 28.82 ± 29.86 ± 47.94 ± 32.90 ± 
8.42 4.51 6.41 5.47 7.10 
36 23 83.89 ± 29.86 ± 34.93 ± 48.96 ± 33.63 ± 
10.35 6.41 5.94 5.24 5.39 
Postpartum 
6weeks 14 78.18± 30.04± 31.11± 47.07± 31.14± 
9.99 6.00 6.49 4.70 3.96 
6 months 12 75.46 ± 28.53 ± 28.75 ± 46.71 ± 30.92 f 
11.56 7.69 8.48 4.31 3.80 
Obese g roup 
Pregnancy 
13 35 92.36 t 35.84 ± 40.37 ± 51.98 ± 34.03 ± 
11.02 6.29 6.99 4.35 2.78 
25 24 98.63 t 38.55 ± 44.38 ± 54.25 ± 35.33 ± 
9.80 5.63 6.06 4.19 3.00 
36 25 102.68 ± 39.83 ± 46.58 ± 55.78 ± 37.60 ± 
9.24 5.64 5.75 4.16 4.57 
Postpartum 
6 weeks 19 93.42 ± 38.80 ± 41.37 ± 52.26 ± 33.97 t 
9.73 5.52 5.60 4.64 4.36 
6 months 17 92.50 ± 38.67 ± 41.56 ± 50.97 ± 33.50 t 
8.52 5.11 5.03 5.52 3.41 
*: Fat masssTm values derived from sum of four skinfold thickness using Van Raaij formula during 
pregnancy and Siri formula for postpartum measurements. 
Q: BI stands for Bio-elctrical Impedance. 
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The individual plots of weight and body compartment changes (fat mass from STM and 
fat mass, lean mass, water from BI), during pregnancy and up to 6 months postpartum in 
each BMI group can be seen in figures 3.9 to 3.13. As shown in the graphs, there are 
some differences in the rate of fat gain during pregnancy and in particular at postpartum 
the trend of changes seem different between the groups. 
Figure 3.9. shows that the pattern of weight changes follow a homogenous trend in 
normal weight individuals. They all seem to increase their weight during pregnancy 
whereas a considerable loss of weight is observed at 6 weeks postpartum. From then to 6 
months postpartum they tend to either reduce slightly or stay at the same level. Over- 
weight women show a divergent pattern. The maximum weight gain and also the 
maximum weight loss are seen in this group. The majority of obese women seem to be 
heavier at 6 month postpartum in comparison to 13 weeks gestation. 
Figure 3.10 and 3.11 represent the individual changes of fat mass obtained by the two 
methods of BI and STM. By the two methods, normal weight women show similar 
patterns of changes in fat mass, over-weight show a very scattered figure and the obese 
women have mostly higher values of fat mass at 6 months postpartum than in early 
pregnancy. 
Figure 3.12 reveals the changes in the lean mass of the individuals. In this set of graphs, 
conversely, over-weight women show a closer pattern of curves. The changes in the lean 
mass seem to be relatively similar in all the groups. 
The least variation is observed in the changes of body water within and also between the 
groups (figure 3.13). Body water is increased considerably from 24 weeks gestation to 36 
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weeks, followed by a sharp fall after delivery at 6 weeks postpartum. Thereafter, it 
remains relatively constant at 6 months postpartum. 
There were only a few people in the under-weight group who completed the course of 
study. They, however, showed a similar pattern to the normal weight subjects. 
In our study a multivariate analysis of variance (MANOVA) on fat mass and weight 
changes during and after pregnancy suggests that BMI and parity of the subjects have 
significant effects on the rate and extent of the changes. Since the groups are matched in 
respect to parity, a one way ANOVA was performed to elaborate the magnitude of the 
effect of BMI on the above mentioned variables. The summary measures calculated, were 
rate of changes, the absolute differences between certain points and also delta area under 
the curve (DAUC) for all the variables. The calculated rates included the rate of changes 
from 13 weeks gestation to 25 weeks (rate 1-2) and from 25 weeks to 36 weeks gestation 
(rate 2-3). 
The absolute mean changes during pregnancy from 13 to 36 weeks gestation (1-3 ), the 
changes from 36 weeks gestation to 6 month postpartum (3 - 5) and also the whole course 
of study from 13 weeks gestation to 6 months postpartum were obtained and compared 
between the groups. DAUC was estimated from 13 weeks gestation to 36 weeks 
gestation, to 6 months postpartum and also from 36 weeks gestation to 6 months 
postpartum. (AAUC3, AAUC5, AAUC3-5 respectively). 
The results showed that there are no significant differences between the rates of fat gain 
and weight gain between the groups. From the comparison of the other summary 
measures, the obese group proved to be significantly different from the normal group in 
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three aspects: fat mass (STM, 3-5), LAUC for fat mass (STM, 3-5) and AAUC for lean 
mass (BI, 1-3). The obese group lost less fat mass (by STM) at postpartum (as measured 
from 36 weeks gestation to 6 month postpartum) than the normal weight group. Delta 
area under the curve (DAUC) was also significantly different between these two groups at 
postpartum period. Using BI, the only significant difference was observed between the 
normal and the obese group in DAUC of lean mass during pregnancy. Nevertheless the 
net changes of lean mass was not significantly different between the groups. This would 
indicate a different pattern of lean mass changes between these two groups. These 
differences are presented in the following table: 
Table 3.16. The significantly different variables observed between the groups of normal 
weight, over-weight and obese women. 
36 wks pregnancy to 6 mo postpartum 13 to 36 wks pregnancy 
AFM (STM) DAUC (FM: STM) AAUC (LM: BI) 
Normal weight -4.11 * -198.94* 25.20* 
Over-weight -1.97 -129.61 40.30 
Obese -0.91 * -65.83* 57.33* 
*: indicates significant difference. 
Comparing direct measurements of skinfolds with fat mass derived from those 
measurements (STM), show identical trends between 36 weeks gestation and 6 months 
postpartum. The obese group are less likely to lose fat over this time period than either 
the normal weight group or the over-weight group (see figures 3.8 and 3.10). 
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C) Study of fetal growth in normal 
prelinanc 
Maternal and fetal carbohydrate metabolism 
Results of glucose tolerance tests: 
A 75 g oral glucose tolerance test (GTT) was performed on 38 volunteers at 29 weeks 
gestation (range: 28 -31). Descriptive statistics of different characteristics for the 
subsample who had GTT are in table 3.17. 
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Table 3.17. Characteristics of the subgroup volunteers who had glucose tolerance test 
(n=38) 
mean SD 
Early pregnancy weight (kg) 80.21 19.07 
Prepregnancy weight* (kg) 75.78 18.16 
Height (m) 1.63 0.06 
Body mass index (kg/m2) 30.07 6.42 
Age at first visit (y) 27.13 4.29 
Parity 0.95 0.66 
fat mass (kg) 32.29 12.42 
lean mass (kg) + 47.90 7.05 
water content (L) 4 31.55 4.46 
Length of gestation (wks) 39.16 1.42 
Waist-hip ratio 0.94 0.10 
Infant birth weight (g) 3508.68 548.38 
Infant length at birth (cm) 51.06 2.25 
Infant head circumference (cm) 37.32 1.34 
Placental weight (g) 620.26 130.94 
Sex ratio (female/male) 21/17 
*: n=31 
4: As measured by Bio-electrical Impedance at first visit. 
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Based on WHO diagnostic criteria (WHO 1985), there were two cases of impaired 
glucose tolerance in this study group (5%). There was also one case of abnormal glucose 
tolerance (fasting glucose: 5.5 mmoUl and 2 hrs value: 12.7 mmol/1) who was referred to 
the antenatal ward in Northern General Hospital for glucose profiles. The results were 
normal, no treatment was prescribed. She remained in the study. 
The other two subjects who had impaired GTT, were referred to the diabetic team in our 
hospital (including diabetic specialist, dietitian and obstetricians) for special care. They 
were prescribed a diabetic diet (high fibre, low fat and high complex carbohydrate). 
These two subjects were also excluded from the analysis in this part of the study. 
Table 3.18. shows the correlation between fasting glucose and maternal obesity and fat 
distribution indices. Fasting glucose level is significantly correlated to each of the indices. 
However, multiple linear regression (stepwise method) with fasting glucose as the 
dependent variable and maternal BMI, WHR, fat mass and lean mass in early pregnancy 
(as independent factors), revealed that only fat mass is independently related to fasting 
glucose (r = 0.54, p=0.0004). 
Table 3.18. Correlation between maternal fasting glucose level with 
maternal anthropometry (n=38) 
BMI Waist/hip Fat mass Lean mass 
r 0.51 0.36 0.54 0.52 
p 0.001 0.02 0.0001 0.001 
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Comparison of the groups: 
The subjects were divided to three groups of under & normal weight, over-weight, and 
obese groups, based on their early pregnancy BMI. In this part of the study, there were no 
significant differences between the three groups in respect to age, parity, gestational age, 
smoking, WHR (index of fat distribution). Table 3.19 shows the values for fasting level, 
and 2 hrs level, after 75g oral glucose load in all subjects and in each BMI group. 
Table 3.19. Fasting and 2 hrs glucose concentration after 75 g glucose tolerance test in 
groups of under & normal weight, over-weight and obese pregnant women. 
Groups (n) fasting values (mmol/1) 2 hrs values (mmol/1) 
Normal & under weight (7) 4.13 ± 0.16* 6.03 ± 0.59 
Over-weight (9) 4.63 ±0.59 6.79 ± 0.55 
Obese (19) 4.96 ± 0.61 * 6.26 ± 1.30 
Total (35) 4.71 ± 0.62 6.36 ± 1.06 
*: indicates a significant difference. 
As is apparent in the above table the fasting blood glucose concentrations rise with 
increasing BMI. Fasting blood glucose, 2 hrs values and the difference between the two 
values (fasting and 2 hrs postprandial) were compared between the groups using one way 
ANOVA. The results show that fasting glucose level is significantly higher in the obese 
group than in the normal & under weight group. 
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To investigate the effect of fat distribution on the glucose tolerance test, the subgroup 
(n=38) were then divided to two groups based on WHR at first visit (13 weeks gestation); 
lower body: WHR < 0.9 and upper body: WHR ? 0.9. Using independent sample t-test, 
fasting blood glucose, 2 hrs postprandial blood glucose levels, the difference between the 
two values were compared between these two groups. Fasting blood glucose and AUC 
(0-2) were significantly higher in the subjects with upper body fat distribution than in the 
other group (table 3.20). 
Table 3.20. The effect of fat distribution (Waist/hip ratio) on glucose tolerance in early 
pregnancy; (WHR<0.9: lower body, WHR? 0.9: Upper body fat distribution) (n=38). 
fat distribution fasting level* 2 hrs values diff (0 - 2hrs) 
upper body (24) 4.86 ± 0.68 6.53 ± 1.22 -1.65 ± 1.32 
lower body (14) 4.43 ± 0.38 6.03 ± 0.62 -1.60 ± 0.75 
*: significantly different (p<0.05) 
diff (0- 2hrs): difference of fasting glucose and 2 hrs postprandial values. 
Glucose metabolism in relation to fetal growth: 
Multiple regression between each of the measured characteristics of the newborn at birth 
(weight, length and head circumference) as independent factors with each glucose 
indicators (dependent), revealed that only fasting glucose is related significantly to the 
birth weight and length. The Spearman correlation coefficients between maternal fasting 
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glucose and birth weight, length, head circumference, placental weight appear in table 
3.21. Fasting glucose was highly significantly correlated to birth weight and placental 
weight. Its significant correlation with baby's length was borderline. 
Table 3.21. Correlation between maternal fasting glucose level with newborn 
anthropometry (numbers in brackets). 
birth weight (38) length (34) head cir. (34) placental wt (38) 
r 0.42 0.34 0.24 0.38 
p 0.009 0.05 0.18 0.02 
To find out which compartment of body composition (in early pregnancy) might predict 
the fasting glucose level, a multiple regression (Backward) was performed between 
fasting level as the dependent factor and each compartment of the body (measured by BI: 
fat mass, lean mass and body water) as independent factors. Fat mass proved to be the 
only significant predictive factor of the three (table 3.22). 
Table 3.22. Backward multiple regression model to predict fasting blood glucose. Body 
water, lean mass and fat mass were considered as independent factors. 
Variable Coefficient b se (b) Beta p 
fat mass 0.029645 
(Constant) 3.724664 
0.007360 0.574128 0.0003 
0.260197 14.315 
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Fetal insulinisation: measurements of cord insulin 
and C-peptide 
Cord blood samples were collected from 62 newborns whose mothers were studied 
longitudinally during pregnancy (two subjects who had impaired GTT were excluded 
from the analyses). C-peptide levels were measured in 60 samples but insulin levels were 
only assessed in those which were not haemolysed (n=48). Physical characteristics of 
these subjects are in table 3.23. 
Table 3.23. Characteristics of the volunteers whose cord blood samples were studied 
(n=60, otherwise indicated in brackets) 
mean SD 
Early pregnancy weight (kg) 72.87 18.02 
Prepregnancy weight (kg) (n=48) 68.78 17.21 
Height (m) 1.63 0.06 
Body mass index (kg/r2) 27.24 6.38 
Age at first visit (y) 26.34 4.58 
Parity 0.79 0.75 
fat mass (kg) 4 26.48 12.59 
lean mass (kg) 4" 46.31 6.34 
water content (L) + 30.67 3.81 
Length of gestation (wks) 39.27 1.33 
Waist-hip ratio 0.91 0.09 
Infant birth weight (g) 3518.31 480.96 
Infant length at birth (cm) (n=46) 51.07 2.29 
Infant head circumference (cm) (n=46) 37.19 1.43 
Placental weight (g) 622.26 118.64 
Sex ratio (female/male) 29/31 
4: As measured by Bio-electrical Impedance at first visit. 
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Table 3.24. C-peptide and insulin concentration in groups of under & normal weight, 
over-weight and obese pregnant women. 
Groups C-peptide (n) Range Insulin (n) Range 
(µmol/1) (µU/1) 
Normal & under weight 0.07 ± 0.05 (0.01- 0.19) 1.61± 2.75 
(n=23) 
0.84 ± 0.96 
(0.20 -12.00) 
Over-weight 
Obese 
(n=28) 
0.10 ± 0.05 
(n= 13) 
0.10 ± 0.06 
(n=19) (n= 13) 
(0.20 - 2.90) 
(0.20 -15.00) 
*: significantly higher than the other two groups (p<0.05) 
As table 3.24 shows, C-peptide levels are not significantly different between our three 
BMI groups. However, insulin level in the obese group is significantly higher than in the 
other two groups (over-weight group and the group including normal & under weight). 
As we expected, a significant correlation was observed between the two measured 
hormones in the cord blood; Insulin and C-peptide levels (r=0.41, p=0.002). Neither of 
them, however, were significantly correlated to birth weight, length, head circumference 
or placental weight. On the other hand cord c-peptide and insulin were highly 
significantly associated with maternal BMI, fat and lean mass at early pregnancy. The 
results of Spearman correlation between C-peptide and insulin levels with each of the 
new born and maternal anthropometric indices are shown in the following table: 
(0.03 - 0.21) 
(n= 10) 
(0.03 - 0.23) 5.28 ± 5.14* 
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Table 3.25. Correlation coefficientsp of Cord blood C-peptide and Insulin level with 
individual infant and maternal anthropometric characteristics. 
New-born 
Birth weight Length Head cir. Placental weight 
C-peptide (n=48*) 0.13 (0.32) 0.08 (0.61) 0.02 (0.87) 0.14 (0.26) 
Insulin (n=34) 0.08 (0.57) -0.20 (0.26) -0.18 (0.32) 0.09 (0.55) 
Maternal early pregnancy 
BMI Waist/hip Fat mass Lean mass 
C-peptide (n=60) 0.33 (0.008) 0.21 (0.09) 0.31 (0.01) 0.24 (0.06) 
Insulin (n=48) 0.44 (0.002) 0.20 (0.18) 0.42 (0.003) 0.39 (0.006) 
9: correlation coefficients (p values in brackets) 
*: Number of compared cases of birth weight was 60. 
Multiple regression analysis (forward method) on each of cord insulin and C-peptide 
(individually) as the dependent factor and maternal early pregnancy LM and FM mass as 
explanatory variables; revealed that maternal fat mass explains the variation in cord 
insulin (p=0.002) and C-peptide (p=0.02) rather than the lean mass. 
Birth weights were corrected for gestational age using birth centiles (Gairdner and 
Pearson 1985). Using birth weight centiles did not improve the correlation of the variable 
with either cord insulin or C-peptide. 
In this part, infants were grouped according to their birth weight centiles into three 
groups: small for gestational age (SGA); defined as birth weight below 10th percentile for 
gestational age, average for gestational age (AGA); between the tenth and ninetieth 
percentiles and large for gestational age (LGA); above the ninetieth percentile. Although 
in the whole group, there was no significant correlation between birth weight (birth 
centiles) and either of cord insulin or C-peptide level, comparing the three birth centile 
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groups (using one way ANOVA) revealed that LGA babies have significantly higher 
levels of cord insulin compared to AGA babies. C-peptide levels were not significantly 
different between these three groups of infants. The values for mean, median and ranges 
for each classified centile are reported in table 3.26. 
Table 3.26. Descriptive of cord insulin and C-peptide for different birth weight centiles. 
Cord insulin (µU/1) C-peptide (µmol/l) 
Birth weight Mean Median Mean Median 
centile (range) (n) (range) (n) 
: 510 2.00 (0.20 -3.80) 2.90 (5) 0.10 (0.05 - 0.21) 0.09 (6) 
11-89 1.31 (0.20- 7.60)* 0.20 (27) 0.07 (0.01- 0.19) 0.07 (31) 
>_90 4.46 (0.20 -15)* 1.10 (16) 0.10 (0.01- 0.23) 0.08 (23) 
*: indicates significant difference (p<0.05) 
The Box and Whisker plot distribution for birth weight centiles against C-peptide are 
shown in figure 3.14 and against insulin in figure 3.15. As it is apparent in the case of 
insulin; for babies with birth weight under 10th centile the distribution was skewed 
towards the left indicating a high number of low values. For babies with birth weight 
above the 90th centile the distribution was skewed toward the higher values. In case of 
C-peptide, there is a similar trend only for babies above 90th centiles. There was no clear 
lack of overlap between these two cord hormone levels for various centile groups that we 
used. 
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Figure 3.14. The relation between cord C-peptide (µmol/l) and birth weight centile for 
gestational age. Boxes contain 50% of values falling between 25th and 75th 
percentiles. Whiskers (I): lines that extend from the boxes presenting 10th-90th 
centile. Horizontal lines (-) indicate median. 
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Figure 3.15. The relation between cord Insulin (µU/1) and birth weight centile for 
gestational age. 
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In an attempt to investigate the relationship between maternal glucose tolerance test and 
fetal insulinisation, we did not see any significant correlation between glucose indices 
(fasting and 2 hrs postprandial values) and either of indicators of fetal insulinisation 
(insulin and C-peptide) individually (table 3.27). 
Table 3.27. Correlation matrix (p values in brackets) of glucose tolerance test with fetal 
insulinisation indices. 
Fasting glucose 2 hrs values 
C-peptide (25) -0.42 (0.84) -0.005 (0.99) 
Insulin (19) 0.02 (0.92) -0.31 (0.21) 
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Study of in vitro measurement of insulin resistance 
in pregnancy 
In vitro insulin resistance was studied using serum blood samples of 12 pregnant women 
in our study. The blood samples were taken at three stages during pregnancy: on average 
at 13,24 and 35 weeks gestation. There were only 6 samples available at 24 weeks, 
mainly because of haemolysis. Summary characteristics of these subjects are presented in 
table 3.28. 
Table 3.28. Characteristics of the volunteers who were studied for insulin resistance 
(n= 12, otherwise indicated in brackets). 
mean SD 
Early pregnancy weight (kg) 73.14 13.12 
Height (m) 1.61 0.06 
Body mass index (kg/m2) 28.05 4.61 
Age at first visit (y) 28.09 4.50 
Parity 1.60 1.58 
fat mass (kg) 4 27.27 8.87 
lean mass (kg) 4" 45.82 5.95 
water content (L) 4 30.55 4.06 
Length of gestation (wks) 39.00 1.61 
Waist-hip ratio 0.96 0.06 
Infant birth weight (g) 3504.55 596.95 
Infant length at birth (cm) (n=9) 51.19 1.76 
Infant head circumference (cm) (n=9) 36.96 1.12 
Placental weight (g) 642.09 169.36 
Sex ratio (female/male) 7/5 
4": As measured by Bio-electrical Impedance at first visit. 
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The basal mean glucose uptake (nmols mg"' protein 10 min') in the presence of maternal 
sera with and without insulin stimulation at each stage of pregnancy are as follows: 
Mean glucose uptake 13 weeks (n=11) 24 weeks (n=6) 35 weeks (n= 12) 
Basal 21.30 24.61 23.47 
Insulin stimulated 27.03 31.39 29.53 
Figure 3.16 represent the changes in insulin responsiveness of myofibres in the presence of 
pregnant sera. Although a proportionate reduction of insulin sensitivity is apparent in this 
diagram, the differences are not statistically significant. Only the difference in percentage 
increase of insulin stimulated glucose uptake from 13 weeks to 24 weeks was borderline 
with p value of 0.07, the others were not significant. 
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Figure 3.16. Diagrammatic presentation of insulin resistance changes throughout gestation; 
presented as % increase of glucose uptake above the basal level, with insulin stimulation in 
mouse myofibres in presence of pregnant sera. (% increased G uptake above the basal level 
= ((stimulated G uptake-basal G uptake)/basal G uptake) x 100). 
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13.0 - 15.0 (n=1 1) 23.0 - 26.0 (n=6) 33.0 - 36.6 (12) 
The difference between percentage increase of stimulated glucose uptake at early and late 
pregnancy (the insulin resistance index) was compared with certain maternal and infant 
anthropometric characteristics, borderline significant difference is seen between the index 
and infant length only. The results are in table 3.29. 
Table 3.29. The correlation coefficient of in vitro index of insulin resistance with 
maternal and infant anthropometry. 
Maternal (early pregnancy) Infant (at birth) 
BMI 
r -0.16 
Waist/hip Fat mass Birth wt Length Head cir. 
-0.34 -0.03 0.32 0.65 0.29 
p 0.64 0.30 0.93 0.33 0.05 0.44 
The relationship of the insulin resistance index was also assessed with the available data 
on C-peptide (n=5) and insulin level (n=3), no significant relationship was observed (0.47 
p=0.42,0.73 p=0.49, respectively). This could well be due to the small number of 
subjects compared. 
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The effect of maternal anthropometry and 
metabolism on fetal growth 
Table 3.30 shows the relationship between infant birth weight and various maternal 
factors including BMI. 
Table 3.30. Matrix correlation coefficients of infant birth weight (IBW) with maternal 
early pregnancy age, body mass index (BMI), height (MH), maternal fasting blood 
glucose (FBG), fat mass and lean mass by the two methods of skinfold (FMv) and Bio- 
electrical Impedance (FMBI and LMBI), gain in fat and lean mass by the two methods 
(FMGv, FMGBI), gestational weight gain (WG), and prepregnancy weight (PPW). 
Age BMI MH FBG FMv FMBI LMBI FMGv FMGBI WG PPW 
r 0.13 0.34 0.23 0.42 0.37 0.35 0.42 0.17 0.17 0.23 0.26 
0.16 P 0.0001 0.01 0.01 0.0001 0.0001 0.0001 0.13 0.12 0.04 0.02 
n 123 123 123 38 123 123 123 80 80 80 85 
The following tables (table 3.31 and 3.32) also present the correlation coefficients and 
corresponding p values for the infant birth weight and various maternal and infant 
characteristics. 
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Table 3.31. Spearman correlation coefficient between birth weight and maternal parity, 
infant gestational age and sex. 
Maternal parity Gestational age Infant sex 
(1: male, 2: female) 
Infant birth weight (r) 0.22 0.36 -0.17 
p 0.01 0.0001 0.07 
n 123 123 123 
Table 3.32. Correlation coefficient between maternal weight gain and infant birth weight 
in different BMI groups. 
Normal weight Over-weight Obese 
r 0.33 0.44 0.17 
p 0.07 0.04 0.43 
n 29 23 25 
Finally the interrelations between new-born anthropometry (weight, length and head 
circumference) with indices of fetal insulinisation as well as maternal anthropometry and 
lifestyle habitus were studied. Multiple linear regression analysis (forward method) were 
performed on birth weight as the dependent variable and other independent factors, 
including: maternal fat mass, lean mass in early pregnancy and weight gain during 
pregnancy, maternal lifestyle (smoking and parity) and fetal insulinisation indices (cord 
insulin and C-peptide). Gestational age and sex of the baby were also taken into account 
(since previous studies suggested these factors are individually important in relation to 
fetal growth). 
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As a result, lean mass in early pregnancy turned out to be the most significant predictor of 
Birth weight (table 3.33 a. ). Looking at the coefficient of determination (R2), lean mass 
explained 13% of variation in birth weight. 
Table 3.33 a. Multiple linear regression analysis of birth weight (n=36). 
Regression SE BR Adjusted Sig 
coefficient (B) R2 
Lean mass (kg) 26.35 11.65 0.13 0.10 0.03 
Constant 2250.20 546.20 0.0002 
Excluded variables at the level of 0.05 significance 
Partial correlation Sig 
Weight gain (13-36 wks) 0.33 0.05 
Smoking -0.05 0.78 
Infant's sex -0.28 0.10 
Gestational age 0.30 
Parity -0.04 
Cord C-peptide -0.15 
Cord Insulin -0.10 
0.08 
0.80 
0.40 
0.56 
Table 3.33 b. Multiple linear regression analysis of birth weight, maternal fasting glucose 
level added to the previous independent variables (n=19). 
Regression SE B R2 Adjusted Sig 
coefficient (B) R2 
Lean mass (kg) 31.66 14.18 0.23 0.18 0.04 
Constant 1976.50 676.34 0.01 
Excluded variables at the level of 0.05 significance 
Partial correlation Sig 
Weight gain (13-36 wks) 0.16 0.51 
Gestational age 0.16 0.52 
Cord C-peptide -0.04 0.88 
Maternal fasting glucose -0.16 0.53 
Cord Insulin -0.07 
Parity -0.05 
Smoking -0.04 
Infant's sex -0.46 
0.77 
0.84 
0.87 
0.06 
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In table 3.33 b. (n=19) maternal fasting glucose was added to the independent variables 
presented in the previous analysis. Lean mass was still the most significant predictor of 
birth weight with 10% increase in the coefficient of determination (R2: 23%>13%). 
The same process was performed for the length of the baby at birth as the dependent 
variable and the above mentioned variables as independent factors (in table 3.33 a). Lean 
mass again came out to be the most significant denominator (table 3.34) (n=30). 
However in the case of head circumference (as the dependent variable) with same factors, 
fat mass in early pregnancy and also baby's sex and gestational age were shown to have 
the highest contribution to the outcome variable (table 3.35). 
Table 3.34. Multiple linear regression analysis of new-born length (n=30) 
Regression SE BR Adjusted Sig 
coefficient (B) R2 
Lean mass (kg) 0.15 0.06 0.21 0.18 0.01 
Constant 43.88 2.65 0.0001 
Excluded variables at the level of 0.05 significance 
Partial correlation Sig 
Weight gain (13-36wks) 0.30 0.12 
Gestational age 0.33 0.09 
Cord C-peptide -0.01 0.97 
Cord Insulin -0.17 0.40 
Parity -0.28 0.14 
Infant's sex -0.37 0.06 
Smoking 0.001 0.10 
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Table 3.35. Multiple linear regression analysis of new-born head circumference (n=30). 
Regression 
coefficient (B) 
SE B R` Adjusted 
R2 
Sig 
Baby's sex* -1.16 0.45 0.15 0.12 0.02 
Gestational age (wks) 0.52 0.18 0.29 0.24 0.008 
Lean mass (kg) 0.08 0.03 0.41 0.34 0.03 
Constant 14.80 7.56 0.06 
Excluded variables at the level of 0.05 significance 
Partial correlation Sig 
Weight gain (13-36 wks) 0.09 0.64 
Cord C-peptide -0.29 0.15 
Cord Insulin -0.22 0.29 
Parity 0.17 0.42 
Smoking 0.18 0.40 
*: Baby's sex: Female: 2, Male: 1. 
Adding fasting glucose to the list of independent variables, in the case of infant's length, 
maternal early pregnancy lean mass was still the most sinificant predictor (B: 0.19, 
Constant: 47.78, R2=0.39 and Sig=0.007). In the case of head circumference, however, 
none of the variables remained significant. 
It should be noticed that in all of these regression models, fat mass has been deleted from 
the computer analyses and that was stated to be because of its correlation with lean mass. 
153 
Follow up of infant growth up to 6 months post partum: 
Weight, head circumference and length of the babies who were followed by 6 month 
postpartum are presented in the following table. 
Table 3.36. Anthropometric characteristics of infants during the postpartum period (Birth 
weight: 3532.02 ± 540.75 g) (n=48). 
1 days pp 6 wks pp 6 mo pp 
Weight (gr) 3361.51 ± 516.38 4686.83 ± 691.90 7610.30 ± 1431.40 
Length (cm) 
Head cir. (cm) 
50.94 ±1.97 
37.12 ±1.42 
56.45 ± 2.62 
40.42 ± 1.18 
67.73 ± 2.52 
45.58 ±1.35 
The ratio of breast to bottle feeding in this population was 31/17 at birth, 26/21 at 6 
weeks and 4/43 at 6 month postpartum. The pattern of breast feeding was not 
significantly different between the BMI groups at each stage. 
Splitting this group based on maternal BMI, there were no significant differences in 
changes in weight, head circumference and length of the babies of normal, over-weight 
and obese group, up to 6 weeks or 6 month postpartum. 
To have an insight into early infant growth (from the available data), a multiple 
regression analysis was performed using infant weight gain as outcome variable and 
maternal factors (body composition and lifestyle habitus) as independent factors. Sex of 
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the baby, gestational age and type of feeding were also included in the list of independent 
factors. 
No parameters were picked up for the infant weight gain up to 6 wks. Weight gain up to 6 
months was however only significantly correlated with sex of the baby as the male infants 
gained more weight (table 3.37) 
Table 3.37. Multiple linear regression analysis of weight gain up to 6 mo postpartum 
(female: 2 and male: 1) (n=48). 
Regression SE BR Adjusted Sig 
coefficient (B) R2 
Baby's sex -889.30 354.63 0.12 0.10 0.02 
Constant 5429.30 589.26 0.0001 
Excluded variables at the level of 0.05 significance 
Partial correlation Sig 
Gestational age (wks) 0.09 0.54 
Lean mass (kg) -0.04 0.77 
Parity 0.01 0.94 
Smoking -0.09 0.57 
Breastfeeding at 6 mo pp -0.01 0.95 
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Chapter 4 
Discussion 
A) Comparison of the methods: 
(Skinfold thickness measurements 
impedance) 
Vs Bio-electrical 
Because of the limited knowledge on the actual changes occurring in pregnancy and 
the limitations of the methodology of this subject, it is difficult to judge the validity of 
the methods. Skinfold thicknesses have been previously used in a number of studies 
to estimate maternal body fat changes during pregnancy and postpartum. The most 
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distinctive one is the study by Forsum et al. (1989) in which gestational fat changes 
were studied longitudinally during the reproductive cycle in 29 Swedish women, using 
TBW, TBK and STM. They also developed new equations for the estimation of 
percent body fat for different stages of pregnancy from STM. It is unwise to 
extrapolate too freely from a study of 29 women but interestingly, they found similar 
results by each method. They concluded that due to the basic alterations occurring in 
fat free mass during pregnancy, each of the current methods of body composition 
measurements is open to question. Bearing in mind that these method related 
limitations, it seems to be appropriate for population studies to use the simpler 
methods which are practically more acceptable. 
Bio-electrical impedance is also a convenient method of measuring body composition 
which is associated with less observer error than STM. BIA is known as an accurate 
method of measuring body water. It has not been validated against other relatively 
standard methods during pregnancy. Since both STM and BIA are convenient 
methods of body composition measurement, it is of interest to compare these methods, 
to see how pregnancy would affect on their results. 
The fact that the two methods were highly correlated, is not enough to ensure the 
comparability of the results obtained by them. The lowest limits of agreement were 
seen in early pregnancy compared to the later stages. The least difference in the mean 
and the limits of agreement are at 6 months postpartum. This would indicate that in 
the non-pregnant state these two methods are more similar in estimating body fat. 
Nevertheless, the limits of agreement are still too wide to claim that these two 
methods can be alternatives to each other. 
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The results of these comparisons show the widely different findings for body fat 
changes during pregnancy, when different methods are used. This is consistent with 
the previous findings of Lederman et al. (1993) who found a variety of figures for fat 
changes during pregnancy using different methods. In their study of 65 pregnant 
women from 14 weeks to 37 weeks gestation, they reported a net fat gain of 0.3 kg by 
TBW and 8.1 kg using TBK. These differences may explain discrepancies between 
studies that use various methods. They also indicate that estimated dietary needs for 
pregnancy will be influenced to a large extent by the method selected to determine 
body composition changes. 
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B) Body composition and anthropometric 
measurements during pregnancy and 
postpartum 
In our previous study on the distribution of obesity in the women attending Northern 
General Hospital in Sheffield (aged 15 - 43), the distribution of BMI was as shown in 
figure 4.1 (Soltani 1993). This compares to figures from the UK National Survey 
(White et al 1993), in which the mean BMI was estimated to be 25.4 kg/m2, and the 
BMI distribution was as follows: 12% UW, 55% NW, 22% OW and 11% OB. The 
only small difference was in the higher proportion of OB women and lower proportion 
of UW. This may reflect the local social class and nutritional status differences. A 
significant correlation between BMI and social class was reported by White et al. 
(1993). 
The mean height of our current study population was 1.62 m and the mean 
prepregnancy weight (n = 85) was 67.5 kg. The mean height and weight of women in 
health survey for England was reported to be 1.61 m and 65.9 kg respectively. 
The mean BMI in our study, in which some women were selected as obese, was 26.95 
including 7% UW, 40% NW, 25% OW and 28% OB. 
159 
of Total Population 
70 
60 
60 
40 
30 
20 
10 
0 
BMI classified Groups 
Figure 4.1. I3ar charts presenting distribution of BMI groups in women attending 
Northern General I lospital in Sheffield (nu 85) (I he results 01' the previous study. 
Soltani 1993). 
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Skinfold thickness changes during pregnancy 
and postpartum 
Each of the five skinfolds showed a good correlation with total body weight, BMI and 
fat mass (derived by both methods). Most of the variation in total skinfold 
thicknesses were explained by subscapular and for supra-iliac skinfolds. The 
subscapular site had also the most significant correlation with the maternal weight, 
BMI and fat mass (from BI and STM). 
Skinfold thicknesses at all sites (except for biceps) increased relatively rapidly from 
15 weeks to 24 weeks gestation and thereafter the rate of increment reduced to a lesser 
extent up to 36 weeks gestation. Like Taggart et al. (1967) and Forsum et al. (1989), 
the results of our study also show that the skinfolds during pregnancy have a tendency 
to increase at central site rather than peripheral sites. Mid-thigh was an exception. It 
increased considerably from 13 to 36 weeks gestation, but of course may be 
influenced by the presence of dependent oedema. 
Triceps and supra-iliac skinfolds decreased by 6 weeks postpartum, the former one 
started to increase afterwards while the latter decreased even further. This trend of 
change in triceps was also observed by Forsum et al. (1989). 
The biceps skinfold changed in a different magnitude from the other sites through 
pregnancy and postpartum. The rate of increase in the biceps was higher in later stage 
of pregnancy (24 - 36 wks) and at the postpartum period it still carried on increasing 
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up to 6 weeks and 6 month postpartum. While triceps and biceps both increased from 
6 weeks to 6 month postpartum, the other three skinfolds showed a clear reduction in 
this period. 
The sudden reduction in the supra-iliac and triceps from 36 weeks gestation to 6 
weeks postpartum might partially be explained by the loss of extra fluid retained 
subcutaneously. It is however difficult to explain these changes. If it was a simple 
relationship to clearance of interstitial fluid, a similar pattern should have been 
observed at mid-thigh skinfold. We could not see this reduction in the other sites by 6 
weeks postpartum. There is a possibility that either the changes in subcutaneous fat 
was that much to cover the changes in the extracellular water retained cutaneously or 
the loss of subcutaneous fluid happened in an earlier stage of postpartum before our 
measurements. Dynamic changes in the early puerperium in fat deposition may have 
resulted in these contradictory observations. 
In total, at 6 weeks or 6 months postpartum, none of the measured skinfolds returned 
to the values measured at 13 weeks of pregnancy. This differs from the findings of 
Taggart in which most of skinfolds had reverted close to their size at early pregnancy 
(at 10 weeks). 
In summary: 
If 80% of fat tissue is stored subcutaneously (Sohlström et al. 1993), the 
measurements of skinfolds in our study does confirm what is believed that pregnancy 
is accompanied by a significant storage of fat. 
If the skinfold measurements can be said to reflect relative changes in adipose tissue 
deposition there is a definite regional rearrangement in pregnancy. This is 
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demonstrated by the relatively great increases in the supra-iliac skinfold in particular. 
In our total population, there is a tendency to develop adipose tissue centrally, during 
pregnancy and sustain the pattern at postpartum. 
Comparison of the pattern of skinfold changes 
between the BMI groups 
There have been studies looking at the pattern of skinfold changes throughout 
pregnancy and postpartum but little information exists on the possible variation 
between different body types. 
Our study strongly suggests that there are essential differences in the magnitude of 
subcutaneous fat storage and mobilisation between BMI groups. Total skinfold 
thickness decreases are significantly divergent between each BMI group. The least 
reduction was seen in the obese group and the highest was seen in the normal weight 
group from 36 weeks gestation to 6 months postpartum. 
The individual diagrams of TSF, compared between the groups, would also show that 
most of the women follow a similar pattern during pregnancy and return close to 
original values by 6 months postpartum. Over-weight women however, show more 
individual variation. In both the over-weight and obese groups there was a tendency 
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to loose less skinfold thickness or even to expand these measurements during the 
postpartum period. 
Despite the fact that all the BMI groups increased fairly similarly at the supra-iliac site 
during pregnancy, the reduction at this site at postpartum period was significantly less 
in the obese group than the normal weight group. 
Indicators of central fat distribution (WHR and waist circumference), were reduced 
significantly in normal weight group from 6 weeks to 6 month postpartum while the 
obese group showed a significant increase in that period. 
All these observations imply that pregnancy affects the pattern of fat distribution, 
differently, in women with higher BMI, than in normal weight women. Obese women 
are prone to develop their obesity further. Central deposition of the new fat depots is 
typical in this group. 
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Maternal body weight and body fat mass changes at 
antepartum and postpartum period 
There have been many previous studies investigating maternal gestational weight gain 
and postpartum weight loss/or retention. Some of them also looked at the 
contribution of body composition to the weight changes. The extent of variation 
between the results of these studies is remarkable. This variability is mainly related to 
the differences in methodology, design of the study but biological variation may be 
contributing as well. Repeated studies on maternal anthropometry and body 
composition in different populations would give a more detailed insight to the energy 
requirements during pregnancy. It may also give some information on the impact of 
pregnancy on subsequent development of obesity and fat retention. 
In our study, from 13 to 36 weeks gestation, mean maternal weight gain was 10.9 kg 
which is very similar to the other studies on Western women of Hytten et al. (1966), 
Emerson et al. (1975), Taggart et al. (1967), Pipe et al. (1979), Campbell (1983), 
Forsum et al. (1988). To achieve a better comparison, a graph of maternal weight 
gain (Hytten and Leitch 1971) was used to estimate the weight that would have been 
gained before and after the measurements made. On the basis of this standard, 
expected additional weight gains are 0.5 kg before 5 weeks, 1 kg before 10 weeks, 4 
kg before 20 weeks, 1.3 kg after 37 weeks, and 0.8 kg after 38 weeks of gestation. 
Applying these corrections, total weight gain in our study would have been a mean of 
13.2 kg. 
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Alternatively assuming a constant rate of weight gain to term and extrapolating 
backwards (from our own data), we obtained an estimation of 17.58 kg net weight 
gain in term pregnancy. This is in line with the study of Swedish women who gained 
about 19 kg over the whole course of pregnancy (Sohlström 1993). It should however 
be noticed that the rate of weight gain might be different after 36 weeks gestation and 
extrapolation based on rate of weight gain in late pregnancy (from 25 to 36 weeks 
gestation) may not be appropriate. 
Using STM technique, fat mass gain from 13 - 36 weeks gestation, was 7 kg. This is 
when, we used Siri equations to convert estimated fat% to fat mass. This way the 
values were considerably higher than original reports by Pipe et al. (1979), Dibblee 
and Graham (1983), Langhoff-Roos et al. (1987) from developed countries, and also 
from study of 5 countries (including: Scotland, Netherlands, Gambia, Thailand, and 
Philippines) by Durnin (1987) (the amount of fat gains were 2.8,4.4,4 and also 2.3,2, 
0.6,1.4,1.3 kg respectively). The same method and equations were computed in 
those studies. 
Importantly, the Van Raaij equation (another formula to convert fat% to fat mass), 
which allows some correction for alteration of hydration constant in maternal tissue, 
resulted in about 4.6 kg gestational fat gain during the course of our study. 
Fat gains from industrialised countries using different techniques, are in the same 
range as the latter estimation of ours. Forsum et al. (1988) using TBW method, 
reported a fat gain of 5.6 kg through pregnancy and Sohlström et al. (1993) using MRI 
also reported a total of 5.5 ± 3.2 kg during a full term pregnancy. 
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In 1991 the panel on Dietary References Values (DRVs) of the Committee of Medical 
Aspects of Food Policy (Department of Health 1991) estimated the average cost of 
pregnancy to be approximately 70,000 kcal for a woman with a prepregnant weight of 
60 kg, depositing 2 to 2.4 kg of fat during pregnancy. The estimation of fat gain 
during pregnancy was considerably higher (with either of the methods) in our study. 
This could be explained by either methodological differences or reduced energy 
expenditure and basal metabolic rate, reduced activity or more possibly it could be due 
to increased energy intake. A survey on energy intake of pregnant women and also 
the information of midwives to advise the patients about the dietary intake would be 
useful to improve the standard of health care provided for pregnant women. 
From a total weight gain of 13.2 kg through whole pregnancy in our study, 34.8% was 
accounted for the products of conception (fetus and placenta). This was consistent 
with the estimation of 35% for affluent countries, compared with the 50% in less 
developed countries (Norgan 1992). 
At 6 weeks postpartum, there was still 2.74 ± 5.01 kg weight retained above the mean 
at 13 weeks gestation. The fat retention in the same period was however, somewhat 
higher than the rate of weight; 3.55 ± 3.63. This finding is similar to the study of 
Forsum et al. (1988), in which 22 healthy Swedish women with mean BMI of 22.3 ± 
3.50 and mean age of 28.7 ± 4.00 were longitudinally studied through pregnancy and 
postpartum. The methods were used to assess maternal body fat in their study were 
TBW and TBK. The amount of fat retention (3.59 ±3.14 kg) from prepregnancy to 6 
month postpartum was higher than the retained weight (1.34 ± 3.62). This might 
suggest that there is an internal interchange of body compartments; fat increase and 
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concurrent reduction of lean body mass (or water). Nevertheless, it could well be as a 
result of methodological limitations associated with the conversion of absolute 
skinfolds to fat mass. 
Another important aspect of this similarity in our findings and those of Forsum is that 
all the women in Forsum's study, started breastfeeding at hospital and half of them 
were still breastfeeding at 6 months postpartum. Conversely, in our study, there were 
only few women (4/48) breastfeeding at 6 months postpartum. 
At 6 month postpartum, there was no significant weight retention, however, fat mass 
was still 2.58 ± 4.4 kg higher than 13 weeks gestation. 
Although weight gain neutralised by 6 month postpartum, using skinfold thickness 
measurements, a substantial amount of fat retention was observed in our study. This 
was also confirmed by direct comparison of skinfolds (previously illustrated). 
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Body composition using Bio-electrical 
Impedence 
The values of fat mass obtained by BI (7.04 ± 3.65 kg), was very close to the values 
from STMs with the uncorrected formula (Siri equation; 6.67 ± 3.38 kg). However, it 
was significantly higher than the results by STMv (4.62 ± 3.35, using Van Raaij 
formula to convert fat% to fat mass). Furthermore, BI overestimated fat gain in 
comparison with previous studies mentioned earlier, using various methods. 
The Impedance method is believed to be an accurate means of assessing total body 
water (Lukaski et al. 1994). 
The present study, showed a significant increase of 3.32 ± 2.79 L water from 13 to 36 
weeks gestation. Considering the timing of the study, this is similar to the finding of 
Forsum et al. (1988), who reported the change from prepregnancy to delivery. She 
used Oxygen-18 labelled water and sampled saliva (rather than blood) to monitor the 
dilution of the isotopically labelled water. 
Other studies (Emerson et at. 1975, Campbell 1983), reported a weight gain of 8.2 to 
12.8 kg from 10 to 38 wks gestation. The estimated gestational changes in total body 
water in those studies ranged from 6.3 to 8.5 L. Lukaski (1994), using Bio-electrical 
Impedance observed an average increase of 7.2 L water, with 14.3 kg weight gain 
from prepregnancy to 38 weeks gestation. His finding was consistent with those 
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reported in cross sectional studies of human pregnancy but notably higher than our 
results or those in the longitudinal study of Forsum et al. (1988). 
Beside the methodological variations, the inconsistency among the results of these 
studies may reflect the differences in experimental design. 
In our study, at 6 weeks postpartum, a retention of 2.74 ± 5.01 fat mass was obvious 
but lean mass was reverted to the original measured values at 13 weeks gestation. 
Like weight changes, at 6 months postpartum, none of these measured body 
compartments were different from the values measured at the first visit at 13 weeks 
pregnancy. This reflects an important difference for the values derived from STM. 
Both methods of STM and BI are supposed to be more reliable during postpartum 
(Norgan 1992). Unfortunately a lack of consistency between the overall results of the 
two methods was observed. One (BI) indicated the complete restitution of body 
composition to the early pregnancy values, the other one however, showed a retention 
of considerable amount of fat at 6 month postpartum. 
This disagreement would of course, complicate the interpretation and conclusion. 
Due to the nature of validation, it is difficult to exclude either of the methods. 
Nevertheless, we prefer the results of STM with Van Raaij formula, since some 
corrections are made and the results are compatible with the previous studies that used 
TBW, densitometry which is believed to be the Gold Standard method in the field. 
More research is required to resolve these methodological problems. There are no 
valid measuring tools to provide the criterion measure at the present time (Girandola 
et al. 1991). 
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Comparison of maternal anthropometry and 
body composition in different BMI groups 
Individual plots of changes in total weight and body composition show that the normal 
weight group show a more homogenous pattern of changes while the other two groups 
are more variable. A similar variation was observed among the groups, in respect to 
total skinfold thickness. Total body water, however, seemed to change in a similar 
pattern in all the groups. 
Although the net changes in the lean mass did not differ significantly between the 
groups, iAUC was significantly higher in the obese group than the normal weight 
group during pregnancy. The obese group gained more lean mass but reverted to 
mean values in the way that the overall net LBM changes during pregnancy were not 
significantly different on the same time scale from the other two groups. 
In the postpartum period (at 6 months), the obese group were again different from the 
normal weight ones, in net fat mass changes as well as in the DAUC of fat mass 
(STM). Obese women lost almost no fat mass from 36 weeks gestation to 6 months 
postpartum, whereas, the normal weight group tended to revert to the values similar to 
early pregnancy. 
The pattern of postpartum weight loss could be variable. The general observation is 
that in association with delivery an average of 4.5-5.8 kg weight is lost. This weight 
loss is attributed to the delivery of the infant and placenta, amniotic fluid and blood 
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loss. During the first three days, some weight gain is typical. This is mainly related to 
the hormonal changes (adrenocortical hormone and arginine vasopressin associated 
with the stress of the labour) which lead to the retention of water and sodium 
(Blackburn and Loper 1992). By the end of the first week, 2 -3 kg weight loss is 
noted, which is mainly secondery to diuresis (Cunningham et al. 1993). 
In many midwifery and obstetrical textbooks, it is assumed that if women gain 11.3 - 
13.5 kg, they will return to their prepregnancy weight by 6 to 8 weeks postpartum. In 
our study however, women weighed about 2-3 kg heavier than in early pregnancy at 
this stage. Whatever the pattern of changes in the early puerperium, the greatest 
weight loss occurs in the first 3 month of postpartum. After 3 months a steady loss of 
weight may be observed (Sadurskis et al. 1988). After 9 months, no changes in BMI 
have been found other than normal weight gain associated with ageing (Tooke 
Crowell 1995). 
Factors affecting postpartum weight loss are reported to be maternal age, parity, 
prepregnancy weight, weight gain during pregnancy, marital status, length of lactation, 
exercise and the mother's desired weight (Tooke Crowell 1995). In our study, the 
original BMI did not have any effect on the postpartum weight changes. However, in 
the postpartum period, obese women were less likely to lose the extra fat gained 
during pregnancy. Therefore, although things look settled on the surface (reversal of 
weight gained), there is always a possibility, in particular for obese mothers to retain 
extra fat with each pregnancy. Excess fat leading to further obesity can have serious 
hazards including; hypertension, cardiovascular disease, diabetes mellitus, elevated 
blood lipids, gallbladder disease, arthritis, and an increase in the incidence of 
endometrial, cervical, ovarian and breast cancer (Pi- Sunyer 1991). Considering these 
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risks and also other psychological dissatisfaction of women at postpartum with their 
body size, would warn the professionals to take this matter more seriously. 
The Institute of Medicine, in 1990, published its recommendation for weight gain 
during pregnancy based on pregravid BMI (Under-weight: 12.5 kg, normal weight: 
11.5 - 16 kg, over-weight: 7- 11.5 kg and obese: 6 kg). To what extent these 
recommendations influence practice is not known. Health care providers as well as 
the women in their care (mothers) need to have a deep and detailed understanding of 
the magnitude and the implications of weight changes during pregnancy and 
postpartum to ensure a better standard of care. A period of at least 6 month 
postpartum is necessary to facilitate the weight loss. 
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C) Study of fetal growth: 
Maternal and fetal carbohydrate metabolism 
Glucose tolerance tests: 
Carbohydrate intolerance is frequently observed in women who exhibit obesity in both 
pregnant and non-pregnant individuals. In non-pregnant state, regional fat distribution 
is also regarded as a risk factor for the development of diabetes mellitus. 
A recent study by Landon et al. (1994) shows the relevance of body fat distribution as 
a factor contributing to the metabolic heterogeneity found during pregnancy in obese 
women. In their study, although a small number of pregnant women were studied (9 
lean and 14 obese), a maximal deterioration of carbohydrate tolerance was observed in 
early pregnancy in upper body obese women compared with women of other body 
subtypes. Previously, Kissebah et al. (1982) in a study of 25 obese and 9 non-obese 
women, reported that plasma glucose and insulin levels during oral glucose loading 
were significantly higher in women with upper body segment obesity than in women 
with lower body obesity. They also showed that the large adipocytes from the 
abdominal region of the former group exhibit a higher rate of lipolysis compared to 
cells obtained from similar sites of the latter group. The increased flux of free fatty 
acids associated with fat cell hyperplasia, might explain the metabolic alterations in 
the upper body segment obese group. Similarly, Evans et al. (1984) discovered a 
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positive correlation between WHR and fasting and postprandial insulin as well as 
glucose levels in 80 premenopausal women. 
Basically, fasting glucose concentration is dependent upon endogenous (primarily 
hepatic) glucose production. In fact, fasting plasma glucose levels are the results of 
the balance between hepatic glucose production and glucose uptake by the tissues (De 
Fronzo 1988). Basal hepatic production primarily represents glycogenolysis (the 
breakdown of the stored glycogen) and to a lesser extent, gluconeogenesis (the 
synthesis of glucose from three carbon precursors and amino acids). In contrast , 
postprandial glucose concentrations are the results of increased glucose availability 
and the interaction of increased insulin (and decreased glucagon) concentrations on 
insulin sensitive tissues. These alterations result in decreased hepatic glucose 
production and increased glucose uptake by insulin sensitive tissues. 
Of course, a single glucose tolerance test would not be sufficient to judge insulin 
insensitivity and there is a need for more sophisticated and more invasive methods for 
this purpose (i. e. insulin clamp). However, the observed positive correlation between 
excess fat mass (/central fat distribution) and plasma fasting glucose in our study, 
would indicate that obese people would either produce more glucose endogenously or 
have a lesser glucose uptake by insulin sensitive tissues (or a combination of both). 
In our study, although in a normal range of healthy women, the positive correlation 
observed between excessive fat content/central fat distribution and plasma fasting 
glucose, would confirm the tendency of obese pregnant women (centrally fat 
distributed) towards carbohydrate intolerance. 
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Putting the results of our study together with the related previous findings would 
indicate that including a simple fat distribution index (WHR) to the list of the criteria 
for gestational diabetes, may be a valuable step. 
We did not find any significant association between 2 hour postprandial glucose 
concentration with indices of obesity. Concurrent measurement of insulin level may 
be more informative in this regard. 
Cord insulin and C-peptide levels 
Glucose is the major substrate for placental and fetal energy metabolism. All glucose 
supplied to the placenta and the fetus is provided by maternal glucogenesis or ingested 
in the pregnant woman's diet. Although maternal arterial glucose concentration is the 
driving force for glucose supply to the placenta, its control is far more complex than a 
simple direct relationship. Glucose crosses the placenta via carrier mediated 
facilitated diffusion and this is believed to be independent of insulin concentration. 
There is no evidence that insulin can cross the placenta from the mother to the fetus or 
vice versa in any significant amount in the human (Kalhan et al. 1975). Although the 
molecular weight of C-peptide is about half of Insulin, insignificant placental transfer 
of this peptide has been reported (Lin et al. 1981). In the model of diabetic pregnancy, 
it is presumed that excessive maternal glucose crosses the placenta and stimulates 
insulin production in the fetus. 
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Some animal studies, have demonstrated a significant increase in fetal weight (in 
monkey) with infusion of insulin (Susa et al. 1979, Susa and Schwartz 1985). Since 
body length and head circumference was not measurably increased and excessive 
adipose tissue was seen, it was concluded that the increase in weight could simply be 
explained by fat and glycogen increment. 
This was not confirmed in a more rigorous study by Stangenberg et al. (1981) (in rats) 
who showed no effect of insulin on fetal dry weight, body weight, body lipid or 
nitrogen. Although species differences may be coming into play here. 
Many studies in humans demonstrate a positive correlation of cord C-peptide and/or 
insulin levels with infant birth weight (Stanley et al. 1992). Lin et al. (1981), 
suggested a persistently low production of insulin in SGA and a high production of 
insulin in LGA infants may lead to the different intrauterine growth rates observed. 
Moreover, the high incidence of macrosomia in the infants of diabetic mothers, are 
considered as an insulin stimulation experiment on intact fetuses. 
In our study, which reports observations within the normal range, a significantly 
higher value of insulin was observed in cord plasma of LGA babies in comparison 
with the AGA babies. This is in line with previously mentioned studies, however, we 
did not observe any significant correlation between birth weight, length or head 
circumference of the babies and cord insulin/C-peptide levels. 
Cord insulin and C-peptide levels were significantly correlated to each other, this is 
understandable since they are secreted in equimolar amounts. Stanely et al. (1992) 
was reported similarly in this respect, nevertheless, Lin et al. (1981) reported no close 
correlation between these two variables. They explained this discrepancy could be 
due to the differences in hepatic clearance of insulin (40% - 60%) vs. C-peptide (<5%) 
177 
and also the slower peripheral clearance of C-peptide than insulin. The first issue 
could be argued by the fact that the clearance of C-peptide will be mainly handled by 
kidneys instead of liver (Steiner 1978). 
What makes our study unique is the finding of a positive significant correlation with 
both cord insulin/C-peptide levels and maternal early pregnancy BMI. This relation 
was in particular explained by maternal fat mass in early pregnancy. Previously, 
maternal fat mass has been found to correlate with insulin level in late pregnancy 
(Karam et al. 1963) but we are not aware of any report of this association of maternal 
fat mass (or BMI) and fetal insulinemia. 
Three basic factors can be speculated from our study: 1. a positive correlation of 
maternal BMI and maternal fasting glucose level 2. a positive correlation of maternal 
early pregnancy BMI (fat mass) with fetal insulinisation 3. significantly higher level of 
insulin in LGA infants. Although within a normal range, our findings are in favour of 
the proposed assumption that excess maternal glucose would cross the placenta and 
may stimulate fetal insulin secretion leading to excessive fetal growth (following 
figure). Above all, maternal BMI has shown a significant role in the production of 
higher glucose in the mother, higher insulin secretion in the baby and eventually 
producing a bigger infant. 
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Figure 4.2. Insulin regulation of intrauterine growth in normal and diabetic women. 
(Lin et at. 1981, with permission) 
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We were not able to see a statistically significant relation between maternal fasting 
glucose and cord insulin or C-peptide directly. This could well be due to the small 
number of samples available for this purpose (19/60 cord blood samples). 
The difference in our study in comparison with Stanley et al. (1992) and Lin et al. 
(1981) was in that we did not find a significantly lower level of cord insulin in SGA 
babies. This could also be, because of smaller number of SGA infants in our study or 
more possibly due to the special characteristics (selected BMI) of the mothers 
involved in our study. There was no (or little) information about the maternal 
physical characteristics in last two mentioned studies or other related studies. 
Silliman and Kretchmer (1995) who studied the relationship of maternal obesity and 
fetal adiposity in 37 pregnant women at 35-36 weeks gestation, observed a higher 
insulin concentration in the obese group than the lean women. Applying multiple 
regression analysis, however, they found that maternal adiposity, fasting glucose and 
gestational age were independently associated with infant adiposity. 
The significant correlation of maternal BMI, in particular fat mass, with fetal 
insulinisation observed in our study of women in a normal range, is of interest but the 
mechanism behind it should be further investigated. 
In conclusion, reducing maternal BMI or more precisely maternal fat mass might have 
an impact on the care of diabetic or potential diabetic women, in the sense that it 
would reduce the risk of fetal hyperinsulinemia and consequent macrosomia. 
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In vitro measurement of insulin responsiveness 
This method which was presented by Bruce et al. (1994), is an in vitro method for 
investigating the changes in insulin responsiveness caused by sera from pregnant 
women. Stanley et al. (1993) demonstrated that this technique would give similar 
results to that of the insulin clamp in vivo. 
There was a significant increase in basal glucose uptake with advancing pregnancy. 
We could see a reduction in insulin stimulated glucose uptake, but these changes were 
not statistically significant. The reduction in insulin sensitivity was borderline only in 
the middle of pregnancy (23 - 26 weeks, p=0.07). 
The index of insulin resistance (decrease in insulin stimulated glucose uptake from 
first to third measurements), was correlated with infant length at birth at borderline 
statistical level (x0.65, p=0.05). It did not show any significant correlation with 
infant birth weight or head circumference. 
It is basically difficult to draw any conclusion, having such a small number of 
subjects. However, the results of our study confirm the previous reports showing a 
significant decrease in insulin sensitivity during pregnancy. The studies of Fisher et al 
(1980); using a high dose glucose infusion test, showed that normal pregnant women 
<85th percentile standard of body weight at 38 to 40 weeks gestation had a decrease 
of about 80% in the insulin sensitivity index of that observed in a non-pregnant group. 
Buchanan et al. (1990) with the minimal model technique, found that insulin 
sensitivity in normal pregnant women at 29 to 36 weeks gestation was only one third 
of non pregnant values. Both these studies were cross sectional. Catalano et al. 
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(1991), in a longitudinal study of non obese pregnant women on a special diet, using 
hyperinsulinemic euglycemic clamp, showed a significant decrease in insulin 
sensitivity through pregnancy. They were however, unable to show any significant 
change in insulin sensitivity during gestation by other estimates that they used ( the 
insulin/glucose ratio with OGTT or glucose disappearance index with the intravenous 
GTT). They blamed this discrepancy between the results of these two latter methods 
and the insulin clamping technique, down to the relatively small number of subjects 
used in their study. 
Our study differs from the previous reports by the nature of longitudinal study design 
and the method used. Considering the fact that the present method is less invasive and 
needs the least co-operation from the volunteers, it seems worthwhile to develop it 
further. Perhaps using maternal tissue (biopsy of fat or lean tissue) would add to the 
value of the technique. 
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Fetal growth and subsequent neonatal growth 
Birth weight is a convenient measure of fetal growth which has both clinical and 
biological significance. The genetics of birth weight has been the subject of many 
studies over the past half century. 
Our study confirms the previous reports of greater neonatal birth weight in males 
compared with females (Catalano et al. 1995). Length and head circumference were 
also reported to be higher in male than female neonates. This pattern of difference 
between boy and girl infants was also observed in our study. Nevertheless, we did not 
observe a difference in the levels of cord blood C-peptide and insulin. Gestational age 
was not significantly different between the two sexes. 
Earlier investigators (Thomson et al. 1968, Naeye 1979, Dougherty and Jones 1982) 
have described a positive correlation between maternal prepregnancy weight, weight 
gain during pregnancy, parity, infant sex and neonatal birth weight. Maternal weight 
and height were also reported to correlate positively with new-born birth weight. 
We also observed a statistically significant correlation between birth weight and early 
pregnancy BMI. When we considered each individual BMI group, there was still a 
highly significant correlation of birth weight and maternal BMI in the over-weight 
group and a border line significant correlation in the normal weight group. A 
significant correlation was not present in the obese group. 
Abrams and Laros (1986), also reported similar findings. They observed a strong 
positive relation between maternal weight gain and new-born birth weight in under- 
weight, normal weight and over-weight group, but not in very over-weight ones. The 
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mean birthweight for each group in the above mentioned study was 3593 ± 514 g, 
after adjusting for maternal age, socio-economic status, cigarette consumption and 
gestational age. In our study, when the groups were statistically matched in the above 
mentioned variables, the mean birth weight for obese group (3681.9 g) was 
significantly higher than the normal weight group (3296.7 g). The over-weight 
women delivered babies with mean birth weight of 3463.1 g, which lies between the 
two other groups. Head circumference and length were not significantly different 
between the BMI groups. The overall mean birth weight was 3433.60 ± 536 g (n = 
123). Above all, maternal age and parity were shown to have a positive correlation 
with infant birth weight. When maternal age was adjusted for parity, there was no 
correlation between maternal age and birth weight (Catalano et al. 1995). 
Spearman correlation showed that infant birth weight has a significant correlation with 
each of maternal early pregnancy fat mass and lean mass, but not with the fat gain. 
The changes in the lean mass had a border line significant relation to the birth weight. 
These results possibly demonstrate a relationship between prepregnancy maternal 
energy stores and fetal growth rather than the energy stores during the time of 
pregnancy. Even if there was going to be a positive correlation between maternal fat 
gain and birth weight that went undetected in the present study, it would appear that a 
quite substantial increase in maternal fat gain would be needed before there was any 
marked effect on the birth weight. 
Lawrence et al. (1991), in a study of 115 women with average body weight and 
fatness, also concluded that there may not be a direct causal link between maternal fat 
gain, energy intake during pregnancy and birth weight. Thus, women who gain more 
fat during pregnancy, may not have bigger babies. 
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Langhoff-Roos et al. (1987), using the skinfold thickness method (and two other 
convenient methods; retained weight gain at 3 days postpartum and factorial method), 
could not find any significant correlation between maternal fat accretion and infant 
birth weight in a sample of 56 healthy Swedish women. 
Although the methods that were used to estimate the fat accretion were not without 
their inherent problems, the results of our study are in accordance with the previous 
studies. No increase in fetal growth is obtained from the increasing maternal fat 
deposits in a well nourished population. 
Unfortunately, we did not have enough under-weight subjects to make any comments 
but it is possible that in women who begin pregnancy with a reduced body weight or 
depleted maternal fat stores, an increase in fat content during pregnancy may be of a 
greater physiological importance. 
Apparently, it is not advisable to encourage a strict diet program and weight control 
for all women (as practised by US physicians in the 1960s). Nonetheless, a modest 
reduction in energy intake for some women is most unlikely to have any adverse effect 
on birth weight, but it may prevent the problem of excessive fat gain by the women. 
Our study is in agreement with the hypothesis that various maternal morphometric 
factors, in particular, prepregnancy weight and gestational weight gain correlated with 
fetal growth. In addition, to genetic and environmental factors, metabolic status may 
have an important effect on the determination of infant size. 
In a sample of 38 women, on whom glucose tolerance tests were performed, maternal 
fasting glucose was found to be related significantly to the neonatal bithweight. This 
was also observed by Langhoff-Roos et al. (1989) who studied 52 healthy women. 
However, the pattern of this relation in conditions like gestational diabetes is a matter 
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of controversy (Tallarigo et al. 1986, Letters 1987). Only twenty percent of infants of 
diabetic mothers are macrosomic or LGA (Miller et al. 1988). Nonetheless, 
macrosomia is considered a hallmark of the pregnancy complicated by gestational or 
pregestational diabetes. 
The positive correlation of fasting glucose with infant birth weight to some extent 
supports the hypothesis that maternal hyperglycaemia, results in greater amounts of 
glucose being available for placental glucose transport to the fetus and subsequent 
over-growth of the fetus. The excess transferred glucose, is supposed to stimulate 
fetal insulin secretion which finally would increase the deposition of lean body mass 
and adipose tissue in the fetus. 
We could not see a statistically significant correlation between C-peptide/insulin level 
and infant birth weight. This could be because of the small number of subjects or the 
composition of the study population, including considerable number of subjects with 
higher BMI. Maternal BMI could be a confounding factor for the effect of glucose 
metabolism on fetal growth, since 39% of the mothers of macrosomic babies were 
found to be obese (Modanlou et al. 1980). 
However interestingly, a direct significant correlation between maternal early 
pregnancy BMI and fetal insulinisation was observed in our study. Fasting glucose 
was also higher in women with greater BMI. Reduced insulin sensitivity during late 
pregnancy, would also facilitate fetal growth by allowing more glucose transfer to the 
fetus. 
Briefly speaking, the present study shows that heavier mothers have higher level of 
fasting glucose and also bigger babies. Furthermore, infants of mothers with higher 
BMI, showed a significantly higher level of insulin and c-peptide in their cord blood. 
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But why we could not see a positive significant relation between fetal insulinisation 
and the birth weight throughout its range, remains uncertain. 
Further investigations on the interrelationship of maternal carbohydrate metabolism 
and infant size in each BMI group may provide more information to eliminate the 
confounding effects of maternal body habitus on this matter. 
Admittedly, the factors affecting fetal growth are highly complicated and involve a 
large number of processes at maternal, fetal and placental levels. Placental hormones 
such as human placental lactogen (HPL), oestradiol, and progestrone are suggested to 
be correlated with placental function and fetal growth (Langhoff-Roos et at. 1989). 
Finally, all possible factors that we found in our study to have a relation to birth 
weight were analysed in a multiple regression model. Maternal early pregnancy lean 
mass turned out to be the most significant predictor of infant birth weight and length. 
The results of multiple regression should be interpreted with caution, since adding or 
excluding a factor may change the final outcome. However, our findings are 
consistent with previous study by Langhoff-Roos et al. (1987) who only considered 3 
factors (fat mass, lean mass and gestational weight gain). Since, lean body mass is 
believed to be hereditarily determined (Pollock 1973, Langhoff-Roos et al. 1987), in 
this population of healthy, well-nourished women, heredity has a major influence on 
fetal growth. 
Vohr et al. (1980), who studied the effect of maternal diabetes on the growth of 
offspring, suggested that macrosomia in the infants of diabetic mothers may be a 
predisposing factor for later obesity. As a follow up study we tried to discover if there 
is any relation between infant growth and various factors investigated in the present 
study (maternal BMI, body composition, maternal lifestyle habitus, cord insulin and 
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C-peptide level). Cord level of C-peptide and insulin did not show a significant 
correlation with subsequent infant growth up to 6 months. There were only few of 
mothers who were breast feeding up to 6 month postpartum therefore it was not 
possible to see a significant difference between breast and bottle fed babies. Maternal 
body status (BMI) did not show any effect on the pattern of infant growth at 
postpartum period. Male infants appeared to have a greater rate of growth up to 6 
month than the female infants. 
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Chapter 5 
Conclusion and practical 
implications 
Conclusions extracted from the present study are summarised as follows: 
" Direct measurement of skinfold thicknesses demonstrates a definite redistribution of 
adipose tissue during pregnancy and postpartum. The magnitude of these changes are 
towards central accumulation of fat tissue. 
9 Various methods in this study confirm the storage of significant amounts of fat during 
pregnancy. 
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" The fat gained during pregnancy does not appear to be beneficial for fetal growth, in a 
well nourished population. The mothers (particularly the obese ones), however, find 
it difficult to lose the extra fat subsequently. This would promote the risk of 
developing obesity after delivery. 
" The lack of association between maternal energy intake reflected in fat storage, and 
birth weight was noticeable in the obese group. The predisposition to fat retention at 
postpartum in the obese group, may have an impact on the implications for 
recommended weight gain during pregnancy. Carefully controlled trials of diet during 
pregnancy and exercise programs at postpartum are necessary to reduce the risk of 
further development of obesity. 
The positive correlation between maternal obesity and central type of fat distribution 
with fasting glucose, would implicate that simple measurement of waist/hip ratio at 
prepregnancy or early pregnancy would be valuable addition to the present screening 
criteria for gestational diabetes. 
" The association of maternal body type (BMI) with level of fetal insulinisation, would 
again, emphasise the importance of weight reduction at prepregnancy in the obese 
women, to reduce the risk of fetal hyperinsulinemia and macrosomia. Further 
investigations are required in particular in the obese diabetic women. 
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" The close relationship between maternal fasting glucose and maternal BMI, and also 
the significant correlation of each of these variables with infant birth weight could 
simply lead to the conclusion that perhaps the effect of BMI is mediated through 
higher values of glucose produced in the heavier mothers. However, the control of 
fetal growth is more complex than this simple relation. Therefore, we only suggest 
that in the studies of glucose tolerance and fetal growth, physical characteristics of the 
mother should be considered as important confounders. 
" Finally, lean body mass is believed to be predominantly controlled by genetics and it 
could also be modified by exercise. If lean mass is the most significant predictor of 
fetal growth, as we could observe in this population of well nourished healthy women, 
manipulation of lean mass (by exercise, etc.. ) in the prepregnancy period might be 
considered. These findings in the other hand, highlight the complexity of fetal 
growth. 
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Appendix 1 
Principles of the Glucose Analyser technique: 
This model is highly specific for glucose and it uses an oxidase enzyme hydrogen peroxide 
sensor. The conversion of glucose and oxygen to gluconic acid and hydrogen peroxide, Reaction 
I, forms the basis for this method. 
Reaction I: 
glucose oxidase 
D-glucose + oxygen ) Gluconic acid + H202 
The probe, then oxidises a constant portion of the hydrogen peroxide at the platinum anode, 
Reaction II. The current thus created is directly proportional to the glucose level in the diluted 
sample. 
Reaction II: 
H202 -+ 2H+ + 02 +2e' 
The circuit is completed by a silver cathode at which oxygen is reduced to water, Reaction III. 
Reaction III: 
4H+ + 02 -* 2H20 -4e' 
The tip of the probe is covered by a compound porous membrane which serves to protect the 
electrodes and to define a diffusion pass to them. It is a two layer membrane of differing 
materials, premounted on an "0" ring and prefilled between the layers with an enzyme. The 
outer membrane is a polycarbonate material with a pore size of . 03 to . 05 micrometers. This is 
large enough to readily pass glucose, oxygen, hydrogen peroxide, water and salt, but small 
enough to exclude cells and to restrict the diffusion of enzymes. 
The glucose oxidase is immobilised between the polycarbonate membrane and the inner 
membrane in a thin layer of resinous material. The inner membrane is a cellulose acetate 
material with much smaller pore size. These pores are large enough to pass H202 , oxygen, 
water, salts, etc., yet small enough to exclude glucose, ascorbic acid and most other potential 
interfering substances. 
Glucose in the vicinity of the probe will diffuse through the outer membrane and come in contact 
with glucose oxidase. At this point Reaction I takes place, converting the glucose to gluconic 
acid and hydrogen peroxide. The hydrogen peroxide in turn diffuses through the inner 
membrane, coming in contact with the platinum anode. Reaction II and III then take place, 
yielding a current proportional to the quantity of hydrogen peroxide diffused. 
The probe is mounted in a measurement chamber controlled at 37° C and filled with pre-warmed 
buffer solution. Standards, controls and samples are injected to the chamber with YSI Syringepet 
(Combination syringe and pipette). The chamber contents are stirred by an air-driven silicone 
diaphragm which assures adequate stirring of the buffer and sample, plus an abundant supply of 
oxygen to support the reaction. 
The current created is proportional to the glucose level in the sample. Integrated electronics 
arrange a display readout of the glucose level. The sample volume is 25 mm3 and the sensitivity 
of the instrument 0.2 mmol/l. 
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226 
Anthropometric d ata collected at first visit 
Underweight datal weightl height BMI waist1 hips1 thigh. cirl upth. cirl 
1 45 39 1.54 16.44459 63 81 40 
2 77* 57 1.73 19.04507 71 89 47 50.5 
3 129 46 1.55 19.14672 73 84 43 46 
4 65 51 1.63 19.1953 78 92 45.5 50.5 
5 57 56 1.7 19.37716 77 87 46.8 48.5 
Normal weight datal weightl height BMI waistl hips1 thigh. cirl upth. cirl 
6 132 51 1.6 19.92188 84 88 44 48.4 
7 17 50 1.58 20.02884 78 82 43 
8 31 62 1.73 20.71569 81 95 50 
9 69 56 1.64 20.82094 75.3 88.4 46.5 50.5 
10 20 60 1.69 21.00767 83 93 53 58 
11 116 49 1.52 21.20845 74.5 83.4 43 49.5 
12 42 57 1.63 21.45357 79 91 48 36 
13 12 58.5 1.65 21.4876 82.5 89.5 44.5 
14 1 53 1.57 21.50189 -75 83 46 
15 23 52.5 1.56 21.57298 82 89 36 48 
16 48 54 1.58 21.63115 80 92 47 
17 78 56.5 1.61 21.797 73.5 90 48.3 52.4 
18 53 58 1.63 21.82995 73.5 89.5 48.5 54 
19 " 68 65 1.72 21.97134 78.5 93.5 49.3 54.4 
20 82 64 1.7 22.14533 84 97 53.2 57.3 
21 86 66 1.72 22.30936 83 96 50.5 55.5 
22 85 70 1.76 22.59814 87 101 48.2 56 
23 133* 63 1.66 22.86253 85.5 96.2 49 56 
24 71 68 1.72 22.9854 87.7 95 50.1 56.5 
25 70 56 1.56 23.01118 72 92.5 49 54.2 
26 21 65 1.68 23.03005 89 91.5 51 
27 3 57 1.57 23.12467 84.8 91.9 50.8 
28 74 63 1.64 23.42356 80.3 95 49.4 54.6 
29 80 63 1.64 23.42356 80.5 96.5 51 57 
30 14 61 1.61 23.53304 89 97 53 
31 13 62 1.62 23.62445 91 95 50 
32 123 62 1.62 23.62445 82 100 48.5 56 
33 104 67 1.68 23.73866 83 95.5 51.4 56.5 
34 37 66 1.66 23.95123 77 103 55 
35 52 67 1.67 24.02381 80.5 96 52 57 
36 95 69 1.69 24.15882 78 101 53.7 60 
37 41 62 1.6 24.21875 83 98 53 
38 44 66 1.65 24.24242 88 97 54- 
3-9 15 57 1.52 24.67105 86 87 48 
40 120 65 1.6 25.39063 86.5 99.2 53.3 59.2 
41 99 69 1.64 25.65437 85 100.5 52 61.5 
42 64 63 1.56 25.88757 81.8 93.8 49.8 54.8 
To be Con tinued in age 233 
P': 227 
tri1 tril. 2 tril. 3 m tnl bil. 1 bil. 2 bil. 3 m bit subl. 1 subl. 2 
8.1 8.2 8.2 8.166667 3.3 3.3 3.2 3.266667 8 8 
8.4 8.4 8.4 8.4 5.1 5 5.1 5.066667 5.4 5.3 
12 12.2 11.8 12 4 3.6 3.6 3.733333 7 7.2 
15.3 15.2 15.25 5.1 5.1 5.1 14 14 
8.2 8.3 8.25 4.3 4.3 4.3 7.2 7.2 
tril tnl. 2 tril. 3 m tril bil. 1 bil. 2 bil. 3 m bit subl. 1 subl. 2 
22 21 22 21.66667 11.4 11.2 11.3 14.2 14.2 
12 11 11 11.33333 6 7 7 6.666667 14 15 
17 17 17 17 6 5 5 5.333333 13 13 
9 9 9 9 4.1 4.1 4.1 4.1 5.3 5.3 
21 20 20 20.33333 6 6 6 6 12 13 
10 9.6 9.6 9.733333 4.8 4.8 4.6 4.733333 8.4 8.6 
9 8 8 8.333333 4 5 5 4.666667 8 8 
16 16 16 - 16 6 6 6 6 15 14 
23 23 8 8 9 
14 13 13 13.33333 6 6 13 
16 16.2 16 16.06667 10 10 11, 10.33333 15 14.5 
21.2 21.2 21.2 21.2 7.1 7.2 7.1 7.133333 9.1 9.1 
10.3 10.3 10.3 4.2 4.2 4.2 4.2 12.2 12.2 
22.2 12.3 12.25 6.4 6.4 7 6.6 8.1 8.1 
20.3 20.2 20.2 20.23333 8.3 8.4 8.3 8.333333 10.3 10.2 
16.3 16.2 16.2 16.23333 6.2 6.2 6.2 1 6.2 9.2 9.2 
14.4 14.4 15 14.6 5.1 5.1 5.1 14.2 14.2 
33 34 33.2 33.4 19 18 18.6 18.53333 35 34.6 
14.1 13.3 14.1 13.83333 7 7.4 7.4 7.266667 8.1 8.3 
21-. 1 21.1 22 21.4 11.2 11.2 12 11.46667 17.4 18.2 
14 14 14 14 7 6 6 6.333333 15 14 
20 19 18 19 6.4 6.3 6.1 6.266667 13 15 
20.1 20 20 20.03333 8.2 8.4 8.4 8.333333 15.2 14.9 
20 20.1 20.4 20.16667 15.3 15.2 15.3 
. 15.26667 12.1 12.1 14 15 15 14.66667 10 10 10 10 22 23 
22 22 21 21.66667 10 10 9 . 9.666667 14 15 
14.8 14.4 13.8 14.33333 6.2 6.4 6.2 ! 6.266667 9.8 10.4 
23 23.8 2.2 16.33333 13 12.2 13 + 12.73333 13 13.2 
20 21 20 20.33333 10 9 9.9.333333 16 17 
24.3 25 24.3 24.53333 10.2 10.2 12; 10.8 18.1 19.1 
30 29.4 29.6 29.66667 14.4 14.8 14.6! 14.6 14 13.6 
24 24 15 16 16 15.66667 18 '19 
21 21 21 21 6 7 6 6.333333 15 15 
21 21 19 20.33333 9 9 99 17 16 
26 25.8 25.8 25.86667 12.6 14 12.8 13.13333 23.2 22.2 
21 20 21 20.66667 8.8 8 10.4 9.066667 15 15.2 
15 14.4 14.4 14.6 6.2 6 6.1 8.3 8.3 
228 
sub'1.3 m sub1 sup1.1 supl. 2 sup1.3 m supl thl. 1 thl. 2 thl. 3 
8 8 5 5 5 5 23 22 23 
5.3 5.333333 4.2 4.3 4.25 19.1 19.2 20 
7 7.066667 11 11.6 10 10.86667 29 28 26 
14 14 7 7.1 7.1 7.066667 27 27 27 
7.2 6.2 6.2 6.2 16 16 
suhl. 3 m subl sup1.1 supl. 2 supl. 3 m supl thl. 1 thl. 2 
_ thl. 3 
14 14.13333 24.8 25.8 26 25.53333 38.2 39.2 39.4 
15 14.66667 9 9 10 9.333333 17 18 17 
13 13 11 11 12 11.33333 32 33 32 
5.3 5.3 6.3 6.4 6.35 19.4 19.4 19.4 
12 12.33333 14 14 15 14.33333 38 37 36 
9 8.666667 8.2 7.8 7.6 7.866667 16 15 15.8 
7 7.666667 6 7 7 6.666667 
. 
17 17 17 
14 14.33333 9 8 7 8 21 21 21 
.9 9.3 9.1 9 9.133333 35 33 33 
13 15 16 14 15 15 16 15 
15.2 14.9 15 16 16 15.66667 29 30 29 
9.1 9.1 8 8.2 8 8.066667 36.2 35.4 35.3 
12 12.13333 6 6 6.1 6.033333 19 19 19 
8 8.066667 9.2 9.4 9.3 23.4 23.4 
10.2 10.23333 14.2 14.2 14.2 31.2 31.2 31.1 
9.2 9.2 7.3 7.3 7 7.2 24.2 24.4 24.1 
14.3 14.23333 13.2 13.2 13.3 13.23333 31 32 28.3 
35 34.86667 30 31.2 32.6 31.26667 43 42.4 44.4 
8.3 8.233333 11.1 11.1 10.3 10.83333 20.1 20 20 
18 17.86667 18 17.4 17.4 17.6 39.3 40.1 39.3 
13 14 9 10 9 9.333333 32 33 34 
15 14.33333 12.2 12.2 12 12.13333 24 18 18 
15 15.03333 13.2 13.1 12.4 12.9 37.2 38 40 
12.1 10.1 10 , 10.1 10.06667 39.3 39 39 22 22.33333 19 20 19 19.33333 32 33 36 
16 15 15 15 14 14.66667 37 
, 
37 37 
10.6 10.26667 9.8 10 10 9.933333 33.4 32.8 32.2 
1.6 9.266667 13.6 13.4 13 13.33333 41 41.2 41.6 
15 16 16 15 15 15.33333 41, 40 41 
19.1 18.76667 19 19 18 18.66667 41 39 40 
14 13.86667 19.4 19.4 19.4 43, 42.4 43.2 
19 18.66667 12 12 12 12 36 35 35 
15 15, 11 12 11 11.33333 31 30 31 
17 16.66667 12 14 14 13.33333 31 35, 36 
23.2 22.86667 18.4 19.8 20.2 19.46667 38.4 38.2 36.2 
15 15.06667 16.4 16.2 14, 15.53333 35.2 34.4 34 
9 8.533333 5.1 5.2 5.1 5.133333 32 33.2 32.3 
229 
data1 m th1 (c) tbsi (m) tbsi den tbsil %fat tbsil fat%1 lean%1 fat(kg)1 
45 22.66667 1.1599 0.0717 1.060382 16.81306 17.9 82.1 7 
77* 19.43333 1.1599 0.0717 1.062196 16.01547 21.1 78.9 12 
129 27.66667 1.1599 0.0717 1.0504 21.24916 23.9 76.1 11 
65 27 1.1599 0.0717 1.043949 24.1613 23.5 76.5 12 
57 16 1.1599 0.0717 A. 058506 17.64008 23.2 76.8 13 
data1 m th1 (c) tbsi (m) tbsi den tbsil %fat tbsil fat%1 Iean%1 fat(kg)1 
132 38.93333 1.1423 0.0632 1.024676 33.07943 25.5 74.5 13 
17 17.33333 1.1599 0.0717 1.043513 24.3592 24 76 12 
31 32.33333 1.1599 0.0717 1.040232 25.85529 24.2 75.8 15 
69 19.4 1.1599 0.0717 1.059981 16.98965 23.2 76.8 13 
20 37 1.1599 0.0717 1.036269 27.675 31.7 68.3 19 
116 15.6 1.1599 0.0717 1.052969 20.09915 22.4 77.6 11 
42 17 1.1423 0.0632 1.051501 20.7556 24.6 75.4 14 
12 21 1.1423 0.0632 1.038227 26.77451 24.1 75.9 14 
1 33.66667 1.1599 0.0717 1.038628 26.59012 24.5 75.5 13 
23 15.33333 1.1599 0.07i7 1.039791 26.05743 32.7 67.3 17 
48 29.33333 1.1599 0.0717 1.034022 28.71322 24.1 75.9 13 
78 35.63333 1.1599 0.0717 1.041021 25.49492 26.8 73.2 15 
53 19 1.1549 0.0678 1.052244 20.42335 24.1 75.9 14 
68 23.4 1.1599 0.0717 1.048126 22.27135 24.6 75.4 16 
82 31.16667 1.1599 0.0717 1.036269 27.675 26.6 73.4 17 
86 24.23333 1.1599 0.0717 1.045954 23.25216 25.8 74.2 17 
85 30.43333 1.1599 0.0717 1.0399 26.00714 27.1 72.9 19 
133* 43.26667 1.1423 0.0632 1.011342 39.44889 27 73 17 
71 20.03333 1.1599 0.0717 1.044903 23.72826 25 75 17 
70 . 39.56667 1.1599 0.0717 1.028357 31.35042 26.8 73.2 15 
21 33 1.1599 0.0717 1.042301 24.91069 26.2 73.8 17 
3 20 1.1549 0.0678 1.038706 26.55432 35.1 64.9 20 
74 38.4 1.1599 0.0717 1.034389 28.54358 27 73 17 
80 39.1 1.1599 0.0717 1.033678 28.87267 27 73 17 
14 33.66667 1.1599 0.0717 1.029282 30.91785 26.2 73.8 16 
13 37 1.1599 0.0717 1.031892 29.70143 27.4 72.6 17 
123 32.8 1.1423 0.0632 1.040506 25.72995 27.4 72.6 17 
104 41.26667 1.1549 0.0678 1.038744 26.5369 34.4 65.7 23 
37 40.66667 1.1599 0.0717 1.031892 29.70143 34.8 65.2 23 
52 40 1.1599 0.0717 1.026399 32.26838 28.4 71.6 19 
95 42.86667 1.1423 0.0632 1.022884 33.92569 27.5 72.5 19 
41 35.33333 1.1333 0.0612 1.020254 35.17343 37.1 62.9 23 
44 30.66667 1.1423 0.0632 1.032983 29.19487 27.3 72.7 18 
15 34 1.1599 0.0717 1.032754 29.30075 35.1 64.9 20 
120 37.6 1.1599 0.0717 1.022934 33.90231 36.9 63.1 24 
gg 34.53333 1.1599 0.0717 1.032234 29.54241 36.2 63.8 25 
64 32.5 1.1423 0.0632 1.045216 23.58627 36.9 63.1 22 
230 
lean(kg)1 waterl age job gravida pars abortion smok/day 
M 
32 22 28 travel con 2 1 0 1-2/week 
45 32 21 bar worker 4 2 1 10 
35 23 29 h/w 2 1 0 10/d 
39 25 22 H/W 2 1 0 0 
_7 43 28 21 h/w 4 2 1 5-10/day 
datal lean(kg)1 water1 age job gravida para abortion smok/da 
132 38 24 35 h/w 3 1 1 0 
17 38 25 22 food opera 1 0 0 12 
31 47 31 22 h/w 3 1 1 0 
69 43 32 25 sell assis 2 1 0 5 
20 41 27 27 tel operat 4 1 2 0 
116 38 26 23 h/w 3 2 0 0 
42 43 29 30 h/w 4 1 2 15/d 
1-2 44 30 36 shopkeep 2 1 0 0 
1 40 27 typist 1 0 0 0 
23 35 23 23 1 0 0 0 
48 41 29 20 hmade 1 0 0 00-Jan 
78 41 26 23 sell assis 1 0 0 10 
53 44 30 16 hair dress 1 0 0 _ 0 
68 49 33 23 h/w 1 0 0 0 
82 47 31 28 admin offic 2 0 1 0 
86 49 34 23 h/w 2 1 0 15/day 
85 51 33 24 secretory 1 0 0 0 
133* 46 31 33 Dr 1 0 0 0 
71 51 37 27 clarck 2 1 0 0 
, 70 
41 26 25 hair dress 1 0 0 .0 
21 48 31 27 h/w 3 1 1 0 
3 37 24 17 St. yts 1 0 0 5 
74 46 31 26 secretory 1 0 0 0 
80 46 31 27 h/w 3 1 1 0 
14 45 30 22 h/w 1 0 0 _ 0 
13 45 29 28 h/w 6 4 1 0 
123 45 29 30 market as 2 1 0 0 
104 44 28 18 h dresser 1 0 0 0 
37 43 28 26 nurse 1 0 0 0 
52 48 31 28 pension as 1 0 0 0 
g5 50 33 sell assiss 1 0 0 0 
41 39 27 43 teacher 1 0 0 0 
44 48 31 30 h/w 3 1 1_ 0 
15 37 25 22 care assis 1 0 0 0 
120 41 27 26 teacher 2 1 0 0 
99 44 29 27 h/w 2 1 0 0 
64 41 30 34 nurse 3 2 0 _ 10 
231 
k 
_----y"F 
Glucose Tolerance test 
datal alcohol meal time ges. age. s ges. age. d fast. level GTT (wks) 120 min 
45 1 3.0 11 10 4.2 9.3 
77* 0 4.0 10 
129 0 f 15.0 15 3.8 28w 6.1 
65 1 4.0 15 16 
57 0 3.5 11 
datal alcohol meal time ges. age. s ges. age. d fast. level 120 min 
132 1 3.5 14 14 
17 1 1.5 13 14 4.2 
31 0 2.0 14 15 
69 0 3.0 11 15 
20 0 4.0 9 9 4.2 6.6 
116 0 4.0 14 14 4.3 29w 5.9 
42 1 f 12 13 
12 1 3.5- 15 16 4.1 6 
1 0 3.5 13 14 
23 0 13 14 
48 0 1.5 12 16 
78 1 2.5 15 15 
53 0 11 
68 0 1.0 15 17 
82 1 2.0 12 12 
86 1 3.0 11 12 4.2 29 5 
85 0 1.0 14 15 
33* 0 15.0 11 11 
71 1 2.0 13 14 
70 1 3.5 13 14 
21 1 4.0 14 15 
3 1 14 
74 1 0.5 13 14 
80 0 2.0 15 15 
14 1 4.0 14 14 
13 0 4.0 10 10 
123 1 2.0 15 15 
104 0 5.0 13 14 
37 1 3.0 14 15 4.1-- 6.6 
52 0 4.0 12 15 
95 1 3.0 14 14 
41 0 3.0 15 17 
44 1 1.0 14 13 
15 1 12 15 
120 0 2.0 14 14 
99 0 3.0 15 16 5.5 12.7 
64 1 3.0 14 16 
1 y' 232 
Continue d from page227(Data collected at 1st visit 
Over-weight datal weightl height BMI waistl hipsl thigh. cirl upth. cirl 
43 54 62 1.54 26.14269 101 98 53.2 56.2 
44 108 68 1.61 26.23356 85.5 101.2 52.4 59 
45 98 71 1.64 26.39798 85.5 97.5 54.4 58.5 
46 92 69 1.61 26.61934 87.4 100.5 52.7 58.5 
47 93 67 1.58 26.83865 85.7 100 55.1 59.6 
48 62 77 1.69 26.95984 92 102 55 60 
49 46 64 1.54 26.986 90 08 , 55 50 58 74 1.64 27.51338 88 101.8 54.5 60 
51 49 69 1.58 27.6398 102 98 49 
52 25 65 1.53 27.7671 96 103 55 , 
53 50 80 1.69 28.01022 109 105.5 53.2 
54 47 70 1.58 28.04038 95 105 54 
55 73 73 1.61 28.16249 81.5 103.9 56.4 62.5 
56 29 80 1.68 28.34467 102 108 60 
57 109 72 1.59 28.47989 96.5 102 57.3 61.4 
58 19 70 1.56 28.76397 100.5 104 56 
59 66 77 1.63 28.98114 106.6 101 53 61.2 
60 56 77 1.62 29.34004 110.6 108.3 50 
61 *117 73 1.57 29.61581 105.3 102.7 55.2 62 
62 110 82 1.66 29.75758 99.5 107.6 60 67.5 
63 128 82.5 1.66 29.93903 95 112.2 60 69.2 
Obese datal weightl height BMI waistl hipsl thigh. cirl upth. cirl 
64 39 78 1.61 30.09143 99 106 59 
65 125 85 1.68 30.11621 " 101.8 109 57 64.7 
66 83 90 1.72 30.42185 102 113.5 61 73.5 
67 90 83 1.65 30.48669 106 107.7 58.7 64.7 
68 112 77 1.58 30.84442 97.5 101.5 53.5 58 
69 24 92 1.72 31.09789 106.5 117 63 
70 87 88 1.68 31.17914 108.5 107.5 57, 62.5 
71 122 78 1.58 31.24499 86.5 103.5 60.5 65.5 
72 118 91 1.68 32.24206 105 112 58 65 
73 96 96.5 1.7 33.391 121 114.5 58.7 65 
74 105 91 1.645 33.62866 113 109.7 56 64.5 
75 7 84 1.58 33.64845 112.5 117.5 61 
76 30 106 1.77 33.83447 106 125 67 
77 27 89 1.62 33.91251 118 120 58 
78 103 96 1.67 34.42217 108.5 117 64.2 71.5 
79 34 82 1.53 35.02926 114 110 59 
80 4 99 1.68 35.07653 101.9 125 69.3 
81 114 98 1.67 35.1393 106.5 114.2 63.5 68 
82 63 85 1.55 35.37981 93 114 66 72 
83 26 93 1.62 35.43667 117 122 65 
84 100 100 1.66 36.28974 129 121.5 61.3 71.5 
85 107 93.5 1.59 36.9843 105.2 115.3 65 72 
86 89 101 1.61 38.96455 123.7 115.5 65.2 71 
87 94 116 1.69 40.61482 131.5 125 65.4 72 
88, 35 113 1.64 42.01368 131 124 75 
89 60 108 1.6 42.1875 129 115 65.8 71 
233 
tri1.1 tril. 2 tril. 3 m tril bil. 1 bil. 2 bil. 3 ,m bit subl. 1 sub1.2 
18.2 18.5 18.1 18.26667 8.2 8.2 8.2 ! 8.2 21 22 
24.4 24 23.6 24 12 12.4 12.2 18 18 
23 21.2 21.2 21.8 8.2 8.2 8.2 12.4 12.4 
29 29 29.8 29.26667 17 17.2 181 17.4 30 30 
22 21.6 21.6 21.73333 15.2 15.4 14.81 15.13333 20 21.4 
20 20.4 21 20.46667 15.3 15.2 15.11 15.2 16.1 16 
22 21 22 21.66667 11 11 11,11 17 18 
26.1 26 26.1 26.06667 14 13.9 13.95 16.1 16.3 
25 25 25 25 14 15 151 14.66667 30 31 
30 29 29 29.33333 20 , 21 22! 21 27 28 30 31 31 30.66667 15.2 15 15.2 15.13333 42 42 
33 32 32 32.33333 15 15 161 15.33333 29 30 
27.1 27.2 27.4 27.23333 14.3 14.2 14.25 24.2 24.2 
27 26 27 26.66667 9 8 8! 8.333333 30 32 
30 31.4 32 31.13333 21 20.4 19.6: 20.33333 27 27.2 
22 23 23 22.66667 12 , 11 10 11 18 18 18.3 18.3 19 18.53333 15 15.1 15.05 28.1 28.3 
28.2 28 28.1 15.2 15.8 16 j 15.66667 38.1 38 
30 31.2 32 31.06667 16 17 18,17 23 23.6 
28 28 28.4 28.13333 12 11 10.6; 11.2 20 20 
25.4 26 25.4 25.6 9.2 9.6 9.2; 9.333333 20 19.4 
tri1.1 tril. 2 tril. 3 m tril bil. 1 bil. 2 bil. 3 im bit subl. 1 subl. 2 
25 26 25 25.33333 12 13 14' 13 28 27 
30 , 30 30.6 30.2 18 17 17.4: 17.46667 35 32.6 
20 20.1 20.2 20.1 11.1 11.3 10.3 10.9 20 20.1 
30.2 31.2 31 30.8 12.1 12.1 12.2: 12.13333 34 33.4 
22 23 21.8 22.26667 11.8 12 131 12.26667 31.6 29.8 
31 30 31 30.66667 14 15 14' 14.33333 28 26 
28 29 28.3 28.43333 12 12.3 12.1 12.13333 39 39.3 
31.2 32 32.4 31.86667 19 17.2 16i 17.4 30 28 
32 31 30 31 17 16.4 16.4! 16.6 36.4 36.4 
33 34 33.2 33.4 21 19 20.41 20.13333 36 37.2 
24 24.6 26 24.86667 10.4 10.2 10,10.2 34 35 
33 32 33 32.66667 22 21 22 21.66667 28 26 
35 35 35 35 28, 27 27.27.33333 39 38 
37 37 36 36.66667 26 25 27' 26 42 40 
31.4 32 32.2 31.86667 17.8 19.2 18.2; 18.4 30.8 30.1 
22 21 23 22 12 13 12,12.33333 31 29 
26 24 25 25 15 18 17' 16.66667 34 35 
33 34 33 33.33333 20, 21 19.8' 20.26667 38 37.4 
35 35.1 35 35.03333 25.1 25.2 25 25.1 35 34.4 
33 34 32 33 23 24 23' 23.33333 40 39 
31.4 31.2 31 31.2 16.4 15.6 16.2.16.06667 43 42 
33 31 33.4 32.46667 18.6 19.2 17.8 18.53333 41 39 
38 39 38.5 24 25 26 25 45 45 
20.4 20.4 20.8 20.53333 34.6 36 35 35.2 40.4 40.6 
36 36 36 36 26 27 26.26.33333 4 47 
31.3 31.3 31.1 31.23333 26 26 26 38 37.1 
234 
Subject NO. 
Over-weight subl. 3 m subl sup1.1 supl. 2 supl. 3 m supl thl. 1 thl. 2 
54 23 22 19 20 19.5 38 39 
108 18 18 24 23.2 22 23.06667 35 37.6 
98 12.6 12.46667 16 15 15.5 37 37.8 
92 31 30.33333 20.2 20.6 21.2 20.66667 40 40.2 
93 21 20.8 18 18.4 18 18.13333 41.6 42 
62 15.9 16 24.1 24 24.05 41 41 
46 18 17.66667 14 15 15 14.66667 35 35 
58 16.3 16.23333 23 23 21 22.33333 37 38 
49 30 30.33333 22 23 22 
, 
22.33333 42 
25 28 27.66667 23 22 23 22.66667 42 42 
50 43 42.33333 34 35 37 35.33333 43 
47 30 29.66667 26.2 26 26 26.06667 44 44 
73 24.2 23.4 23.3 24 23.56667 42 , 41.1 
29 31 31 19 19 18 18.66667 42 42 
109 27 27.06667 30 32 30 30.66667 43 44 
19 18 18 28 27 27 27.33333 35 36 
66 28.2 27 27.1 27.05 32.4 32.4 
56 39 38.36667 33.3 33.2 33.25 42 42.5 
117 23.4 23.33333 35 36 37 36 45 45.2 
110 20 20 26 25.8 26 25.93333 43.6 44 
128 18.6 19.33333 29 31 32 30.66667 42 41 
Obese subl. 3 m subl sup1.1 supl. 2 supl. 3 m sup1 thl. 1 thl. 2 
39 27 27.33333 16 15 17 16 43 43 
125 32.4 33.33333 38 39 39 38.66667 46 47 
83 20.4 20.16667 25.3 25.3 25 25.2 44 44.2 
90 33.2 33.53333 23.4 24, 24 23.8 44 43.4 
112 30.2 30.53333 26.4 26 27 26.46667 27 24.4 
24 28 27.33333 31 30 31 30.66667 41 40 
87 38 38.76667 33 32 32.5 46 45 
122 28 28.66667 30 31 30.5 34 34.8 
118 38 36.93333 38 37 39 38 47 47 
96 38.4 37.2 34 32 33 33 43.8 43.8 
105 34.8 34.6 33.8 33 32.4 33.06667 43 41.2 
7 28 27.33333 26 27 26 26.33333 43 42 
30 39 38.66667 36 35 34 35 47 47 
27 42 41.33333 28 27 29 28 47 
103 31.6 30.83333 31.6 32 31.2 31.6 42 41.2 
34 30 30 23 24 26 24.33333 47 44 
4 32 33.66667 24 25 22 23.66667 44 42 
114 37.7 39 41 40, 47 
63 34.1 34.5 27 24 ' 24 25 44 47 
26 42 40.33333 28 29 30 29 47 
100 42.5 34 37.2 38 36.4 47 47 
107 39 39.66667 38 36 35.4 36.46667 48 
89 45 37 38 37.5 47 44 
94 40.8 40.6 32.4 32.6 33 32.66667 44.2 44 
35 45.5 36, 33, 36 35 47 47 
60 37.55 34 37 35.5 44 47 
235 
ubject NO. 
data1 thl. 3 m th1 (c) tbsi (m) tbsi den tbsil %fat tbsil fat%1 Iean%1 
54 38 38.33333 1.1423 0.0632 1.026499 32.22166 38.7 61.3 
108 37.4 36.66667 1.1549 0.0678 1.026894 32.03606 36.8 63.2 
98 37.4 37.4 1.1599 0.0717 1.03348 28.96422 28.2 71.8 
92 39.8 40 1.1599 0.0717 1.017235 36.61313 37.7 62.3 
93 42 41.86667 1.1599 0.0717 1.025128 32.86666 37.3 62.7 
62 41 41 1.1599 0.0717 1.025162 32.85053 37.7 62.3 
46 35 35 1.1599 0.0717 1.029914 30.6226 37.5 62.5 
58 39 38 1.1549 0.0678 1.026397 32.26972 37.8 62.2 
49 42 28 1.1423 0.0632 1.018089 36.20487 39.1 60.9 
25 42 42 1.1599 0.0717 1.016293 37.06422 38.5 71.5 
50 43 1.1599 0.0717 1.009936 40.13012 40 60 
47 44 44 1.1599 0.0717 1.015459 37.46435 38.6 61.4 
73 42 41.7 1.1599 0.0717 1.020041 35.27443 1 38.4 61.6 
29 47 43.66667 1.1599 0.0717 1.021683 34.49469 31.3 68.7 
109 43.6 43.53333 1.1599 0.0717 1.013759 38.28152 38.9 61.1 
19 34 35 1.1423 0.0632 1.02237 34.169151 40 60 
66 33.1 32.63333 1.1599 0.0717 1.020187 35.20511 39 61 
56 42.25 1.1423 0.0632 1.011973 39.1437 39 61 
*1 77 46 45.4 1.1599 0.0717 1.014277 38.032371 41.1 58.9 
110 45 44.2 1.1423 0.0632 1.020275 35.16343 40.2 59.8 
128 41 41.33333 1.1599 0.0717 1.021585 34.541131 40.6 59.8 59 
datal th1.3 m th1 (c) tbsi (m) tbsi den tbsil %fat tbsil I fat%1 lean%1 
39 43 43 1.1599 0.0717 1.022806 33.962561 39.7 60.3 
125 47 46.66667 1.1599 0.0717 1.010909 39.65816 41.2 58.8 
83 44.1 1.1423 0.0632 1.0233 33.72889; 41.1 58.9 
90 43 43.46667 1.1599 0.0717 1.016417 37.00481 41 59 
112 24 25.13333 1.1599 0.0717 1.019255 35.64894 40.3 59.7 
24 41 40.66667 1.1423 0.0632 1.015089 37.64212; 41.3 58.7 
87 47 46 1.1599 0.0717 1.013017 38.639171 40.9 59.1 
122 35 34.6 1.1599 0.0717 1.013979 38.175871 41 59 
118 46 46.66667 1.1423 0.0632 1.010322 39.94265' 41.8 58.2 
96 22.6 36.73333 1.1423 0.0632 1.010055 40.0724 42.7 57.3 
105 40.8 41.66667 1.1423 0.0632 1.01516 37.60794; 44 56 
7 42 42.33333 1.1423 0.0632 1.013788 38.26795; 44 56 
30 47 47 1.1599 0.0717 1.006925 41.595571 43.4 57.6 
27 47 1.1423 0.0632 1.00828 40.93519' 43.8 56.2 
103 39.2 40.8 1.1599 0.0717 1.012777 38.75515 44.8 55.2 
34 46, 45.66667 1.1599 0.0717 1.020246 35.1773' 43.9 56.1 
4 40 42 1.1599 0.0717 1.016813 36.8152; 45.5 54.5 
114 47 1.1599 0.0717 1.00802 41.06148 42.9 57.1 
63 45.5 1.1599 0.0717 1.010918 39.65396 44.7 55.3 
26 47 1.1599 0.0717 1.009386 40.39717,44.1 55.9 
100 47 47 1.1423 0.0632 1.00952 40.33189,46 54 
107 48 1.1599 0.0717 1.009025 40.57278 45.45 54.8_54.3 
89 45.5 1.1423 0.0632 1.005513 42.28608 E 46.5 53.5 
94 44.2 44.13333 1.1599 0.0717 1.008571 40.79355' 47.4 52.6 
35 47 47 1.1599 0.0717 1.005399 42.34198; 47.8 52.2 
60 45.5 1.1599 0.0717 1.008262 40.94359' 47.2 52.8 
236 
ý, ý- 
I1 
ubject NO. 
Over-Teig fat(kg)1 Iean(kg)1 waterl age job gravida Para abortion 
54 24 38 24 34 h/w 2 1 0 
108 25 43 29 
98 20 51 36 22 h/w 2 1 0 
92 26 43 28 24 dental 1 0 0 
93 25 42 28 25 clarical as 1 0 0 
62 29 48 31 29 educ. & de 2 0 1 
46 24 40 28 27 care assis 2 1 0 
58 28 46 30 19 hair dress 1 0 0 
49 27 42 28 33 shop keep 3 2 0 
25 25 40 26 24 care assis 1 0 0 
50 32 48 29 29 pharmaci 1 0 0 
47 27 43 27 20 unemploy 1 0 0 
73 28 45 31 26 secretory 1 0 0 
29 25 55 36 24 h/w 3 
109 28 44 30 27 cook 7 2 4 
19 28 42 29 30 officer 3 2 0 
66 30 47 31 25 Clark - 2 1 0 
56 30 47 34 31 civil seran 2 1 0 
*117 30 43 26 24 bakery 2 1 0 
110 33 49 35 35 nurse 41 1 2 
128 33_34 49_49 32 24 h/w 2 1 0 
Obese fat(kg)1 lean(kg)1 waterl age job gravida ' para abortion 
39 31 47 32 26 secretory 2 1 0 
125 35 50 31 20 un employ 4 0 3 
83 37 53 37 31 sells ass 2 r1 0 
90 34 49 32 26 receptioni 1 0 0 
112 31 46 33 28 h/w 3 12 0 
24 38 54 35 30 h/w 2' 1 0 
87 36 52 34 21 h/w 1 3i 
122 32 46 31 28 cashier 1; 0 0 
118 38 53 37 32 blood trap 3! 1 
96 41 55 37 32 h/w 3; 2 0 
105 40 51 34 33 h/w 5; 3 
7 37 47 30 32 nurse 3; 1 0 
30 46 60 38 27 nurse 1: 0 0 
27 
103 
39 
43 
50 
53 
33 
33 
31 
23 
h/w 
videograp 
5; 4 
2i 1 0 
34 36 46 31 24 h/w 31 1 
4 45 54 68 , 
28 ex. teacher 21 _0 
114 42 56 38 22 credit cont 3' 1 0 
63 38 47 30 23 h/w 2' 1 0 
26 41 52 34 29 cook 1 0- -- 
0 
100 46 _ 54 33 35 h/w 21 0 
107 42 43 51.5_51 32 24 glass artist 1: 0 0 
89 47 54 36 30 h/w 3.1 1 
94 55 61 37 27 care taker 31 1 
35 54 59 37 25 nurse 1' 0 0 
60, 51 57 38 26 h/w 31 0 
it' I 
ýýýý` 
237 
Subject NO. Continuati on from page 6 
smok/day alcohol meal time ges. age. s ges. age. d Over-weight fast. level GTT (wks 120 min 
0 0 10 13 54 5.2 7.2 
108 
5 1 3.0 13 13 98 
0 0 3.0 13 14 92 
0 0 1.0 14 14 93 
0 1 0.5 14 15 62 
10 1 1.0 9 9 46 
15 1 2.0 14 58 4.2 6.4 
0 1 4.0 14 14 49 4.1 7 
0 0 2.0 12 16 25 4.1 6.8 
0 0 2.0 11 10 50 
2-3/day 0 2.0 11 47 
0 0 2.5 13 14 73 4.4 29w 5.6 
0 0 12 14 29 
0 1 4.0 15 15+ 109 
20 0 3.5 15 14 19 
0 1 2.5 13 14 66 4.5 7 
0 0 4.0 13 15 56 4.4 9.4 
0 10 *117 4.6 29w 7.3 
1 3.5 13 14 110 5.9 28w 6.5 
r 
0 10.0 13 14 128 4.7 31w 7.3 
ok/d alcohol meal time ges. age. s ges. age. d Obese fast. level 120 min 
0 3.0 12 15 39 4 5.3 
0 0 2.0 13 14 125 
0 1 3.0 15 15 83 4.7 5.6 
0 0 1.5 13 14 90 
O f 14 14 112 5.2 28 6.4 
0 2.0 15 15 24 4.9 8.2 
E5/day 
0 3.0 13 15 87 5.1 30 5.1 
1 1 14.0 15 122 
0 1 2.0 - 15 15 118 
0 0 2.0 13 96 6.3 29 7.4 
0 0 4.0 13 15 105 4.1 29w 6.4 
0 0 4.5 10 7 
0 0 0.5 15 16 30 5 5.6 
0 1 3.0 12 14 27 
0 0 4.0 13 15 103 5.1 30w 5.1 
3 1 4.0 14 15 34 4.4 7.3 
0 0 3.0 14 14 4 5.1 6.1 
10 0 4.0 15 15 114 5 1 28 3.9 
0 0 3.5 14 15 63 4.5 1 5.6 
0 0 4.0 15 16 26 gest. diab. 
10 1 1.5 15 15 100 5.5 28 w 5.3 
0 1 _ 11 11 107 4.3 29w 7 
0 0 3.0 14 15 89 6.1 8.8 
0 1 4.0 13 94 6 
0 1 2.0 15 35 5 8.5 
1 0 0.0 5 60 5.3 29 wks 5.5 
! pi f 
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Cord blood samples collected at birth 
NO UNIT NO HAEMOL 
YSIS 
INSULIN 
MU/1 
C-PEPTIDE 
ml 
1. (17) 2 0.19 
2. (63) 543457 <0.2 0.080 
3.64 <0.2 0.060 
4. (73) 581266 1.6 0.13 
5.21 569439 3.2 0.07 
6. (30) 449763 2.9 0.075 
7. 1.7 0.030 
8. (36) <0.2 0.040 
9. (104) 771023 <0.2 <0.02 
10.6 <0.2 0.025 
1L(39) 574048 ++ NA 6.0 0.070 
12. (20) 516357 0.5 0.050 
13. (54) 539152 <0.2 0.060 
14. (60) 454654 10.2 0.17 
15. (90) 473979 + NA 0.5 0.040 
16. (106) 522812 <0.2 0.065 
17. (115) 351491 0.5 0.050 
18.125 762227 7.6 0.075 
19.55 719813 <0.2 <0.02 
20.71 288438 2.3 0.065 
21. (19) 426481 2.9 0.12 
22. (113) 536631 6.0 0.17 
23. (50) 1.9 0.08 
24. (94) 472905 8.8 0.14 
25. (100) 392084 1.6 0.075 
26.52 569559 12 0.060 
27. (107) 579905 12.8 o. 17 
28. (78) 361802 <0.2 0.05 
29.26 569641 15 0.14 
30. (68) 578815 <0.2 0.025 
31.1 730812 ++ NA 2.9 0.075 
32.7 526533 ++ NA <0.2 0.070 
33.82 545138 0.070 
34.84 516944 3.0 0.080 
35.124 513960 <0.2 0.12 
36. (10) 316100 <0.2 0.05 
37.43 425149 <0.2 0.04 
38.128 505104 <0.2 0.14 
39.49 530166 <0.2 0.21 
40.80 714410 ++ NA 0.19 
41. (105) ++ NA 0.06 
42. (62) 468906 <0.2 0.065 
43. (58) 714629 0.5 0.075 
44(118) 479299 0.23 
45. (96) 410145 ++ NA 16.5 0.12 
46.99 522036 <0.2 0.13 
47.32 518081 1.12 0.18 
48" 23 522911 1.5 0.070 
49.42 498442 ++ NA 0.050 
50. (75) 481850 ++ NA<0.2 0.080 
51.89 GDM 316936 ++ NA 0.035 
52. (37) 467459 +++ NA 0.045 
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NO UNIT NO ILAEMOL 
YSIS 
INSULIN 
mU/1 
C-PEPTIDE 
nglml 
53. (109) 513539 ++ NA 0.030 
54. (116) 235078 3.8 0.10 
55. (4) 429048 NA 0.030 
56. (35) 741932 <0.2 0.085 
57. (45) 539149 <0.2 0.020 
58.48 265069 0.050 
59. (101) 581298 ++ NA 0.10 
60. (121) 271522 ++ NA 0.12 
61. (24) 265636 ++ NA 0.11 
62. (12) 546118 <0.2 0.070 
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sited Tics taken for the purpose of insulin sensitivity measurements. 
*: samples that were used in our study. 
No. Subject No. BMI 1st blood 2nd sample 3rd sample GTT Cord blood 
(kgfm) sample (wks) (wigs) (wigs) sample 
1 35) 42.01 - 25 35 + + 
2 (GDM) 89) 38.96 15 24 35 + + 
3 100) 36.28 - 25 36 + + 
4 114) 35.13 28 36 + - 
5 34) * 35.02 14 24 36 + - 
6 27) " 33.91 12 28 36 - + 
7 105) " 33.62 13 - 36 + + 
8 96) 33.39 13 - 38 + + 
9 118) 32.24 15 25 36 - + 
10 39) 30.09 12 - 35 + 
11 128) 29.93 14 26 34 - + 
12 110) " 29.75 13 24 36 + + 
13 (GDM) 56) 29.34 14 26 34 - + 
14 29) " 28.34 12 25 35 - - 
13 73) 28.16 13 - 36 - + 
16 49) " 27.63 14 25 35 + + 
17 58) 27.51 - 26 37 + + 
18 62) * 26.95 14 - 35 - + 
19 92) 26.61 13 25 35 - - 
20 120) 25.39 14 - 36 - - 
21 15) " 24.67 12 - 35 - - 
22 95) 24.15 14 24 - + 
23 37) 23.95 14 - 36 + + 
24 13) " 23.62 10 - 35 + 
25 14) 23.53 14 - 36 - - 
26 80) * 23.42 15 - 37 - + 
27 23) " 21.57 13 - 35 - + 
28 1) 21.50 13 - 37 - + 
29 12) 21.48 - - 37 + + 
30 116) 21.20 - 24 36 + + 
31 17) 20.02 13 - 35 + + 
32 (IGT) 45) 16.44 11 29 36 + + 
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MIDWIFE, M MED SCI IN HUMAN NUTRITION & PhD STUDENT 
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TTtLE 
LONGITUDINAL CHANGES IN BODY COMPOSITION WITH ADVANCING 
PREGNANCY AND THE RELATIONSHIP OF MATERNAL FAT DEPOSITION 
TO FETAL GROWTH: 
Obesity has long been recognised as a risk factor for the development of diabetes mellitus, 
particularly in later life and in young women it widely thought to predispose towards 
impaired glucose tolerance and gestational diabetes. Obesity is not only common but it is 
increasing in prevalence despite efforts to avoid it made by many people. We now know 
that, there is more to obesity than the actual amount of excess weight. The distribution of 
subcutaneous fat and type of obesity might have significant effects on glucose tolerance 
and insulin levels. 
In my M Med Sci dissertation (1), the prevalence of obesity among pregnant women in 
Sheffield was compared with a city in north of Iran (Tabriz). The results showed that more 
than 35% of the population under study in Sheffield were overweight or obese. This was 
contrasted with an obesity rate of 14.6% in Tabriz. 
Studies on body fat during pregnancy, have produced variable results. Hytten and Leitch 
(2), suggested that pregnant women store body fat at least up to 30 weeks gestation to 
provide an energy bank for the demands of late gestation and lactation. 
On the other hand, a study on a randomised series of pregnant, non-pregnant and 
postpartum women (3) did not show a consistent trend for fat deposition. 
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A study by Lanchoff-roos et al (4), in which maternal fat stores and fat accretion during 
pregnancy were estimated, in a small group of women, showed a wide range of maternal 
fat accretion during pregnancy, and the amount of fat accumulated was correlated to the 
total weight gain. Maternal fat accretion during pregnancy was found to have little 
relationship with the infant birthweight at term. 
A recent investigation on 22 Swedish healthy pregnant women (5), suggests that 60% of 
net pregnancy fat gain was already present at 16 gestational weeks. In that study fat gain 
was not correlated with infant birth weight. 
There are several studies on maternal body composition and outcome of pregnancy (6,7, 
8,9) but few data exist on the effect of maternal fatness on fetal metabolism. 
The present work will examine further the question of fat storage by means of a 
longitudinal study to establish changes in body fat during normal pregnancy and 
postpartum, and also its relationship to fetal metabolism, new-born anthropometry and 
early infant growth. 
The aims are to: 
1. Study Body Composition (BC) longitudinally in pregnancy and its relation to BC after 
delivery in healthy volunteers selected on the basis of initial body weight. 
2. Establish any relationship of obesity/type of obesity to Diabetes and/or Impaired 
Glucose Tolerance in late pregnancy. 
3. Investigate the metabolic status of new-born in relation to maternal body composition 
and degree of obesity, by measurements of new-born anthropometry and insulin levels of 
cord blood. 
4. Short term follow up of maternal fat distribution (6 months postpartum) in relation to 
changes seen in pregnancy and infant feeding behaviour. 
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Cohorts of normal weight, underweight, overweight and obese women will be identified 
amongst the attenders to N. G. H antenatal clinics. 
30 volunteers subjects with Body Mass Index less than 19.8 as underweight, 30 volunteers 
subjects with BMI: >26-29 as overweight, and 30 volunteers subjects with BMI more than 
29 as obese subjects will be recruited at first visit to NGH Antenatal Clinics at 10-12 
weeks gestation. In addition, 30 volunteers subjects with BMI: 19.8-26 will be recruited as 
normal weight controls. 
Women will be recruited from the antenatal clinics of all the consultants at NGH (with 
permission). 
During pregnancy, serial measurements will be made on three occasions on each patients, 
at 10-14,24-28 weeks and at 34-3 8 weeks gestational age, calculated from the date of the 
last menstrual period, confirmed by Ultrasound scanning. 
Two more measurements will be made at 6/52 and 6/12 after delivery. 
Waist and hip circumferences will be measured at first visit to identify body type of 
pregnant women. 
Body composition will be analysed by electrical impedance using EZ COMP 1500 (Body 
Composition Analyser) and skin fold thicknesses, using Harpenden Callipers, will be 
measured at 5 sites of body (triceps, biceps, sub scapular, suprailliac and mid thigh). 
A 75g oral glucose tolerance test will be performed at 28-34 weeks. 
Ten ml blood samples will be collected at the booking visit and late pregnancy (34-36) to 
measure insulin sensitivity, by an in vitro technique using cultured rat myoblasts. 
Birth weight, placental weight, new-born anthropometry (length, head circumference, ) and 
cord blood for fetal insulin levels will be assessed for each women's baby. 
Maternal BC, skin fold thickness and infant anthropometry will be performed at 6/52 and 
6/12. 
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The measurements and tests will be performed on the maternity unit at NGH. Each test 
will require 20 minutes to perform. 
An explanatory consent form will be signed. 
Travelling and child care expenses will be paid. 
DATA ANALYSIS 
Using SPSS, statistical package an Analysis of variance (ANOVA) will be made to find 
the significance of differences between the four study groups, and within the overweight & 
obese groups by type of obesity. 
The A-weight and A-fat distribution in each group will be compared in relation to 
variables such as age, parity and etc. 
The type of obesity will be characterised. 
To relate outcome of pregnancy to the different variables measured during study, we will 
use the multiple regression technique the whole group. 
ETHICAL CONSIDERATIONS 
The measurement of the body fat by Harpenden callipers and bioelectrical impedance is 
quite safe, and was the subject of an earlier successful application to this committee. 
Bioelectrical Impedance makes use of the fact that body fluids are excellent conductors of 
electrical current. This technique, uses a very small current and has been extensively 
evaluated in pregnancy and is known to be safe. 
The blood samples will be taken at the same time as routine blood check (booking visit 
and late pregnancy for Hb checking). 
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Information Sheet 
STUDY 
Project to study fat changes during pregnancy, after delivery and effects of maternal fat on 
baby growth: 
This study is important as it will help us to understand the pattern in which fat might be 
laid down in the body in pregnancy. It should help to get more information about whether 
there is a relationship with body weight and risk of diabetes when you are pregnant. 
At the first visit which is your booking visit in the Antenatal Clinics at Northern General 
Hospital, we would measure your body weight and height. Also your body composition 
will be estimated by measuring your skin thickness and using a small electrical instrument 
which will measure your body composition. This method is totally safe and will not harm 
you or your baby. 
The measurements will be repeated at 24-28 weeks and 34-3 8 weeks of your pregnancy 
and also 6 weeks and 6 months after the birth of your baby. 
Glucose Tolerance Test (GTT) will be performed at 28-34 weeks (Information sheet 
about GTT is also available). 
Blood samples will be taken as the same time as routine blood check. 
After birth blood will be taken to measure the insulin levels, this blood is not taken from 
the baby but from the after birth once it has been separated. 
Baby's weight, length, head circumferences will be measured at birth and 6 weeks and 6 
months later. 
All visits will be in Antenatal Clinics of NGH. 
Travelling and child care expenses will be paid. 
You can change your mind and withdraw from the study at any stage. 
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Hora Soltani, Midwife, M Med Sci in Human Nutrition & PhD Student 
CONSENT FORM 
STUDY: Project to study fat changes during pregnancy, after delivery and effects of 
maternal fat on baby growth: 
I have read the above information sheet and any other queries have been answered. I 
understand that I may withdraw from the study at any time. 
NAME: 
ADDRESS: 
SIGNED: 
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TEAM: 
NO. 
HOSP. NO. 
WEIGHT 
HEIGHT 
BMI 
W/H ratio 
WAIST: 
HIP: 
THIGH: 
SKINFOLDS 
TRICEPS: 
BICEPS: 
SUB SCAPULAR 
SUPRAILLIAC: 
THIGH: 
BODY COMPOSITION 
FAT%: 
LEAN%: 
FAT(Kg): 
LEAN(Kg): 
WATER. 
DATE: 
AGE 
JOB 
GP 
SMOKING 
ALCOHOL 
TIME OF LAST MEAL 
PREPREGNANCY Wt 
EDD 
GEST. AGE (BY SCAN): 
(BY DATE): 
SECOND Appt. 
THIRD Appt. 
250 
MO'THER'S NAIVE 
NO. 
TYPE OF FEEDING 
BABY'S SEX 
BIRTH WEIGHT 
PLACENTAL WEIGHT 
BABY'S GESTATIONAL AGE 
BABY'S WEIGHT 
LENGTH 
HEAD CIRCUMFERENCE 
DATE 
DATE. OF DELIVERY 
DAY OF DELIVERY 
TYPE OF DELIVERY 
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